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Thesis Overview 
 
Psychogenic  nonepileptic  seizures  (PNES)  can  be  defined  as  paroxysmal 
events  that  resemble  epileptic  seizures,  without  being  associated  with  either 
abnormal  electrical  activity  of the brain  or  primary  physiological  disturbances 
otherwise.  It  is  estimated  that  about  10%  of  new  presentations  seen  in  an 
epilepsy clinic, and up to 30% of patients with intractable epilepsy will eventually 
be diagnosed as having PNES (Benbadis & Hauser, 2000).                                     
 
Attributing a specific ‘cause’ to PNES is conceptually and clinically contentious 
but  it  seems  reasonable  to  say  that  they  represent  a  physical  expression  of 
psychological  distress  involving  behaviour  that  the  patient  finds  difficult  or 
impossible to control or disavows as being intentional. 
 
Most patients with PNES are initially thought to have epilepsy and treated with 
antiepileptic drugs (AED), sometimes for many years. Up to 40% of patients are 
inappropriately  maintained  on  AEDs  after  the  diagnosis  of  PNES  has  been 
established.  As  such,  rather  than  being  intrinsic  to  the  condition,  the  widely 
reported  poor  outcomes  associated  with  PNES  may  be  substantially 
confounded  by  continued  inappropriate  medical  management  and  iatrogenic 
harm.   
 
Withdrawing or continuing antiepileptic medication in patients with PNES could 
have important physical and psychological consequences, which may affect the 
prognosis  of  the  attack  disorder.  If  this  is  the  case,  manipulating  medication 
following the diagnosis of PNES may have a role in the management of this 
disorder. The work contained in this thesis aims to explore some aspects of the 
effects that continuing or withdrawing AED has on the course and outcome of 
PNES.  
 
Following  an  initial  general  overview  on  the  subject  of  PNES  (chapter  1),  a 
systematic  review  of  the  literature  is  presented  in  chapter  2;  the  conclusion 
being  a  lack  of  good  quality  and  reliable  evidence  for  the  effects  of  AED 
treatment in patients with PNES and a need for further original research in this 
area.  The rationale and programme of research is presented in chapter 3 
   3 
Chapter 4 presents the results of a large observational study to establish the 
feasibility  and  safety  of  supervised  AED  withdrawal  in  patients  with  an 
established diagnosis of PNES. Only 3 of the 78 patients included reported a 
new type of event requiring the reintroduction of AED, and no serious medical 
events  were  reported.  The  study  therefore  shows  that,  with  appropriate 
diagnostic investigations and surveillance during follow-up, withdrawal of AED 
can be achieved safely in patients with PNES. 
 
A  randomised  controlled  trial  presented  in  chapter  5  aims  to  evaluate  the 
potential therapeutic effect of AED withdrawal. Of the 25 subjects recruited, 14 
were randomised to immediate withdrawal (IW) and 11 to delayed withdrawal 
(DW).  Patients  randomised  to  IW  had  a  significant  reduction  in  the  use  of 
emergency treatment for PNES, and a lower proportion was found to be using 
emergency services. The IW group also had a sustained reduction of attacks 
throughout the study and by 18 months post-diagnosis 50% were attack free as 
compared with 27% in the DW group. 
 
The results of this exploratory trial suggested a possible therapeutic effect of 
AED withdrawal, with a sustained reduction of attacks following the withdrawal 
of medication, coupled with a significant reduction in health care utilisation and 
no evidence of any deterioration.  
 
The  last  original  paper  presented  in  chapter  6  investigates  the  longer  term 
psychosocial outcome of PNES with an observational study of the 25 patients 
included  in  the  RCT.  This  study  reports  a  significant  improvement  in  some 
psychological  measures;  particularly  in  illness  representations  and  mood,  as 
well as for some measures of social adjustment. 
 
The evidence presented in these three studies (chapter 4, 5 and 6) suggests 
that a clear delivery of the diagnosis of PNES, followed by AED withdrawal, is 
safe  and  has  possible  beneficial  effects  on  the  clinical  and  psychosocial 
outcome of PNES.  In particular medication withdrawal in and of itself appears 
to be a helpful concomitant in the successful removal of an inappropriate label 
of label of epilepsy, reduces the potential for iatrogenic harm, may help patients 
to shift towards a more psychologically-based explanation, and is associated 
with positive psychosocial outcomes.   4 
Finally, chapter 7 gives a summary of the main findings as well as discussing 
methodological limitations of the current research. The clinical implications of 
the evidence from this body of work are also discussed, as well as possible 
avenues for future research in the field. 
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1.1.  Definition 
 
Psychogenic  nonepilepstic  seizures  (PNES)  can  be  defined  as  paroxysmal 
events that resemble or can be mistaken for epilepsy, without being associated 
with abnormal EEG activity or primary physiological disturbance otherwise.  
 
Different  terms  have  been  used  to  describe  this  clinical  phenomenon,  from 
hysterical seizures or pseudo seizures to, dissociative seizures or nonepileptic 
attack disorder.  Up to 15 other terms have been used (Scull, 1997). Some of 
these  terms  are  seen  as  pejorative  and  unacceptable  by  patients  and  have 
been gradually abandoned (Stone et al, 2003). For the purpose of the paper we 
will use the term, psychogenic nonepileptic seizures (PNES), which is the term 
that has been most consistently used in recent papers by the main researchers 
in the field (Reuber, 2008; Duncan and Oto, 2008; La France et al, 2008). 
 
Although  not  the  specific  subject  of  this  thesis  the  difficulties  in  finding  a 
universally agreed and acceptable term for this disorder is a good illustration of 
the wider problems of “identity” of PNES (Kanner, 2003), with ongoing debate 
on questions as fundamental as whether it is a distinct disorder (Taylor, 2001; 
Wesseley  &  White  ,  2004),  what  is  the  underlying  mechanism  (Tojek  et  al., 
2000; Reuberet et al, 2003a; Goldstein et al., 2004a ; Bowman, 2006), or which 
specialist should manage these patients in the first place (Harden &  Ferrando, 
2001; O’Sullivan et al, 2006).  
 
1.2.  Epidemiology of PNES and associated harms  
 
To appreciate the impact of PNES, different aspects other than the absolute 
number have to be considered. It is important to be aware that patients with 
PNES are as disabled by this condition as patients with epilepsy, are high users 
of medical services and, as a consequence, at great risk of iatrogenic harm.  
 
Epidemiological  studies  of  PNES  are  difficult  since  most  patients  are  initially 
misdiagnosed  as  having  epilepsy  and  the  eventual  diagnosis  often  depends 
upon  the  possibility  of  PNES  being  considered  in  the  first  place.  In  one 
epidemiological study the authors noted an increase of the incidence of PNES   15 
during  the  course  of  the  study,  possibly  reflecting  an  increase  level  of 
awareness on the part of physicians (Szaflarski et al, 2000).  
 
Specific epidemiological studies of the incidence and prevalence of PNES are 
sparse but a reasonable estimate can be gained from data on the misdiagnosis 
of  epilepsy,  which  remains  a  significant  problem  (Chadwick  &  Smith,  2002). 
Good quality, community-based epidemiological studies have reported rates of 
misdiagnosis of epilepsy ranging from 20 to 26% and PNES has been found to 
be  the  second  most  common  condition  to  be  mistaken  for  epilepsy  after 
syncope (Scheepers et al, 1998; Smith et al, 1999; Zaidi et al, 2000) 
 
There are two epidemiological studies on the incidence of PNES. The first, from 
Iceland, calculated the incidence of PNES as 1.4 per 100.000, with the highest 
incidence  for  the  15  to  24  age  group.  This  study  also  estimated  that  PNES 
affects  5%  of  all  patients  newly  presenting  with  seizures  (Sigurdardottir  and 
Olafsson, 1998). The second study was based in Hamilton County in Ohio and 
estimated the mean incidence of PNES at around 3.03/100000. This study also 
reported a higher rate of epilepsy than the Icelandic study, which could explain 
difference  in  incidences  of  PNES  between  the  two  studies  (Szaflarski  et  al, 
2000). 
 
PNES are particularly prevalent in certain settings. Up to 30% of patients with 
intractable  epilepsy  referred  to  an  epilepsy  specialist  centre  for  further 
assessment will eventually be diagnosed as having PNES (as opposed to about 
10%  of  new  presentations  seen  in  an  epilepsy  clinic  (Benbadis  &  Hauser, 
2004)).  Outwith  neurology,  PNES  are  not  uncommonly  seen  in  patients 
subjected  to  acute  stressors  including  mild  head  injury  (Westbrook,  1998; 
Hudak,  2003) or after a general anaesthetic (Allen et al, 1992; Lichter et al, 
2004; Reuber et al, 2000). 
 
In marked contrast to former series, there is an emerging consensus that the 
coexistence of epilepsy and PNES is the exception rather than the rule. Recent 
research has consistently reported figures of around 10% (Martin et al, 1998; 
Benbadis et al, 2001; McKenzie et al, 2009). Although earlier studies reported a 
co-morbidity  of  epilepsy  and  PNES  as  high  as  50%  (DeTimary  et  al,  2002; 
Reuber et al, 2003b), these numbers are likely to reflect a combination of highly   16 
selected  samples  deriving  from  tertiary  referral  centres,  and  the  more  liberal 
definition  of  epilepsy  adopted  in  older  work,  in  particular  the  practice  of 
diagnosing  or  assuming  epilepsy  on  the  basis  of  non-specific  EEG 
abnormalities.  
 
Even in cases where co-morbidity is confirmed, the clinical picture is generally 
of frequent PNES in the context of well controlled epilepsy, with the exception of 
patients with learning difficulties where there tends to be a higher prevalence of 
coexisting active epilepsy (Duncan & Oto, 2008). 
 
Clinical and psychosocial outcomes are poor.  Iatrogenic factors are probably 
widespread  and  are  certainly  responsible  for  potentially  serious  adverse 
physical in particular in the context of ‘pseudostatus’ (Howell et al, 1989; Brady, 
1997;  DeToledo  et  al,  2005).  By  analogy  with  epileptic  status,  pseudostatus  
refers  to  prolonged  nonepileptic  attacks,  which  can  attract  an  erroneous 
diagnosis of epileptic status and inappropriate and aggressive treatment, often 
in an ITU setting. About 10% of patients with PNES will present in pseudostatus 
at  some  point  and  of  patients  referred  to  a  neurological  unit  with  refractory 
status, 25% will turn out to have PNES (Walker et al, 1996).  Inappropriate use 
of  intravenous  AED,  general  anaesthesia  and  intubation,  are  the  most 
immediate and serious iatrogenic harms in PNES  (Cohen et al, 1988; Howell et 
al, 1989; Pakalnis, 1991; Doretzky et al, 2006), the morbidity and mortality for 
intubated patients being  just  as high irrespective of whether the diagnosis is 
epileptic status or pseudostatus. 
 
AEDs  have  important  unwanted  effects  which  have  a  negative  impact  on 
patient’s  quality  of  life  (Morrow  et  al,  2006;  Meador  et  al,  2007)  and  acute, 
chronic and cumulative iatrogenic harm results from inappropriate prescription 
of AEDs (Benbadis, 1999; Bode et al, 2007; Duncan & Oto, 2008). The adverse 
effect profile differs greatly between AEDs, however all can produce detrimental 
cognitive side effects (Meador et al, 2007). 
 
Patients  with  PNES  also  tend  to  be  treated  with  multiple  rather  than  single 
AEDs, at higher dosages and with the newer and more expensive AEDs, all 
factors with a clear economic implication. There is evidence that patients with 
PNES  report  more  side  effects  or  allergies  as  compared  with  patients  with   17 
epilepsy. A significant number have been reported to reach toxic drug levels 
(Krumholz & Niedermeyer, 1983; Reeves et al, 1998; Hantke et al, 2007).  
 
Many AEDs are teratogenic and the risk increases with polytherapy, a feature of particular 
importance given that the majority of PNES patients are women of childbearing age on 
more than one AED (Sigurdardottir et al, 1998; Szaflarski et al, 2000). There is now 
concerning evidence that children who have been exposed to AED pre-natally have higher 
rates of developmental delay and that children exposed to Sodium Valproate in utero have 
a significantly lower IQ when compared with controls. This issue is  relevant for patients 
with PNES with an important number treated with Sodium Valporate as the attack disorder 
is often mistaken for primary generalized epilepsy (Meador et al, 2009).. 
 
The  economic  burden  of  this  disorder  is  undoubtedly  relevant  and  probably 
substantial  but  the  problems  of  definition,  prevalence  and  highly  selected 
samples  again  make  precise  estimates  difficult.  Direct  medical  costs  for  the 
average patient with PNES before diagnosis, has been estimated to be between 
$8000  and  $15000  per  month  (Martin  et  al,  1989;  Binder  &  Slinsky,  2007). 
Indirect costs and the impact on social and occupational functioning are harder 
to estimate but the cost associated with loss of work on its own is estimated as 
$22000 per patient per year (Binder et al, 2007). 
 
Unfortunately, once established reviewing an erroneous diagnosis of epilepsy is 
expensive  and  often  involves  inpatient  stays,  repetition  of  imaging  and 
prolonged EEG (Smith et al, 1999).  
 
1.3.  General characteristics of patients with PNES 
 
Patients with the diagnosis of PNES represent a heterogeneous group in terms 
of  the  aetiology  and  the  manifestation  of  the  disorder  (Leiss  et  al,  1992; 
Kalogjera-Sackellares, 1997; Cragar et al, 2005; Baslet et al, 2010), however, 
some common characteristics have been consistently reported.  
 
A  consistently reported finding  is the  over-representation  of  women amongst 
patients  with  PNES,  with  most  studies  reporting  figures  around  75% 
(Sigurdardottir et al, 1998; Szaflarski at al, 2000; Gates, 2002; DePaola et al, 
2006). The only exceptions to this are rates reported in children under the age   18 
of 12, or in older patients (Wyllie et al, 2002; Duncan et al, 2006). However 
when  compared  directly  demographic,  clinical  and  psychpathological 
associations of PNES in males and females are broadly similar apart from the 
higher number of women reporting sexual abuse (Oto et al., 2005). 
 
The reasons for this gender difference are outwith the remit of this thesis but 
have been a subject of study, comment by a variety of disciplines with PNES 
and its various equivalents in various historical and cultural milieu being cited as 
the exemplary socially constructed disease by workers from many theoretical 
backgrounds.  No  clear  conclusions  are  apparent  but  Showalter 
comprehensively covers this interesting issue in her book “The Female Malady” 
(Showalter, 1985). 
 
The age of presentation of PNES is frequently reported as between 20 and 40 
years of age. However, it is important to bear in mind that PNES can manifest at 
any age; for example they are not uncommon in children (Wyllie et al, 2002; 
Bhatia & Sapra, 2005) and have also been described in older adults (Behrouz et 
al, 2006; Duncan et al, 2006). A large percentage of children with PNES report 
psychological stressors related to school or relationships with peers (Ercan et 
al, 2003; Vincetiis et al, 2006) and a recent study of older patients with PNES 
found  lower  reports  of  abuse,  suggesting  different  aetiologies  in  different 
demographic groups (Duncan et al, 2006) 
 
High levels of comorbid psychopathology have also been reported in this group 
of  patients,  particularly  depression  and  anxiety  (Bowman  &  Markand,  1996; 
Kanner et al, 1999; Mokleby, 2002) as well as personality disorders, specifically 
borderline type (Kalogjera-Sackellares & Sackellares, 1997a; Binzer et al, 2004; 
Reuber  et  al,  2004).  The  important  issue  of  associated  psychopathology  is 
discussed in detail later on in this chapter.   
 
In summary, although patients with PNES do not conform to a single stereotype 
it can be said that younger females with high levels of psychopathology and 
past history of abuse are over represented amongst this patient group (Moore & 
Baker, 1997). 
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1.4.  Diagnosis 
 
An accurate clinical diagnosis of PNES following thorough history taking and in 
particular a direct observation of the attacks by an epilepsy specialist is possible 
in the  great majority of  cases.  (Roberts, 1998; Reuber & Elger,  2003c). The 
diagnosis  of  PNES,  however,  poses  specific  challenges,  since  most  patients 
come with a previous diagnosis of epilepsy, which may have gone unquestioned 
for many years (Reuber et al, 2002; Bodde et al., 2007; Duncan & Oto, 2008; 
Kuyk  et  al,  2008).  In  most  cases,  therefore,  the  diagnostic  process  not  only 
involves making the positive diagnosis of PNES but also removing the firmly 
attached label of epilepsy.  
 
Taking  into  account  the  above  considerations  as  well  as  the  potential 
consequences  of  a  misdiagnosis,  video  EEG  confirmation  of  the  clinical 
diagnosis  is  frequently  deemed  necessary  (Leiss  et  al,  1992;  Cragar  et  al, 
2005).  
 
As well as epilepsy, PNES must also be distinguished from other paroxysmal 
events, which are mediated by physiological or psychological causes (Roberts, 
1998). There are a number of conditions that can present with sudden changes 
of behaviour or level of consciousness; syncope being by far the most common 
but  the  differential  diagnosis  is  exceptionally  wide.  This  introduction  will  not 
expand further on the differential diagnosis of blackouts; however for a clear 
and comprehensive overview see reviews by Roberts and Benbadis (Roberts, 
1998; Benbadis, 2009). 
 
1.4.1.  Clinical diagnosis 
 
In terms of the clinical diagnosis the ictal semiology or clinical features of the 
attacks,  although  not  attracting  their  former  level  of  attention,  are  important 
aspects  of  the  diagnosis.  Several  studies  have  investigated  this  issue  and 
reported a range of clinical features that should alert clinicians to the possibility 
of  PNES.  The  most  common  clinical  features  that  distinguish  PNES  from 
epileptic attacks are listed in table 1.  It is important to recognise however that 
there is no single semiological feature pathognomonic for PNES, and that no   20 
symptom should be considered in isolation when making the clinical diagnosis 
of PNES (Leiss et al, 1992).  
 
Table 1.1: Clinical characteristics of PNES.  
PNES Characteristics
Gradual onset of attacks (Luther, 1992; Meierkord, 1991; Luther, 1992) 
 Out of phase movements (Gates, 1985)
 Side-to-side head movements (Gates, 1985; Groppel, 1999)
 Sustained eye closing (Flugel, 1996; DeToledo, 1996; Sirven & Glosser, 1998)
Undulating motor activity ( Leis, 1992)
Attacks longer than 2-5 min (Gates, 1985, Binder & Salinsky, 2007)
Quick recovery (Krumholz 1989; Leiss, 1992; Ettinger, 1999)
 
As  well  as  the  clinical  features  reported  in  Table  1,  other  symptoms  less 
commonly seen in PNES can also assist in the differential diagnosis; swooning 
attacks  (limp,  still  and  unresponsive),  purposeful  moments,  rhythmic  pelvic 
movements, responsiveness, and stuttering or weeping during the attack are all 
more commonly seen in PNES when compared with epileptic attacks (Luther et 
al, 1982; Gates et al, 1985; Meierkord et al, 1991; Bergen & Ristanovic, 1993; 
Walczak et al, 1996; Hoerth et al, 2008). 
 
Conversely,  certain  clinical  features  considered  typical  of  epilepsy  can  aften 
present  in  PNES.    These  include  autonomic  manifestations  like  tachycardia, 
flushing and sweating (Goldstein et al, 2007), incontinence and injury, including 
tongue biting (Pegero et al, 1995; Stone & Duncan, 2006) and provocation of 
attacks  by  specific  triggers  such  as  flashing  lights  (Meierkord  et  al,  1991). 
Nocturnal attacks have often been thought to be a feature of epilepsy (Roberts, 
1998) but are frequently reported in PNES (Duncan et al, 2004). 
 
As well as behaviour during the attacks, other features of patients’ behaviour 
can provide some clues and alert clinicians to the possibility of PNES. Patients 
with PNES are more likely to have attacks in medical settings (Benbadis, 2005) 
and  to  take  age-inappropriate  soft  toys  into  hospital  (Burneo,  2003).  PNES 
patients also appear to have a particular and distinct way of communicating and 
talking about their attacks that distinguishes them from patients with epilepsy 
(Schwabe et al, 2007; Plug, 2009).     21 
 
As detailed in Table 2 (overleaf) various factors in the history and background of 
patients can often indicate or support a diagnosis of PNES (Reuber & Elger, 
2003c). 
 
Table 1.2: Factors in patient background history that should raise suspicion of PNES (adapted 
from Reuber & Elger, 2003). 
Differential Characteristics PNES  Epilepsy 
Attacks started before 10 years of 
age 
Rare  Common 
Attacks in medical settings  Common  Uncommon
Recurrent “status”  Common  Uncommon 
Multiple operations and invasive 
tests 
Common  Uncommon 
Other medically unexplained 
symptoms (pain, fatigue)
Common  Uncommon 
History of sexual abuse  Common  Uncommon 
Psychiatric treatment  Common  Uncommon 
 
It is important to point out that listing sexual abuse as a common feature of 
PNES  (table  2)  is  an  oversimplification.  If  at  one  point  in  the  past  it  was 
assumed  that  sexual  abuse  was  the  causal  event  which  resulted  in  patients 
developing PNES (Betts & Boden, 1996), it is now more the case thatsexual 
abuse  is  understood  in  the  context  of,  and  as  perhaps  merely  a  particularly 
specific  marker  of;  poor  attachment,  family  dysfunction  and  emotional  and 
physical neglect. As mentioned later in this chapter, it is this neglect that results 
in  the  person’s  vulnerability  and  the  risk  of  developing  PNES  (Bowman  & 
Markand, 2005). 
 
It is also important to point out yet again that some of the features listed in table 
2 can also be features in the background of patients with epilepsy; for example, 
a  traumatic  (as  distinct  from  specifically  sexually  traumatic)  past  does  not 
appear to distinguish between patients with or without epilepsy (Berkhoff et al, 
1998; Fleisher, 2002). 
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1.4.2.  Diagnostic tests 
 
 Video  EEG  recording  of  a  typical  attack  remains  the  gold  standard.  This 
diagnostic  technique  has  high  specificity  and  sensitivity.  It  consists  of 
simultaneous video and EEG recording of typical attacks (Cragar et al, 2002; 
Cuthill & Espie, 2005). 
 
Unfortunately, Video EEG recording remains an expensive and scarce resource 
(Silva et al, 2001) but less time consuming and resource intensive diagnostic 
techniques have been proposed. Short video EEG is an outpatient test, which 
uses  activation  or  suggestion  techniques  including  photic  stimulation  and 
hyperventilation aiming to induce a typical attack. This test represents a cost-
effective,  as  well  as  an  accurate  diagnostic  technique  for  PNES,  having  a 
diagnostic  yield  of  50%  to  60  %  (Bhatia  et  al,  1997;  Srikumar  et  al,  2000; 
McGonigal, 2002a). 
 
The use of provocation techniques that aim to increase the diagnostic yield of 
video  EEG  remains  controversial  (Devinsky  &  Fisher,  1996a).  Some  authors 
consider these methods as unethical particularly when placebo is used (Gates, 
2001) but others feel that the use of induction techniques is justified in this area 
where  making  an  accurate  and  prompt  diagnosis  is  crucial  (Lancman  et  al, 
1994; Wasserman et al, 2003; McGonigal et al, 2002b). 
 
The role of other tests such as post-ictal prolactin blood levels, SPECT scan or 
personality profiles as assessed with the MMPI are limited as diagnostic tools 
since none of them has high enough sensitivity or specificity to be used alone. 
Inter-ictal or routine EEG is also of little help and can in fact be misleading since 
non  specific  abnormalities  are  common  in  the  general  population  and  their 
misinterpretation has often led to the erroneous diagnosis of epilepsy in the first 
place (DeTimary, 2002; Chadwick & Smith, 2002; Benbadis & Tatum, 2003).  
 
In summary, many studies have been undertaken to identify specific symptoms 
or psychological features that can aid the diagnosis of PNES and although no 
feature is pathognomonic an accurate clinical diagnosis of PNES is possible for 
the  majority  of  patients.  Due  to  the  intrinsic  complexities  of  this  group  of   23 
patient’s however, video EEG confirmation is often required for the definitive 
diagnosis of PNES.  
 
1.5.  Classification of PNES 
 
Several  classifications  of  PNES  have  been  suggested  over  the  years,  which 
variously  take  as  their  basis  the  semiological  characteristics  of  the  attacks, 
personality  profiles  or  an  underlying  psychosocial  mechanism  (table  1.3).  
PNES  are  classified  according  to  the  main  psychiatric  classification  systems 
ICD-10 (WHO, 1992) and DSM-IV (American Psychiatric Association, 1994) as 
dissociative disorders or somatoform conversion, respectively.  
 
Table 1.3: Criteria for different classification systems for PNES.  
1 . Classification according to main psychiatric classification (DSM-IV & ICD-10)
2 . Classification based on clinical features of PNES 
3 . Classification according to personality profiles (as assessed by MMPI)
4 . Classification according to underlying mechanism of PNES 
 
 
PNES classification, on the basis of clinical manifestation, range from simple 
dichotomous  classifications  of  convulsive  versus  non-convulsive  attacks 
(Meierkord et al, 1991; Gates, 2002) to more complex distinctions of different 
aspects of the semiology (Flugel et al, 1996). Some authors have linked certain 
clinical features with specific aetiologies or outcomes, for example Betts and 
Boden  describe  “abreactive  attacks”  in  sexually  abused  females  (Betts  & 
Boden,  1996)  and  patients  with  more  dramatic  ‘grand  mal’-like  attacks  have 
been found to have a poorer prognosis (Selwa et al,  2000; Reuber et al, 2002). 
 
The classification of PNES on the basis of clinical characteristics has limited use 
and  can  distract  from  the  main  issue  of  the  underlying  psychological 
mechanism.  Semiological  classifications  are  more  or  less  based  on  the 
classification of epileptic seizure proposed by the International League Against 
Epilepsy  (ILAE)  and  tend  to  reduce  PNES  to  a  false  or  ‘pseudo’  version  of 
‘genuine’  seizures,  rather  than  a  complex  and  highly  heterogeneous 
psychologically driven phenomenon in its own right. As Leiss et al remark in   24 
their  paper  on  diagnostic  pitfalls  ‘this  type  of  classifications  may  artificially 
produce a focused patient group when none exists’ (Leiss et al, 1992). 
 
Several authors have also attempted to classify PNES according to personality 
profiles,  mainly  with  reference  to  the  Minnesota  Multiphasic  Personality 
Inventory  (MMPI).  Although  some  studies  have  been  able  to  identify  distinct 
groups (Gumint, 1986; Cragar et al, 2005; Reuber et al., 2004) most studies 
emphasise  the  heterogeneity  of  personality  profiles  among  PNES  patients 
(Kalogjera-Sackellares, 1997a; Cragar et al, 2002). 
 
Finally  PNES  have also been classified according  to  the possible underlying 
mechanism.  Most  of  these  classifications  include  broadly  similar  categories, 
which  are  summarised  in  table  1.4.  With  this  type  of  classification  in  mind 
LaFrance and Zimmerman have designed a potentially useful semi structured 
clinical interview to categorise patients with PNES according to the underlying 
psychopathology (LaFrance & Zimmerman, 2010). 
 
Table 1.4: Classification of PNES according to suspected aetiology.  
Misinterpretation of physical symptoms Alsaadi & Marquez, 2005.
Reinforced behaviour  Ford, 1993; Alsaadi & Marquez, 2005.
Cognitive difficulties  Ford, 1993; Lesser, 2003; Alsaadi & Marquez, 2005; LaFrance, 2008.
Stressors and interpersonal difficulties  Ford, 1993; Lesser, 2003; Bowman & Markand, 1996; Alsaadi & 
Marquez, 2005.
Personality traits  Lesser, 2003.
History of trauma  Bowman & Markand, 1996; LaFrance, 2008.
Psychiatric pathology  Lesser, 2003; Alsaadi & Markand, 1996; LaFrance, 2008.
 
 
In  summary  many  authors  have  attempted  to  classify  PNES  using  different 
criteria.  The individual classification systems remain unvalidated and although 
they  contribute  towards  further  understanding  and  conceptualisation  of  this 
complex disorder they serve most to illustrate its heterogeneity.  
 
1.6.  Aetiology  
 
Major advances in the recognition and diagnosis of PNES have not translated 
into an increase of our understanding of the underlying cause of the disorder, or   25 
an effective evidence-based management (Reuber, 2008; Brooks et al, 2007). 
Part of the problem is that patients represent a heterogeneous group (Baslet et 
al, 2010) and PNES seem to be a symptom of different underlying causes rather 
than an illness in itself (LaFrance, 2008). 
 
Diagnosis with reference to the current psychiatric classification systems, DSM-
IV and ICD-10, has not been particularly useful with PNES being classified as a 
dissociative disorder under ICD-10 and a conversion disorder under DSM-IV, let 
alone the fact that many patients also fulfill the criteria for mood and anxiety 
disorders, PTSD, episodic dyscontrol or, in a minority, factitious disorder (Alper 
et al, 1995; Bowman, 2001; Fiszman et al, 2004). 
 
Dissociation  refers  to  a  disturbance  in  the  normally  integrated  functions  of 
identity, memory and consciousness, and conversion refers to a loss of function 
presumed to be of psychological origin. The issue of whether PNES are a result 
of conversion or a symptom of dissociation is a subject of controversy in some 
circles (Kuyk et al, 1996; Bowman, 1996; Brown & Trimble, 2000; Goldstein et 
al, 2000; Prueter et al, 2002) whereas yet others consider somatisation as the 
characteristic process (Alper et al, 1997; Devinsky et al, 1998; Tojek et al, 2000; 
Reuber et al, 2003a). Some authors have attempted to resolve these polarities, 
for example Harden argued that PNES are a form of dissociation which involves 
conversion-like  triggers  (Harden,  1997)  and  Bodde  et  al  pointed  out  that 
dissociation has to be seen as one mechanism rather than a cause of PNES 
(Bodde et al, 2009).  
 
Since  there  does  not  seem  to  be  a  single  mechanism  that  explains  the 
underlying cause for all patients, the conceptualisation of this disorder using a 
more general model of predisposing, precipitating and perpetuating factors as 
often applied to other functional or medically unexplained symptoms has been 
proposed as more useful for PNES (Stone et al, 2005; Reuber, 2007). 
 
This model, however, has its limitation and some aspects are difficult to fit in or 
overlap. For example, trauma can be a risk factor or a precipitating factor and 
depression can predispose or perpetuate the problem. In a recent review Bodde 
et  al  attempted  to  overcome  some  of  these  problems  by  using  a  modified 
version  which  included  shaping  factors  and  divided  predisposing  factors  into   26 
those  indicating  a  psychological  aetiology  or  conferring  a  psychological 
vulnerability (Bodde et al, 2009). 
As regards the model adopted for the purpose of this thesis, and as illustrated in 
figure 1.1, PNES are conceptualised as arising and existing within a causal 
matrix with biological, psychological and social aspects. 
 
 
 
Figure 1.1: Bio-psycho-social model of PNES   
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In  summary,  there  are  a  number  of  factors  in  the  patients’  background  that 
place them at a higher risk of developing PNES in the face of certain stressors, 
a further set of factors then determine the more or less chronic course of the 
disorder.  Very importantly, the model acknowledges that a substantial influence 
on the course is independent of the subject, in particular the response of health 
care providers. 
 
1.6.1. Predisposing factors  
 
Past  traumatic  experience  is  one  of  the  most  frequently  reported  associated 
factors; reports of childhood abuse are high amongst PNES patients and may 
be predisposing (Alper et al, 1993). A recent review paper for example found 
rates of reported trauma ranging between 40 -100% and of physical or sexual 
abuse between 23-77% (Fiszman et al, 2004). 
 
Sexual abuse was considered at one point as one of the main cause of PNES. 
However,  over  the  last  10  years  there  has  been  a  shift  towards  a  more 
nonspecific  but  possibly  more  nuanced  view  of  trauma,  with  sexual  abuse 
conceptualized  as  a  marker  of  more  severe  emotional  and  physical  neglect, 
rather than a specific toxin in itself.  Emotional and physical neglect and the 
associated  failure  of  attachment  seem  to  be  a  predisposing  feature  in  
somatoform disorders in general (Moore & Baker, 1997; Krawetz et al, 2001; 
Bowman & Markand, 2005; Reuber et al, 2007; Bakvist et al, 2009).  
 
In certain subpopulations of patients with PNES, however, reports of abuse are 
much lower and other aetiological factors appear more relevant. Patients with 
learning disabilities for example are likely to develop PNES as a direct response 
to specific stressors, and for the group of patient that develop PNES later in life, 
anxiety related to personal health or that of a close relative is often the main 
trigger (Duncan et al, 2006; Duncan et al, 2008a).  
 
Pathological personality traits are frequently found in patients with PNES, with 
reports of proportions of patients as high  as 75% to 90% fulfilling diagnostic 
criteria for personality disorder. Borderline personality disorder appears to be 
the most prominent, although avoidant and dependant personality profiles are   28 
also reported (Reuber et al., 2003a; Galimbierti et al., 2003; Bailles et al., 2004; 
Binzer et al., 2004).  
 
There  is  also  evidence  that  certain  pre-morbid  personality  traits  and  coping 
styles are associated with PNES. A relationship between PNES and alexithymia 
(inability  to  express  feelings  and  emotions)  as  assessed  by  the  Toronto 
Alexithymia scale (TAS-20) has been reported (Bewley et al, 2005) and patients 
with  PNES  also  appear  to  exhibit  disproportionate  levels  of  fear  sensitivity 
(Goldstein et al, 2000).  
 
In terms of coping styles, PNES patients tend to perceive their lives as more 
stressful when compared with epilepsy patients, and use avoidant and hostile 
coping mechanisms (Frances et al, 1999). 
 
Associated  psychopathology  can  also  been  seen  as  a  possible  predisposing 
factor, although at times it is difficult to determine whether psychopathology is 
part of the primary cause or a factor contributing to the subjects susceptibility to 
develop  PNES.  For  example,  post-traumatic  stress  disorder  (PTSD)  is 
frequently diagnosed in patients with PNES and can be seen as a cause or a 
predisposing factor, since clearly not all patients suffering with PTSD develop 
PNES  (Bowman  and  Markand,  1999;  Galimberti  et  al,  2003;  Kanner  et  al, 
1999). Rather than proposing a specific causal role for any particular psychiatric 
diagnosis, psychiatric ‘caseness’ may simply be a marker of a tendency to use 
maladaptive coping strategies such as dissociation or somatisation, these being 
likely  to  significantly  predispose  patients  to  develop  PNES  (Goldstein  et  al, 
2000; Prueter et al, 2002; Reuber et al, 2004; Lawton et al, 2009), 
 
Physical illness and disability can also contribute to someone’s vulnerability to 
develop  PNES.    Reports  of  minor  head  injury  are  common  among  PNES 
patients (Westbrook, 1998; Pakalnis, 2000). Although not as prevalent as once 
assumed patients with epilepsy (particularly in the context of learning difficulties) 
have higher rates of PNES (Lesser et al, 1983; Drake et al, 1992; Moore and 
Baker, 1997; Barnhill, 2005).    
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1.6.2. Shaping factors  
 
Many of the factors that appear to predispose patients to develop PNES also 
apply  to  other  functional  or  somatic  symptoms;  however,  why  an  individual 
patient happens to develop PNES is not clear.  
 
The  modelling  theory  is  based  on  the  fact  that  patient  presentations  mimic 
symptoms seen in others (or even themselves) and has been proposed as a 
possible explanation for a subgroup of patients. Bautista et al. found that up to 
60 % of PNES patients reported having witnessed a seizure in the past, and 
there  is  also  evidence  that  when  compared  with  patients  diagnosed  with 
epilepsy, people with PNES report higher rates of a family history of epilepsy 
(Bautista et al, 2008; Aldenkamp et al, 1997). 
 
For another group of patients a paroxysmal physiological event, for example 
syncope, or a panic attack, may be the initial event that shapes the ongoing 
attacks.  When going through the history it is not unusual in this group for the 
first event to have been a faint or a prolonged panic attack, the level of distress 
and alarm often being subsequently compounded by involvement of emergency 
services, the administration of powerful sedatives, and transfer to nigh intensity ‘ 
medical environments. The subsequent labelling of the attack as ‘epileptic’ and 
the apparent life saving intervention  of powerful medical authority, in concert 
with preexisting vulnerabilities and experience, can potently influences illness 
beliefs  and  PNES  can  quickly  evolve.  This  process  is  referred  to  as 
pathoplasticity  and  explains  how  particular  somatic  symptoms  are  shaped 
according to the medical diagnostic label given to the patient (Barsky & Borus, 
1999).  
 
1.6.3. Precipitating factors 
 
Precipitating  factors  can  be  divided  into  stressors  or  situations  that  would 
facilitate  the  attack  disorder  to  emerge  at  a  particular  time,  and  immediate 
stimuli  or  situations  that  would  predictably  trigger  attacks  in  patients  with 
established  PNES.  A  variety  of  factors  have  been  described  as  immediate 
triggers for PNES: flashing lights, tiredness or as a direct response to stress 
(Lancman et al, 1994; Benbadis, 2005).   30 
 
Stressful or traumatic life events previous to the start of the attack disorder can 
be identified in the majority of patients (Fleisher et al, 2002; Binzer et al, 2004). 
A  wide  variety  of  events  have  been  reported  as  possible  triggers  for  PNES 
including;  family  conflict,  relationship  problems,  bereavement,  abuse,  and 
money and work difficulties, amongst others (Gardner, 1982; Pakalinis, 1991; 
Moore  &  Baker,  1997;  Bowman  &  Markland,  1999;  Salomon  et  al,  2003). 
Bowman  clearly  distinguished  between;  immediate,  remote  and  contextual 
precipitating factors, and concluded that the most common mechanism seems 
to be “the reactivation of emotions of past trauma by a variety of precipitants” 
(Bowman & Markland, 1999). 
 
Physical stressors like surgery, pregnancy have also been reported (William & 
Huff, 1997; Reuber et al, 2000; Lichter et al, 2004; Collard, 2010). Toxic levels 
of  AED  have  also  been  linked  to  the  genesis  of  PNES  (Niedermeyer  et  al, 
1970).  
 
The  problem  with  most  of  this  research,  however,  is  that  the  temporal 
relationship of the event and the start of PNES are often not clearly defined and 
remote, ongoing or acute events are often reported together. Another issue is 
that  most  of  these  studies  are  not  controlled  or  compared  to  patients  with 
epilepsy, limiting their relevance. As Bowman points out, it is likely that these 
different triggers have to be been seen in the context of an individual patient’s 
vulnerability  and  past  experiences  (Bowman  &  Markland,  1999;  Bowman, 
2001).  
 
1.6.4. Perpetuating factors 
 
Having an illness can excuse patients from certain responsibilities as well as 
entitling  them  to  compensation  in  the  form  of  financial  and  practical  help.  
Secondary  gain,  the  notion  that  behaviour  is  motivated  by  explicit  material 
reward  as  well  as  implicit,  or  unacknowledged  psychic  conflict,  is  possibly 
needlessly pejorative and a substantial oversimplification of the plight of patients 
who  get  stuck  in  the  sick  role.  However,  receipt  of  enhanced  state  benefits 
could be a powerful disincentive to recovery and has certainly been reported as   31 
a factor for a poor prognosis (Kristensen & Alving, 1992; McKenzie et al, 2009, 
Sharp et al, 2010).  
 
Relatives’  beliefs  and  their  reinforcement  of  the  illness  behaviour  can  also 
perpetuate the symptoms (Sirven & Glosser, 1998; O’Malley et al, 1999). Family 
dynamics can also play an important role; families of patients with PNES have 
been  found  to  be  more  hostile  and  less  supportive  when  compared  with 
epilepsy patients (Mokleby et al, 2002; Stanhope, 2003; Lacey et al, 2007).  
 
A potentially preventable perpetuating factor is clinical iatrogenesis, since health 
care  professionals  have  an  important  role  in  magnifying  and  perpetuating 
PNES. ‘Medicalisation’ refers to the exclusive and reductive adoption of a model 
that emphasizes passivity in the face of an organic process and reliance and 
dependence  upon  medical  technology.    Medicalisation  can  have  a  powerful 
effect  on  any  patient  unfortunate  enough  to  attract  a  diagnosis  of  epilepsy, 
erroneous  or  not,  but  is  of  particularly  relevance  in  a  group  of  patients  who 
already have a tendency to interpret their attacks as unpredictable and out of 
their control and to attribute their symptoms to physical causes in the first place 
(Stone et al, 2004; Goldstein & Mellars, 2006). 
 
Patients often report feelings of anger and uncertainty following a diagnosis of 
PNES  (Green  et  al,  2004;  Carton  et  al,  2007).    These  problems  are 
considerably  compounded  by  ambiguous  management  (such  as  leaving 
patients  on  AED  following  the  diagnosis),  and  repetition  of  speculative, 
redundant or unnecessary medical tests with low diagnostic yield in a fruitless 
attempt to bring about consensus (Martin et al, 1998). 
 
In  summary,  patient  illness  perceptions  as  well  as  external  factors  that  can 
reinforce their behaviour can influence the course of PNES once established. 
 
1.7.  Management and prognosis 
 
Our knowledge of the best management strategies for PNES remains limited 
and  although  several  psychotherapeutic  interventions  have  been  described 
there is  little  evidence for any  one  in  particular (Brooks  et  al, 2007). This  is 
possibly a reflection of the fact that PNES is not a disease entity but a symptom   32 
of  a variety  of  underlying  psychological  and  psychiatric  problems  requiring  a 
range of treatments (Leiss et al, 1992; Kalogjera-Sackellares, 1997b; Cragar et 
al, 2005; Baslet et al, 2010). 
 
However,  while  acknowledging  this  therapeutic  uncertainty  the  initial 
management of PNES in terms of assessment, diagnosis, communication and 
the  withdrawal  of  iatrogenic  harm  is  a  generic  intervention  independent  of 
associated psychopathology (Shen et al, 1990; Farias et al, 2003; Thompson et 
al, 2005; Howlet et al, 2007; Hall-Patch et al, 2010).  Effective communication is 
particularly important in a group of patients who are often hostile and frequently 
report  feeling  confused  and  angry  after  the  diagnosis  (Green  et  al,  2004; 
Thompson et al, 2009).  
  
The clinician’s familiarity and confidence with  the diagnosis in this context is 
paramount since patients have generally had many contradictory explanations 
for  their  symptoms  and  usually  challenge  the  initial  diagnosis  (Harden  et  al, 
2003).  A  better  outcome  has  been  associated  with  patients’  belief  in  and 
acceptance of the diagnosis of PNES (Ettinger et al, 1999b).  
 
Communicating  the  diagnosis  in  a  clear  and  supportive  manner  is  for  some 
patients the only intervention required, and even when attacks persist there is 
evidence  that  following  a  confident  diagnosis  of  PNES  there  is  a  significant 
reduction of health care utilisation by the patients (Buchanan & Snars, 1993; 
Martin et al, 1998; Kanner et al, 1999; Farias et al, 2003).   
 
Standardised ways to communicate the diagnosis have been proposed and a 
recent  study  from  Hall-Patch  et  al.  assessed  the  acceptability  of  a 
comprehensive  communication  protocol  supported  with  written  information 
(Hall-Patch et al, 2010).  Subsequent work has this protocol to be an acceptable 
and effective component of efforts to communicate a psychological explanation 
for PNES (Shen et al, 1990; Betts & Boden, 1992). 
 
As most patients with PNES are treated with AED, withdrawing medication is 
the  next  logical  step  following  the  delivery  of  the  diagnosis.  Up  to  40%  of 
patients, however, are left on medication at this point (Benbadis, 1999; Reuber 
& Elger, 2003c; O’Sullivan et al, 2007; Hall-Patch et al, 2010). This not only   33 
places  them  at  an  increased  risk  of  iatrogenic  harm  but  also  contributes  to 
feelings of confusion following the diagnosis (Green et al, 2004). 
 
There  is  some  evidence  for  the  effectiveness  of  psychotropic  medication  in 
medically unexplained symptoms.  However in the context of PNES, although 
antidepressants,  particularly  SSRIs,  have  been  recommended  and  other 
psychotropic medication has been used, the evidence of benefit is anecdotal 
and use of psychotropic medication in PNES is indicated mostly on the basis of 
co-morbid  psychopathology  (Alper  et  al,  1997;  Reuber  &  Elger,  2003c; 
LaFrance & Devinsky, 2004).  
 
When the diagnosis of PNES is established most patients are referred on for 
further  psychological  treatment  (LaFrance  et  al,  2008)  although,  as  already 
mentioned,  there  is  little  evidence  for  any  particular  psychotherapeutic 
management  strategy  although  a  wide  variety  of  psychotherapeutic 
interventions  have  been proposed.   Behavioural  approaches,  psychodynamic 
based interventions, hypnosis, psycho education andr family therapy amongst 
others have been all described in small case series (Griffith et al, 1995; Kuyk et 
al,  1995;  Aboukasm  et  al,  1998;  Prigatano  et  al,  2002;  Zaroff  et  al,  2004; 
Kallogjera-Sackellares,  2004;  for  reviews  see  Reuber,  2003;  LaFrance  & 
Devinsky, 2004; Barry et al, 2008; Bodde et al, 2009).  
 
Of all the different interventions, Cognitive Behaviour Therapy (CBT) is the one 
that has been more systematically evaluated. LaFance et al tested the effects of 
their CBT protocol specifically designed for patients with PNES in an open label 
study  and  reported  significant  improvement  in  a  range  of  clinical  and 
psychological factors (LaFrance, 2009). Following a pilot study, Goldstein et al. 
published one of the only RCTs on treatment of PNES, they randomised 66 
patients to 12 sessions of weekly CBT or standard medical care and concluded 
that  CBT  is  more  effective  in  reducing  attack  frequency,  however  they  were 
unable to detect changes in most of their psychosocial outcomes (Goldstein et 
al, 2004; Goldstein et al, 2010).  
 
The only Cochrane review on the treatment of PNES, managed to identify three 
small randomised controlled trials, two comparing the effects of hypnotherapy   34 
and a third one comparing paradoxical intention treatment to regular Diazepam 
No overall conclusion could be reached (Brooks et al, 2007).   
 
Another  recent review found some  evidence  of better  outcomes  for inpatient 
multidisciplinary treatment strategies (LaFrance, 2007;  Kuyk et  al, 2008), but 
other authors have pointed out the importance of treating patients in their own 
environment  as  more  relevant  to  addressing  precipitating  or  perpetuating 
stressors  and  triggers  for  PNES  (Betts  &  Boden,  1992;  Buchanan  &  Snars, 
1993). 
 
Although intensive interventions appear to  result  in  attack freedom in a high 
proportion of patients in the short-term, gains tend not to be maintained and the 
majority  of  patients  relapsed  over  subsequent  follow-up  (Farias  et  al  2003; 
O’Sullivan et al, 2006) according with the fairly general finding that whatever the 
treatment modality employed only a third to a half of patients are reported to be 
attack free within two years of the diagnosis (Iriarte et al, 2003; Reuber, 2003; 
DePaola et al, 2006). 
 
The usefulness of much of the literature is somewhat diluted by doubts about 
the validity of attack freedom or reduction as an outcome. There is evidence 
that reduction or cessation of attacks, although useful as an objective clinical 
outcome  measure,  may  not  correlate  with  psychosocial  recovery  and  the 
importance of including comprehensive and relevant psychosocial measures of 
outcome has been stressed by a number of authors (Quigg et al, 2002; Reuber 
et al, 2003b; LaFrance et al, 2008).  
 
As  shown  in  table  1.5  (overleaf),  several  studies  have  reported  prognostic 
factors  for  the  outcome  in  PNES.    Methodological  problems  are  generally 
apparent (Ettinger et al, 1999b) and all that can be said with confidence is that 
measures reflecting good pre-morbid social adjustment and functioning, as well 
as lower levels of psychopathology, correlate with a better outcome. 
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Table 1.5: Studies reporting prognostic factors for PNES outcome. 
 
Study
No. 
subjects
Attack 
free
Good prognosis for NES Poor prognosis for NES
1 Aboukasm et al 1998 Therapy +feedback
by epilepsy specialist
2 Arain et al 2007 Higher education
Mostionless spells
Accompanied to clinic
3 Drake et al 1992 20 NA~
Patients with conversion improved when AED 
withdrawn
4 Ettinger et al 1999 Believing the diagnosis
In employment
Perceived good health
5 Kanner et al 1999 Personality disorder
Recurrent depression
6 Lancman  et al 1993
7 Kristensen et al 1992
8 Meierkord et al 1991 Female
Independent life
Formal psychotherapy
No coexisting epilepsy
9 O’Sullivan 2007 Resistant to psychotherapy
Impaired social function
10 Selwa 2000 Less dramatic attacks 
Shorter duration of the disorder 
11 McKenzie et al 2009 History of anxiety & depression
Receiving state benefits
12 Silva et al 2001 Independent life style
Accepting diagnosis
Low IQ
13 Violent behavior
14 Walczak 1995 Shorter duration of NES
No psychiatric disorders
61 53%
48 35%
56 51.80%
45 29%
28 45% Receiving state benefits
96 25.40%
None of the factors tested was associated 
with poor outcome
110 40%
38 16%
57 40%
187 38% Male gender
McDade & Brown 1992 18 44.40%
17 38%
51 35%
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1.8.  Conclusion 
 
This  introduction  provides  an  overview  of  the  main  aspects  of  PNES,  and 
although  informed  as  comprehensively  as  possible  by  published  evidence,  it 
must be made clear that this is not a systematic review and reflects to some 
extent the views of the author. The main objective of this chapter was to set the 
scene for the original research of the thesis. 
 
PNES are not uncommon and represent a significance problem to a variety of 
clinicians. Compared with our ability to diagnose PNES, our understanding of 
this  disorder,  in  terms  of  its  underlying  mechanisms,  and  particularly  with 
reference to treatment, remains limited.  Beyond diagnosis there is very little 
evidence for any particular therapeutic intervention and as Reuber discusses in 
his review we are left with more answers than questions (Reuber, 2008). 
 
One of the major issues in patients with PNES is the potential for iatrogenic 
harm,  largely  associated  with  AED.  In  this  area  many  questions  remain 
unanswered; Is withdrawing the medication necessary in all cases? Is it harmful 
to leave or withdraw patients’ AED? Or is AED withdrawal an intervention in its 
own right? A panel of experts intending to design a treatment trial for PNES also 
discussed all these questions (La France, 2006). The current thesis intends to 
answer  these  questions  with  a  combination  of  observational  studies  and  an 
RCT on the effects of AED withdrawal. 
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Chapter 2: 
 
 
Does discontinuation of antiepileptic drugs affect the outcome of nonepileptic 
seizures? A systematic review of the literature.  
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2.1. Abstract 
 
Background:  Psychogenic  nonepileptic  seizures  (PNES)  are  psychologically 
mediated  attacks  that  resemble  and  are  often  mistaken  for  epilepsy.  Most 
patients  are  initially  treated  with  antiepileptic  drugs  (AED)  and  a  significant 
proportion continue to receive this medication after the diagnosis of PNES has 
been confirmed. Continuing antiepileptic medication in patients with PNES may 
have important physical and psychological consequences and may affect the 
prognosis of this disorder. 
 
Objectives:  To  review  the  current  literature  for  any  evidence  of  an  effect  of 
continuation of AED treatment on the outcome of PNES. 
 
Methods: Search strategy; Ovid MEDLINE (to Aug 2009), EMBASE (Oct 2009), 
PsycINFO (Oct 2009), Cochrane database of systematic reviews. According to 
our selection criteria; English language studies of adults with PNES containing 
data on the impact of AED on the prognosis, were included. 
 
Results: The search identified 3 observational studies, two of which reported the 
continuation of AED as having a negative effect on the outcome and a third no 
effect. All of the selected studies had important methodological limitations. 
 
Conclusions: Because of the limited quality of the selected studies it was not 
possible  to  conclude  that  there  is  a  correlation  between  taking  AED  and  an 
adverse  outcome.  A  randomised  controlled  trial  would  be  the  only  way  to 
establish if  withdrawing  AED  at diagnosis contributes to  a  better outcome in 
patients with PNES.  
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2.2. Introduction 
 
Psychogenic  non-epileptic  seizures  (PNES)  may  be  defined  as  paroxysmal 
events  that  resemble  and/or  are  treated  as  epileptic  seizures  without  being 
associated with any measurable alteration in the electrical activity of the brain 
and are thought to have a psychological underlying cause. Outcome is often 
reported as poor but there is little evidence-based knowledge on how best to 
treat this disorder.  
 
Most patients with PNES are diagnosed with epilepsy and therefore treated with 
AED, sometimes for many years (Benbadis, 1999; Bode et al, 2007; Duncan & 
Oto,  2008).  As  described  in  chapter  1  (page16),  the  effect  of  inappropriate 
prescription  in this  population  has been increasingly recognized,  investigated 
and  reported.    Specific  maladaptive  patterns  of  medication  taking,  possible 
unrecognised psychotropic effects of AED, and the impact that taking AED may 
have on the patient’s understanding of their disorder have  been described or 
proposed (Reeves et al, 1998; Hantke et al, 2007; LaFrance et al, 2006; Carton 
et al, 2003) . 
 
The role of AED in the diagnosis of PNES has been frequently reported in the 
literature. For example, a lack of response to AED and higher reports of side 
effects  support  the  diagnosis  of  PNES  as  opposed  to  epilepsy  (Bowman  & 
Coons, 2000; Hantke et al, 2007). There is also some anecdotal evidence to 
suggest  that  AED  can  be  implicated  in  the  genesis  of  PNES  and  possible 
mechanisms have been proposed; from forced normalisation, AED toxicity or 
the consequence of an idiosyncratic side effect (Trimble, 1996; Neidermeyer et 
al, 1970; Weaver, 2004). 
 
Although  tapering  AED  after  diagnosis  is  recommended  as  being  part  of 
treatment as usual for PNES (LaFrance, 2008) up to 40% of patients with PNES 
continue to be prescribed AED after the diagnosis is established.  This in itself 
may adversely influence the  outcome (Reuber et al,  2003a; O’Sullivan  et al, 
2007). 
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Withdrawing or continuing antiepileptic medication in patients with PNES can 
therefore have important physical and psychological consequences, which may 
affect  the  prognosis  of  the  attack  disorder.  If  this  is  the  case  manipulating 
medication  following  the  diagnosis  of  PNES  could  have  a  role  in  the 
management of the disorder. 
 
Our hypothesis is that withdrawing medication after the diagnosis of PNES is a 
congruent and important therapeutic step in management, with positive effects 
on the outcome. 
 
The purpose of this paper is to review the current literature for evidence about 
the effect of taking AED on the outcome of PNES.  
 
2.3. Methodology 
 
Research question:  
 
Does  discontinuation  of  antiepileptic  drugs  influence  the  outcome  of 
nonepileptic seizures?  
 
Search strategy: 
 
The electronic search included the following databases Ovid MEDLINE (to Aug 
2009),  EMBASE  (Oct  2009),  PsycINFO  (Oct  2009),  Cochrane  database  of 
systematic reviews. 
  
The  search  terms  included  [Pseudoseizure$],  [Pseudoepilepsy]  or 
[Hysteroepilepsy]  [Nonepileptic],  [dissociative],  [hysterical],  [conversion]  or 
[psychogenic  ]  combined  with  [  seizure  ]  or  [attack]  combined  or  not  with 
[disorder]. 
 
The above search was linked to the terms [Antiepileptic drug$], [Antiepileptic 
medication] and [Anticonvulsant$]. 
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The references of several review articles identified through the search were also 
examined in order to identify further relevant studies and improve the sensitivity 
of our search. 
 
2.4. Data collection and analysis  
 
Inclusion criteria:  
 
·  Papers where the study population had the diagnosis of PNES 
·  Studies including data on AED, particularly on its effects on course and 
prognosis of PNES  
·  Studies written in English  
·  Studies including adult populations only 
 
Assessment of the quality of the studies   
 
To our knowledge there are no rating scales to assess the quality of outcome 
studies on PNES. We have therefore designed a scale based on a suggested 
checklist of items that should be included in reports of observational studies by 
the STROBE statement and suggestions from a Consensus statement on the 
characteristics of a clinical trial on outcome measures for PNES (La France et 
al, 2006).  
 
A study of PNES ideally will include only patients with video EEG confirmation 
of the  diagnosis  and  exclude patients  with  coexisting epilepsy.  The  outcome 
measures  should  include  psychosocial  outcomes  with  a  follow  up  time  of  at 
least 12 months to be sensitive to changes of all outcomes. In terms of sample 
size we considered a sample that at least would be able to detect (or exclude) a 
large effect. 
 
Our 14 point scale (see appendix A) combined generic methodological points as 
well as specific issues for PNES (LaFrance et al, 2006). 
 
The checklist from the STROBE statement (appendix B) was also used as a 
template for the methodological review of the individual papers.   42 
2.4.1. Selection of studies 
 
The search yielded 194 citations in total. The author inspected all the citations 
identified  from  the  search  and  selected  20  relevant  studies  of  patients  with 
PNES that reported prognostic factors.  These papers were fully inspected for 
inclusion criteria by the author and a research assistant independently and in 
case of disagreement, a decision was reached by discussion. Of the 20 papers, 
two  were  reviews  and  therefore  not  included  and  14  had  no  data  on 
continuation of AED as a prognostic factor.                                                                                                                  
 
No  randomised  controlled  trials  were  identified.  Of  the  studies  containing 
outcome  data  we  found  four  observational  studies  that  had  data  correlating 
outcome of PNES with taking AED’s. Two of these studies were based on the 
same sample and methodology therefore we have reported them together. 
 
For the break down of selected papers see the flow chart below. 
 
Figure 2.1: Flow-chart of paper selection for review. 
 
   
 
Initial search 
194 papers identified 
 
 
PNES + prognosis data 
papers 18 
 
 
Excluded: 174/194: 
-84 unrelated to PNES 
-10 pediatric population 
-80 no data on prognosis 
SELECTED PAPERS: 3 
Continuation of AED as a prognostic factor 
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2.5. Results  
 
2.5.1. Summary of the rejected studies  
 
Of the relevant studies, 14/18 were not included since they contained no data 
on continuation of AED as a prognostic factor (see table 2.1).  
 
Table 2.1: Description of rejected studies. 
 
No. Subjects AED At diagnosis AED At follow up Attack Free Good Prognosis for NES Poor Prognosis for NES
Aboukasm et al 1998 61 63.90% 22.90% 53% Therapy +feedback
by epilepsy specialist
Arain et al 2007 48 85% 100% 35% Higher education
Mostionless spells
Accompanied to clinic
Drake et al 1992 20 100% NR NA~
Patients with conversion 
improved when AED withdrawn
Ettinger et al 1999 56 48.20% 32.40% 51.80% Believing the diagnosis
In employment
Perceived good health
Kanner et al 1999 45 NR NR 29% Personality disorder
Recurrent depression
Chronic abuse
Lancman  et al 1993 93 53.80% NR 25.40%
None of the factors tested 
was associated with poor 
outcome
Kristensen et al 1992
Meierkord et al 1991 110 NR NR 40% Female
(majority ) Independent life
Formal psychotherapy
No coexisting epilepsy
O’Sullivan 2007 38 1.5 +/-1.4 35% 16% Resistant to psychotherapy
(mean number ) Impaired social function
McKenzie et al 2009 187 52% 13.2%* 38% Male gender
History of anxiety & 
depression
Receiving state benefits
Silva et al 2001 17 72.70% 36.30% 38% Independent life style
Accepting diagnosis
McDade & Brown 1992 18 1.88 NR* 44.40% Low IQ
(mean number) Violent behavior
Walczak 1995 51 38/51(74.5%) 53% 35% Shorter duration of NES
No psychiatric disorders
Selwa et al 2000 57 NR 32% 40%
Shorter duration of the disorder, 
Less dramatic attacks 
*Intent to withdraw AED reported
NR = not reported
Receiving state benefits 28 86% 62.50% 45%
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 All  these  studies  were  observational  and  from  tertiary  referral  centres.  As 
shown in table 2.1, samples size ranged from 18 to 187 subjects and the follow 
up times varied from days to years, not only between studies but also within 
subjects as individual studies report a wide range of follow-up lengths amongst 
patients. 
 
As is detailed in table 2.1, in terms of prognosis, most papers report measures 
reflecting independent life style and social adjustment of the subjects as positive 
prognostic factors. On the other hand, receiving state benefits, the chronicity of 
the  disorder  and  high  level  of  psychopathology  are  correlated  with  poor 
prognosis, with the exception of the two larger studies that found no relationship 
with chronicity and attack freedom.  
 
In terms of the number of patients exposed to AED, most studies report high 
percentage at diagnosis, however not all studies report the number of patients 
continuing on AED at follow up. Only two studies make reference to the number 
of patients who are attack free and not on AED.  Buchanan et al. found that the 
less chronic group, with a high percentage of attack free patients at follow up, 
are less likely to be on AED; and Drake reports an improvement of all patients 
with conversion disorder (n=10) following the withdrawal of medication.  
 
In the study by Arain et al, medication was withdrawn in all patients following the 
explanation  of  the  diagnosis.  At  follow  up  (time  was  not  specified),  35%  of 
patients were attack free.  
 
The  study  by  O’Sullivan  et  al  also  considered  the  possibility  of  different 
outcomes  between  subjects  taking  AED  with,  or  without,  mood  stabilising 
effects, and found no significant difference in a range of psychosocial outcome 
measures. The same authors also found that males were more likely to be on 
AED before and after the diagnosis.  
 
2.5.2. Selected studies: Description of selected studies  
Two of the 4 selected papers, presented different outcome data from the same 
study and are therefore described together (see table 2.2 for description of 
studies and table 2.3 for assessment of quality criteria).  
Table 2.2: Description of selected studies. 
 
 
Sample Follow up
Design Population N
Epilepsy 
included
% Video 
EEG 
diagnosis
Response 
rate Management
Folllow-up: 
Years (sd)
% Attack 
free
AED at 
diagnosis
% ongoing 
AED
Continuation 
of AED effect 
on outcome
Predictors of 
good outcome
Predictors of poor 
outcome
Carton et 
al 2003
Postal 
questionnaire 
Cohort
Specialist 
centre
84 No NR
84/115 
(73%)
No Treatment 
Protocol
4.7(NR)* 28% NR 32% Negative
Employed, 
reaction to 
diagnosis (relief 
of not having 
epilepsy) 
Continuation of 
AED, reaction to 
diagnosis 
(confusion or 
anger)
Bode et al 
2007
Phone 
questionnaire 
cohort
Specialist 
centre
21 No 100%
22/28 
(78.5%)
No Treatment 
Protocol
4.7(1.3) 47.6%* 13.50% NR No effect
Higer education, 
younger onset of 
NES, less 
dramatic attacks
Higer scores on 
dissociation, 
higher scores on 
personality traits 
(inhibitedness, 
emotional 
dysregulation & 
impulsivity)  
Reuber et 
al 2003
Postal 
questionnaire 
cohort
Specialist 
centre
164 Yes 55.40%
164/329 
(49.8%)
No Treatment 
Protocol
4.1 (3) 28.60% 75% 40.70% Negative -
Associated 
psychopathology, 
high scores of self-
avoudant 
behaviour 
*4 to 6 years   NR, not reported   
 
 
 
            45 2.5.3. Paper 1- Non-epileptic seizures: patients' understanding and reaction to 
the diagnosis and impact on outcome. (Carton, S., Thompson, P.J. & Duncan, 
J.S)  
 
This was an open non randomised postal questionnaire study  of 84 patients 
with confirmed PNES without coexisting epilepsy, seen at an epilepsy specialist 
centre and reviewed 6 months to 7 years following the diagnosis. 
 
Patients answered a semi structured interview over the phone and demographic 
information was sourced from medical notes. A short questionnaire was also 
sent to their GP’s. 
 
The main outcome of the study was attack freedom, and the prognostic factors 
considered in the paper related to the understanding of, and reaction to, the 
diagnosis  of  PNES  by  the  patient.  The  authors  also  considered  prognostic 
factors previously reported in the literature, which they grouped into precipitating 
factors, negative impact of PNES on daily life, and psychological follow up. 
 
The sample was drawn from 115 patients diagnosed with PNES only during an 
inpatient assessment at a tertiary referral centre over a period of 8 years. 
 
The follow up period ranged between 6 month to 7 years and the length of the 
disorder ranged between 1 month to 41 years (no data on standard deviation 
were given). 
 
By the end of the study, 28% of patients were seizure free and a further 48% 
reported a >50% reduction of attacks, almost a third of patients (32%) remained 
on AED. Only a third of the patients had some understanding of the diagnosis of 
PNES and the most common reaction to diagnosis was confusion. 
  
In terms of prognostic factors patients who; continued the AED (p<0.0001), or 
had  described  confusion  (p<0.001),  or  anger  (p<0.002)  at  the  diagnosis  of 
PNES, were more likely to continue to have attacks. Conversely, patients who 
reported relief following the diagnosis of PNES (p<0.0001), or were employed 
(p< 0.009), were more likely to be attack free.  
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Methodological quality   
 
The  introduction  of  the  paper  contained  good  background  information  and 
clearly  stated  the  objectives  of  the  study,  however  did  not  specify  the  main 
hypothesis. 
 
For the study design a combination of qualitative and quantitative methods was 
used and this was clearly described. The settings and data collection were also 
well described. 
 
The sample came from the inpatient population of a tertiary referral centre which 
makes it comparable to most of the published studies on PNES; however, the 
population may not be representative of patients selected from the community, 
or a general practice setting. 
 
It is unclear how the 115 patients were selected; whether they were consecutive 
or what percentage of the total number of patients assessed they represented. 
 
The  eligibility  criteria  of  the  participants  appeared  clear,  patients  had  an 
unequivocal diagnosis of PNES; however, the percentage of patients with video 
EEG confirmation, which was one of our quality criteria, as shown in table 2.3, 
was not reported. 
 
Another  point  in  our  quality  criteria  scale  was  the  exclusion  of  patients  with 
epilepsy,  and  although  that  was  the  case  for  this  study,  the  authors  did  not 
define the criteria for the diagnosis of epilepsy. 
 
The outcome variables were clearly described and steps were taken to ensure 
precise  and  unbiased  measurement.  This  was  achieved  by  combining  self 
report  with  GP  data  and  by  assessing  inter-rater  reliability  for  the  qualitative 
data.  The  prognostic  factors  were  also  fully  defined  and  appropriate  to  the 
objectives of the study. 
 
The  sample  was  also  well  described  and  the  characteristics  comparable  to 
samples  of  other  similar  studies.  The  rest  of  the  results  were  also  clearly   48 
presented  and  although  the  outcome  data  is  quantitative,  some  appropriate 
qualitative data is presented. 
 
Simple and appropriate statistical tests were used; however, multiple testing, 
particularly considering the small sample, was an issue. 
 
One  of  the  main  drawbacks  of  the  paper  is  the  lack  of  definition  or 
standardisation of the intervention. It is not clear whether all patients had the 
same  type  of  assessment,  or  how  and  by  whom  the  diagnosis  was 
communicated. Considering that the main objective of the study was to assess 
the reaction and impact of diagnosis, the above points are particularly relevant 
since there is evidence that the initial intervention of delivering the diagnosis is 
very important and can influence the prognosis (Ettinger et al, 1999b).  
 
Another important factor that can affect prognosis, and was not accounted for in 
this  paper,  was  the  chronicity  of  the  disorder,  which  varied  greatly  between 
patients from months to years.  
 
The  type  of  psychological  intervention  that  patients  received  was  not  clearly 
described, however it appears that there was not a standard approach for all 
subjects and the length of the intervention also varied widely. 
 
The above points were potential sources of bias particularly in this study were 
the  outcome  of  interest  was  the  understanding  of,  and  reaction  to,  the 
diagnosis.  
 
Another  important  point  when  considering  the  quality  of  the  study  is  the 
homogeneity of the subjects in terms of follow-up times. The length of follow up 
varied widely from 6 months, which would be considered short term, to 7 years, 
which is obviously long term. There is evidence that short term outcome is more 
favourable and this is also not taken into consideration in the present study. 
 
In  terms  of  the  rating  of  the  methodological  quality,  this  paper  scored  the 
highest  (table  2.3);  however,  as  with  most  studies  in  the  field,  important 
interventions are not standardised and although that was only one of our points   49 
in our quality checklist, this represents a particularly important point when trying 
to interpret the results. 
  
Table 2.3: Quality criteria for selected studies.  
Carton et al  Reuber et al  Bodde et al
Representative sample 
Explicit inclusion criteria  X X X
Coexisting epilepsy excluded X X
Avoid patient selection bias  X X X
Video EEG diagnosis X
Similar disease length 
Sample size > 75 X X
Sufficient length of follow up  X X
Similar length of follow up 
Drop out rate <40% X X
Standardized intervention
Valid outcome measures  X X
Clearly stated outcome 
measures 
X X
Objective measure of outcome  X X X
Final score  8/14(57%) 7/14(50%) 7/14(50%)
 
  
2.5.4.  Paper  2-,  Factors  involved  in  the  long-term  prognosis  of  psychogenic 
nonepileptic  seizures.  (Bodde,N.M.G.,  Janssen,A.M.A.J.,  Theuns,  C., 
Vanhoutvin, J.F.G., Boon, P.A.J.M. and Aldenkamp, A.P). 
 
This was a prospective observational study of 22 patients with confirmed PNES 
and  no  associated  epilepsy,  assessed  at  baseline  and  4  to  6  years  post-
diagnosis with an average of 4.7 years post diagnosis (SD 1.3). 
 
The  aim  of  the  study  was  to  investigate  factors  involved  in  the  long-term 
prognosis of PNES. Improvement was defined as any reduction in attacks from 
baseline.  
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As outcome measures, the authors included self reported attack frequency, and 
psychological rating scales including the Symptom Check List, The Dissociative 
Questionnaire and the MMPI. 
 
Out of the 22 patients included in the study 86.4% were female; the average 
age was 30.4 years (range 15- 49); and there was an average diagnostic delay 
of 7.2 years. At baseline only 13.5% of patients were on AED and 41% reported 
daily attacks. At follow up, 7/22 (31.8%) of the sample had been attack free for 
at least one year. 
 
No  relationship  was  found  between  attack  reduction  and  any  of  the 
demographic or clinical data at baseline, including use of AED’s. 
 
Linear  regression,  used  to  analyse  possible  psychological  predicting  factors, 
showed that higher psychopathology and self-avoidant behaviour predicted poor 
improvement. No association was found between any specific personality profile 
and improvement. 
 
Methodological quality  
 
In the introduction of the paper the reasoning behind the study was explained 
together  with  clear  background  information;  however,  the  specific  objectives 
were not clearly stated and there was no hypothesis defined. 
 
The  study  design  was  not  fully  described  and  the  ‘settings’  were  unclear, 
particularly information on how and by whom the patients were assessed, and 
on how the data was collected. The eligibility criteria for the subjects were clear 
with  precisely  described  diagnostic  standards  and  a  good  description  of  the 
instruments used to measure outcomes.  
 
The  objective  of  the  study  was  to  investigate  possible  associations  between 
attack reduction and a series of measures. The way the results were presented, 
however,  was  confusing:  it  was  not  clear  which  were  the  important  or  most 
relevant  findings  and  some  of  the  outcome  data  was  reported  for  the  whole 
group rather than comparing the good and poor outcome subjects. 
   51 
For our quality checklist the sample had to be greater than 75 and the sample of 
this  study  was  much  smaller  (n=22).  The  small  sample  size  was  particularly 
problematic considering the amounts of statistical tests that were performed. 
 
From the point of view of association between AED and outcome, the fact that 
the number of patients on AED was very small, and the majority of patients had 
a reduction of attack frequency, a negative result should be viewed with caution. 
 
As  shown in  table 2.3,  the lack of valid outcome measures  was an issue in 
terms  of  the  quality  of  the  study.  The  author’s  definition  of  a  good  outcome 
included any reduction of attacks from baseline, which cannot be considered a 
good outcome in itself since most published studies show a reduction of attacks 
following  diagnosis,  regardless  of  intervention  (Bodde  et  al,  2007).  We  can 
argue, therefore, that some of these patients did not in fact have a clinically 
meaningful change, and that a minimum reduction of 50% of attacks, as used in 
many  studies,  would  have  been  more  relevant  as  an  outcome  measure  of 
improvement. 
 
Another measure with questionable validity is the use of the MMPI to assess 
changes in psychological symptoms. The MMPI is a personality inventory, and 
since personality, by definition, is a set of reasonably stable traits, a different 
scale designed to assess changes particularly in such a short time-frame would 
have been more appropriate. 
 
The discussion of this paper suggests that the good outcome of the study in 
terms of attack freedom may have been a result of the impact of the diagnostic 
process and delivery. The problem is that there is no evidence in the paper that 
there was any standardised or agreed procedure for delivering the diagnosis 
and therefore it does not appear that all subjects had the same intervention. 
From this point of view an association cannot be made. 
      
The main weaknesses of this paper, in terms of methodological quality, were 
the small sample size and the fact that the main outcome measure was not valid 
to assess improvement of PNES.  
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2.5.5. Paper 3(a)- Outcome in psychogenic nonepileptic seizures: 1 to 10-year 
follow-up in 164 patients. (Reuber M., Pukrop R., Bauer  J., Helmstaedter C., 
Tessendorf N., Elgar C.E.)  
 
This study was a postal questionnaire on the long term outcome of PNES with 
or without epilepsy. Of the 329 patients identified from a tertiary referral centre 
database, 164(49.8%) responded. 
 
The aim of the study was to identify clinical and psychological factors that may 
predict the outcome of patients with PNES. Outcome measures included; attack 
freedom,  social  adjustment,  personality  traits  and  level  of  psychopathology. 
Patients were grouped into good, intermediate or poor outcome according to 
attack freedom and level of social functioning.  
 
Of the 164 responders, 130 (79.3%) were women and only a minority had been 
in higher education. The mean age was 38.6 (sd: 14) and the mean duration of 
follow up was 4.1 (sd: 3) years.    
 
Following the diagnosis, patients were managed by the local referring team. A 
high number were treated as inpatients; 68(41.5%) on a psychiatric ward and 
134(81.9 %) in a neurology ward. 
 
At  follow  up  43.9%  of  patients  had  a  “poor”  outcome  and  only  16.2%  were 
considered to have a good global outcome which implied being attack free and 
working. The majority of subjects, 116 (71.2%), continued to have attacks and 
66 (40.5%) were still dependant. 
 
In  terms  of  factors  predicting  outcome;  younger  age,  higher  educational 
attainment,  less  dramatic  attacks,  few  somatoform  complaints  and  low 
dissociation scores had a better prognosis. 
 
Lower levels of psychopathology and low scores on the personality dimensions 
of  inhibitedness,  emotional  dysregulation,  and  compulsivity,  also  predicted  a 
better outcome. 
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In terms of the effects of AED on outcome, the authors report that in patients 
with  PNES  only,  the  continuation  of  AED  is  associated  with  persistence  of 
attacks and inability to lead an independent life. 
 
Methodological quality  
  
The  background  and  objectives  of  this  study  were  clearly  explained  in  the 
introduction; specific research questions, study design and different time lines 
were well described. 
 
In terms of eligibility, the diagnostic criteria for epilepsy and PNES were clear, 
however,  only  just  over  half  of  the  subjects  had  the  diagnosis  of  PNES 
confirmed by video-EEG, although alternative measures were taken to ensure 
patients had as accurate a diagnosis as possible.  
 
A potential source of systematic error in the study was the high percentage of 
patients  that  had  the  coexisting  diagnosis  of  epilepsy.  From  a  postal 
questionnaire it would be impossible to determine what kind of attack was being 
reported by the subjects, whether epileptic or not.  
 
The reasons for choosing specific outcome measures were clearly argued and 
the different sources of data well described. There was no evidence, however, 
that there was a system in place to minimise bias when placing subjects into the 
different outcome groups. 
 
The management of a large proportion of subjects as inpatients with PNES is 
unusual and probably reflects the characteristics of the German health service. 
The majority of subjects were treated as in-patients, some under neurologists 
and others in psychiatric units. From a methodological quality point of view there 
was also no evidence that any specific treatment protocol had been used. 
 
The statistical tests used are appropriate and well described and the analysis 
addressed the issue of multiple testing. 
 
The number and characteristics of participants at each stage of the study were 
clearly reported. As shown in table 2.2, one of the main problems of the study   54 
was the number of responders, which was lower than 60%. Although, in terms 
of basic clinical and demographic data, responders appear similar to patients 
lost  to  follow  up,  the  two  groups  could  have  been  very  different  in  terms  of 
outcomes and psychological profile. 
 
Considering  the  large  amount  of  data  presented  the  results  were  clear  with 
helpful tables illustrating the main findings.  
 
The discussion clearly summarised the main findings as well as acknowledging 
the limitation and potential bias of the paper. 
  
2.5.6.  Paper  3(b)-  Measuring  outcome  in  psychogenic  nonepileptic  seizures: 
how relevant is seizure remission? (Reuber M., Mitchell A.J., Howlett S, Elger 
C.E).  
 
This was another study from the postal questionnaire with the same data and 
sample but a different research question. The aim of this second paper was to 
investigate  the  validity  of  attack  remission  as  a  single  outcome  measure  by 
investigating the correlation between attack freedom and social adjustment. The 
study  found  that  attack  freedom  could  not  be  used  as  a  comprehensive 
measure of a good outcome. 
 
This  study  only  included  patients  with  PNES  only  and  investigated  potential 
differences between patients in remission or not at follow up. It was found that 
patients in remission were as likely as patients that continued to have attacks to 
remain  on  AED.  This  was  a  direct  comparison  between  the  relevant  groups 
(n=86) using the Chi square, a more robust test than the one used in the original 
paper  where  the  authors  looked  for  significant  relationships  between  many 
factors including persistence of AED and three different outcome categories . 
 
2.6. Discussion  
 
The papers included in the present systematic review are all observational and 
from that point of view none of the studies are protected against bias. As shown 
in table 2.3, all samples were drawn from tertiary referral centres and therefore 
from a highly selected population.   55 
 
None of the studies provided a scientific rationale for the chosen sample size. 
For  the  purpose  of  quality  assessment,  we  chose  the  cut-off  of  75  subjects 
which  by  general  convention  is  sufficient  to  detect  a  moderate  effect  size 
(Cohen, 1992).  However this was only a rule of thumb as there was substantial 
heterogeneity  of  patients  and  clinical  settings  and  no  study  was  specifically 
powered to detect changes in outcome between patients who remained on or 
off AED. 
 
In terms of the validity of the studies, factors other than the absolute sample 
size also need to be considered. For our methodological quality criteria, a good 
study  would  only  include  patents  with  video  EEG  confirmation  of  PNES  and 
exclude patients with co-morbid epilepsy (table 2.3). In the study by Reuber et 
al., only 55% of the sample had the diagnosis confirmed by video EEG, and 
60%  had  coexisting  epilepsy  -  resulting  in  a  much  smaller,  valid  sample. 
Conversely, the study by Bode et al, has the smallest, though ‘purest’, sample 
from  this  point  of  view,  since  all  patients  had  video  EEG  confirmation  and 
subjects with coexisting epilepsy were excluded. 
 
Response  bias  is  also  an  issue  for  the  paper  by  Reuber  et  al.,  where  the 
response rate was less than 50% compared with the almost 80% from the study 
by Bode et al. 
 
The variability on the length of follow up times, within subjects, varied between 
months to several years in all three papers. There is evidence that outcomes 
are better in the short term (months to two years) and that studies with follow up 
times over 5 years report worse results, particularly for psychosocial outcomes 
(Farias et al, 2003; O’Sullivan et al, 2006). 
 
As shown in table 2.3 another of our quality criteria was whether the length of 
follow up was long enough to detect changes for all the outcomes of interest. 
Changes in mood or attack frequency can be detected at a shorter follow-up, 
compared to vocational status or medical disability, which may take years. The 
paper by Carton et al included patients from 6 months after the diagnosis, which 
is probably too short and, although the other two studies assessed patients at   56 
least a year after the diagnosis, there was large variability in the length of follow 
up within samples. 
 
A common problem and one of the main weaknesses of the three papers is the 
lack  of  definition  and  standardisation  of  the  intervention.  There  was  no 
management protocol in any of the studies, with high variability in how subjects 
were  managed  within  and  between  studies.  Considering  that  these  were 
outcome  studies,  the  fact  that  only  some  patients  may  have  had  potentially 
effective interventions makes the interpretation of results difficult. 
 
When evaluating and weighing up the different studies, the issue of outcome in 
patients with PNES is complicated by the fact that there is no clear definition of 
what  constitutes  a  good  outcome.  There  is  increasing  evidence  that  attack 
reduction or even attack freedom is not valid as the only measure of a good 
outcome; and that more comprehensive measures, taking into account social 
adjustment and psychological  status,  have  more  validity  when assessing  the 
outcome  of  patients  with  PNES  (Reuber  et  al,  2005;  Quigg  et  al,  2002; 
LaFrance et al, 2006).  
  
Reuber  et  al’s  definition  of  a  good  outcome  was  clear  and  comprehensive, 
including measures of social adjustment. In contrast, Bode et al. defined a good 
outcome  as  any  reduction  in  attacks,  which  cannot  be  considered  a  valid 
measure  since  most  outcome  studies  report  reduction  of  attack  frequency 
following the diagnosis. Most patients with a good outcome in this latter paper 
would be classified as having a poor outcome in the other two studies.  
 
Another  factor  that  will  affect  the  validity  of  the  selected  studies  is  the 
percentage of patients on AED, since this is our outcome of interest. From this 
point of view, the selected sample by Bodde et al. had only 3/22 (15%) patients 
on  medication,  which  clearly  affects  the  power  to  detect  any  significant 
differences in terms of outcome of patients on or off AED.  
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2.7. Summary  
 
Of the three selected papers for the present systematic review, the two largest 
studies report an association between continuing AED and a poor outcome of 
PNES; whereas the smallest and least powered study reported no association. 
 
The results of the present review appear to support our hypothesis however, 
because of the described methodological limitations of all the studies we can’t 
conclude that any correlation between taking AED and an adverse outcome was 
free from confound or bias. 
 
The quality  of most of the research  on  PNES is  limited,  partly reflecting  the 
practical and methodological difficulties when studying this group of patients. 
Carrying out outcome studies in this area has particular challenges due to the 
relatively small incidence of the disorder, the heterogeneity of the group and the 
absence of a universal treatment approach (LaFrance et al, 2006). 
  
The  current  published  studies  on  outcome  of  PNES  (including  our  selected 
papers)  are  difficult  to  compare  and  interpret  since  there  is  great  variability 
amongst the selected populations, as well as a lack of consensus on what is a 
good outcome or a reasonable follow up period (Bowman & Markand, 2005; 
LaFrance et al, 2007).  
 
These studies, however, recognised the potential effect that taking AED may 
have on the outcome of PNES. The Carton et al study presents some qualitative 
data where continuation of AED reflects patients’ and GP’s views on the cause 
of the disorder, in this case “epilepsy” rather than PNES (Carton et al, 2007). 
 
Following this systematic review we are unable to conclude whether failing to 
withdraw AED has an effect on the outcome of PNES, however the data does 
suggest that a substantial number of patients with PNES continue to take AED 
and that these subjects have a poorer outcome. A randomised controlled trial 
would be the only way to establish if withdrawing AED at diagnosis contributes 
to a better outcome in patients with PNES.  
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Chapter 3:  
 
Going forward: Prologue to the original thesis research 
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3.1. Aims and objectives of the thesis portfolio  
 
In the overview in chapter one, evidence was presented to show that PNES, 
within certain settings, is not an uncommon disorder entailing a major impact on 
patients’  mental,  physical  health  and  social  functioning  (Breuer  et  al,  1998; 
Bowman & Markand, 2005). Since the majority of these patients are wrongly 
diagnosed  as  having  epilepsy,  most  are  treated  with  AEDs  often  for  many 
years. As described in chapter 1 (page 16), the routine use of AED in this group 
of patients has important and overwhelmingly negative consequences.  
 
There is a lack of evidence for an effective treatment in the current literature 
(Brooks et al, 2002). The scarce evidence for the management of PNES is not 
surprising  considering  that  PNES  is  a  symptom  of  a  variety  of  underlying 
causes, making the formulation of a single theoretical framework upon which to 
base  any  particular  management  strategy  very  difficult.  The  wide  range  of 
treatments  described  in  small  observational  studies,  possibly  reflects  the 
heterogeneity of the patient group.  
 
Although  a  definitive,  universal  psychotherapeutic  intervention  cannot  be 
recommended this does not belie the fact that PNES is a condition associated 
with substantial harm that has to be recognized and diagnosed. There is reason 
to believe that if performed confidently and sympathetically the delivery of the 
diagnosis in association with a clear ‘undiagnosis’ of epilepsy can constitute an 
effective intervention in itself. Reuber in particular has questioned the likelihood 
or appropriateness of elaborating a single management strategy and proposes 
a  stepped  care  approach  with  the  essential  initial  generic  step  including  the 
presentation of the diagnosis (Reuber, 2008). 
 
The  present  thesis  aims  to  focus  on  the  component  parts  of  this  initial 
intervention.  Since  most  patients  with  PNES  are  initially  thought  to  have 
epilepsy  and  treated  inappropriately  with  AED,  the  withdrawal  of  medication 
should be part of this initial process, but is sometimes delayed because of a 
variety  of  background  factors  and  concerns  outlined  below.  The  primary 
hypothesis  of  this  thesis  is  that  withdrawing  AED  following  the  diagnosis  of 
PNES is in itself a therapeutic step and enhances the positive effects of a clear 
delivery of the diagnosis.   60 
 
Although the effect of diagnosis and medication withdrawal was elucidated to an 
extent by the systematic review in chapter 2, this was not the specific focus of 
any of the papers and the role of a clear diagnosis and medication withdrawal 
was  obscured  by  methodological  and  clinical  heterogeneity,  a  lack  of 
explicitness  or  standardistion  of  the  intervention,  loss  to  follow  up  and 
differences  in  reported  outcomes.    Overall,  although  continuing  inappropriate 
prescription  of  AED  was  associated  with  a  poor  outcome  this  could  not  be 
shown  at  a  level  that  would  endorse  the  specific  efficacy  and  safety  of 
medication withdrawal as an intervention in patients with PNES.  
 
There is some evidence to suggest that the intervention of withdrawing AED in 
this  group  of  patients  is  perceived  as  unsafe  by  clinicians  (O’Sullivan  et  al, 
2006), which would partly explain why such high numbers of patients with PNES 
are left on AED. Concerns exist regarding the accuracy of the diagnosis and the 
recurrence  of  possible  epilepsy  following  the  withdrawal  of  medication,  in 
particular the precipitation of potentially fatal status epilepticus. These concerns 
together  with  the  perception  that  leaving  patients  with  PNES  on  AED  is  not 
harmful would naturally incline physicians to err on the side of caution and not 
withdraw medication following the diagnosis of PNES (Reuber & Elger, 2003c). 
 
The  issue  regarding  the  accuracy  of  the  diagnosis  has  been  extensively 
researched and there is good evidence that an accurate diagnosis is possible 
with the right expertise and diagnostic tests. For the purposes of the current 
thesis all subjects were diagnosed as suffering from PNES on the basis of the 
current  gold  standard;  video  EEG  confirmation  of  a  clinical  diagnosis  by  a 
clinician experienced in the diagnosis and treatment of both epilepsy and PNES.   
 
The  safety  of  AED  withdrawal  is  another  issue  and  in  this  case  there  is  no 
evidence on the absence of harm of this intervention. Establishing the safety of 
AED withdrawal in this patient group has to precede any study on the possible 
therapeutic effects of withdrawing medication.  
 
The first study therefore aims to answer the question of whether withdrawing 
AED  in  patients  with  PNES  is  a  safe  intervention.  For  this  purpose  an 
observational study was conducted, consisting of a case series of a group of   61 
patients  with  NES  followed  up  over  a  period  of  twelve  months  after  AED 
withdrawal. 
 
The first study can be conceptualised as a Phase one trial preliminary study 
directed toward demonstrating the safety and tolerability of an intervention with 
regard to the risk of untoward health related events.  The intervention in this 
case  would  be the  diagnosis  of  PNES  and  subsequent AED  withdrawal,  the 
untoward event would be either the misdiagnosis of epilepsy as PNES or the 
‘induction ‘of epilepsy by withdrawal of AED. 
 
In  this  context  an  observational  study  was  considered  adequate  and   
methodological rigour was maintained by ensuring that the design included the 
points below: 
 
·  The study was based on a clinic population of the only regional service 
assessing patients with PNES from primary and secondary care 
·  Standardised intervention 
·  Clear protocols for diagnosis and drug withdrawal  
·  Clear inclusion criteria and well defined outcomes 
 
As well as determining the safety of the intervention the observational study was 
an opportunity to show that for the purpose of generalisability and replication a 
reliable  and  valid  diagnosis  of  PNES  could  be  made  and  withdrawal  of 
medication undertaken with the resources available to other tertiary centres. 
 
Once there was evidence that withdrawing AED in patients with PNES was a 
safe intervention it  was possible  to proceed to addressing the next research 
question of whether withdrawing AED has a positive therapeutic effect. 
   
As outlined above the systematic review of the literature (chapter 2) revealed 
that  the  only  evidence  for  the  possible  effects  of  discontinuation  of  AED 
following  the  diagnosis  of  PNES,  comes  from  three  observational  studies  of 
limited quality and with conflicting results. Further observational work along the 
same  lines  would  replicate  the  flaws  identified  in  the  review  and  only  an 
experimental  design  would  be  likely  to  further  investigate  the  effect  of  AED   62 
withdrawal in a way that would be free from confounding and bias as far as 
possible. 
 
The specific choice of a randomized controlled design with groups randomized 
to delayed and immediate withdrawal was justified as follows: 
 
·  The natural history of PNES is not so clearly defined that a before and 
after methodology would be adequate as the possibility of spontaneous 
recovery could not be discounted or anticipated in a predictable way. 
 
·  Only  randomization  to  parallel  groups  could  address  the  known  and 
probable unknown confounders in this heterogeneous disorder.    
 
·  In  terms  of  the  basics  of  study  design  and  anticipating  likely 
methodological and practical issues most of the current evidence on AED 
withdrawal  had  to  be  extrapolated  from  epilepsy  research.    Although 
most of this evidence is irrelevant to PNES, design and methodological 
issues are similar and in particular gives clear guidance on the timing, 
dosage  schedules  and  monitoring  of  drug  withdrawal.  A  randomised 
controlled  trial  comparing  the  effects  of  withdrawing  AED  immediately 
following  the  delivery  of  the  diagnosis  versus  a  delayed  withdrawal 
appeared the most appropriate study design and had clear and relevant 
precedents in the epilepsy literature. 
 
·  Blinding  of  patients  to  their  status  as  regards  delayed  or  immediate 
discontinuation was not possible, or desirable.  The aim of the study was 
to ascertain the efficacy of two plausible alternatives.  However, although 
subjects had to be aware of their status, neither arm was aware which 
intervention was the control and which the intervention. 
 
The study was designed to include a replication phase on the effect of AED 
withdrawal.   
 
There is evidence that reduction or absence of attacks is not valid as the sole 
measure  of  a  good  outcome  in  patients  with  PNES  (Reuber  et  al,  2005). 
Psychological and particularly social outcome measures are frequently reported   63 
as poor even in patients where attacks are controlled or significantly reduced.  
Hence,  although  the  trial  took  attack  freedom  and  frequency  as  its  primary 
outcome, a comprehensive range of psychosocial measures were included to 
allow a more detailed exploration of the psychosocial aspects of PNES.  Care 
was  taken  to  include  measures  along  the  lines  used  and  reported  by  other 
workers in the field to allow comparison between our relatively prescriptive and 
behavioural paradigm and the approach of other workers.  
 
The systematic review of the literature also highlighted the methodological flaws 
of many of the outcome studies on PNES; in particular the inclusion of epilepsy 
patients, the absence of a standardised intervention, and the variable length of 
follow up amongst subjects. By the end of the replication phase of the RCT data 
was  available  for  a  group  of  prospectively  collected  patients,  subject  to  the 
same assessment and intervention and followed up for the same length of time. 
 
In summary, this thesis will attempt to answer the main research question of 
whether  AED  withdrawal  has  a  therapeutic  effect  on  patients,  utilizing  a 
combination of study designs, in three stages.  
 
Overall the research portfolio can be conceptualized in the following way: an 
initial  phase  one  trial  to  investigate  safety  aspects  of  the  AED  withdrawal 
intervention; a phase 3 trial aiming to establish potential therapeutic effects of 
AED  withdrawal;  and  a  third  paper  which  can  be  seen  as  an  open  label 
surveillance  study  aiming  to  obtain  a  detailed  and  comprehensive  picture  of 
outcome.  
 
The thesis portfolio includes the following papers: 
 
- A systematic review of the literature on evidence of the effects of AED on the 
prognosis of PNES.  
 
- An observational study on the safety of AED withdrawal of 78 patients with 
psychogenic nonepileptic seizures. 
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-  A  Randomised  Controlled  Trial  comparing  the  effects  of  immediate  versus     
delayed  withdrawal  of  Antiepileptic  drugs  withdrawal  in  patients  with 
psychogenic nonepileptic seizures. 
 
-  The  psychosocial  outcomes  of  24  patients  with  psychogenic  nonepileptic 
seizures 18 months after the diagnosis.  
 
The main objectives of the thesis are:  
 
- To establish the clinical safety of antiepileptic drug withdrawal in patients with 
PNES. 
 
- To investigate the potential therapeutic effects of antiepileptic drug withdrawal, 
in patients with PNES.  
 
- To explore short-term psychosocial outcomes of patients with PNES following 
a management strategy which includes AED withdrawal. 
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Chapter 4: 
 
Can we safely withdraw antiepileptic medication in patients with psychogenic 
non-epileptic seizures? Descriptive analysis of outcome data on patients with 
PNES treated with antiepileptic drugs. 
 
An abbreviate version of the contents of this chapter are published as follows: 
 
Oto,  M.,  Espie,  C.,  Pelosi  A.,  Selkirk,  M.  Duncan,  R.  (2005).  The  safety  of 
antiepileptic drug withdrawal in patients with non-epileptic seizures. Journal of 
Neurology ,Neurosurgery and Psychiatry, 2005 ,76(12);1682-1685. 
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4.1. Abstract 
 
Background: Psychogenic nonepileptic seizures (PNES) or pseudoseizures are 
psychologically  mediated  attacks  that  resemble  and  are  often  mistaken  for 
epilepsy.  Most  patients  are  initially  misdiagnosed  as  having  epilepsy  and 
inappropriately treated with AED. A significant percentage continues to receive 
AED even after the diagnosis of PNES has been confirmed, partly reflecting 
reluctance from the clinicians that perceive the withdrawal of AED as potentially 
unsafe. 
 
Objective: To determine whether withdrawal of anticonvulsant medication (AED) 
can be carried out safely in patients with psychogenic non-epileptic seizures. 
 
Methods:  Prospective  evaluation  of  safety  and  outcome  in  78  patients  with 
PNES  who  satisfied  a  standardised  set  of  criteria  for  the  diagnosis  of  ‘no 
epilepsy’. 
 
Findings:  The  patients  were  taking  from  1-3  AED.  Sixty  four  patients  were 
withdrawn  as  outpatients,  14  as  inpatients.  Five  patients  stopped  their 
medication abruptly, and two had AED inappropriately restarted and had to be 
withdrawn  again. Otherwise all patients adhered to  withdrawal schedules.  A 
new  type  of  attack  was  seen  in  3  patients,  in  all  3  cases  complex  partial 
seizures.  In  two  of  these  cases  the  existence  of  controlled  epilepsy  was 
unsuspected. PNES frequency declined in the group as a whole over the period 
of the study (follow up 6-18 months), in all individuals except for 8 patients in 
whom there was a transient increase. Fourteen patients produced new physical 
symptoms during withdrawal.  
 
Interpretation: With appropriate diagnostic investigation and surveillance during 
follow up withdrawal of AED can be achieved safely in patients with PNES. 
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4.2. Introduction 
 
Psychogenic  nonepileptic  seizures  (PNES)  are  psychologically  mediated 
attacks  that  resemble  and  are  often  mistaken  for  epilepsy  Diagnosis  and 
management of PNES represents a significant clinical problem, since patients 
may  present  to  a  variety  of  doctors  with  attacks  that  are  mistaken  for  and 
treated as epileptic seizures or status epilepticus (Howell et al, 1989; DeToledo 
et al, 2000; Reuber et al, 2002). 
 
Most patients with PNES do not have epilepsy, however up to 80% are exposed 
to  at  least  one  antiepileptic  drug  (AED)  leading  to  morbidity  and  mortality 
(Benbadis,  1999).  Even  after  the  diagnosis  of  PNES  is  confirmed  and  no 
evidence of epilepsy has been found, 20-44% patients remain on a single or 
multiple AEDs (Reuber & Elger, 2003c; O’Sullivan et al, 2007; Hall-Patch et al, 
2010). 
 
There  is  also  evidence  that  this  paradoxical  prescribing  practice  is  not  an 
exclusive phenomenon of PNES but also applies to other medically unexplained 
symptoms  where  patients  are  left  on  medication  despite  no  evidence  of  a 
physical problem (Barsky & Borus, 1999; Mayou et al, 2000).              
 
Little  attention  has  been  given  to  the  reasons  for  this  group  of  patients 
remaining  on medication despite  a  clear  diagnosis  of  PNES,  or  the  possible 
adverse consequences of drug withdrawal should it take place. 
 
There  is  a  substantial  literature  however,  looking  at  AED  withdrawal  in  the 
context of patients with proven epilepsy. The consensus amongst experts in the 
field is that AED withdrawal should be considered for all patients with epilepsy 
who  have been seizure free for more than two years,  even though we have 
evidence that the average risk of recurrence of epilepsy is between 40 and 60 
% within 2 years (Chadwick & Scherokman, 1991). 
  
If a clinician treating a patient with epilepsy is willing to accept a risk of this 
order, why is there an apparent reluctance to withdraw AED in patients who did   68 
not have epilepsy in the first place? It seems that the risks and benefits of AED 
withdrawal in patients with PNES are appraised in a very different way. 
 
There are various good reasons why patients with PNES in whom there is no 
evidence of epilepsy, should not be prescribed AED’s.  For example, avoiding 
iatrogenic  harm,  particularly  teratogenicity,  in  a  population  with  a  majority  of 
women of childbearing age (Sigurdardottir & Olafsson, 1998; Szaflarski et al, 
2000, DeToledo et al, 2005). There is also some evidence that medication may 
exacerbate PNES (Damaschke et al, 1988; Niedermayer et al, 1970) and that 
continuation of AED after diagnosis may be associated with a poor prognosis 
(Reuber  et  al,  2003b).    There  are  also  obvious  cost  implications  of  giving 
unnecessary expensive medicines (Martin et al, 1998) and in the longer term 
potential medico legal consequences. 
 
Despite  all  of  the  above,  the  reality  is  that  many  patients  with  PNES  are 
maintained on AED long after the diagnosis. Although there is little published 
research  in  this  area,  some  factors  may  explain  the  reasons  behind  the 
reluctance to withdraw medication in this group of patients as summarised in 
table 4.1. One important factor to clinicians may be a lack of confidence in the 
diagnosis  and  concerns  about  missing  possible  underlying  epilepsy,  with 
consequent perception that AED withdrawal is associated with significant risk of 
serious adverse outcomes such as status epilpticus. Even when this is not the 
case,  drug  withdrawal  does  entail  a  non  medical  explanation  for  the  attacks 
leading  to  a  potential  collision  with  patients  expectations  (Doust  &  DelMar, 
2004).  
 
In order to determine whether it can be safe to withdraw AED in patients who 
have  PNES  only,  we  conducted  an  observational  study  investigating  the 
outcomes of a group of patients with video-EEG confirmed diagnosis of PNES 
and no evidence of epilepsy who were withdrawn form AED’s.   
 
 
 
 
 
   69 
 
Table 4.1: Clinician concerns of AED withdrawal.  
 
Possible clinician concerns of AED withdrawl
1 Accuracy of the diagnosis of PNES or unrecognised underlying epilepsy
2
 Morbidity and mortality associated to AED withdrawal if patient has 
unrecognised epilepsy
3
AED withdrawal producing an exacerbation of psychological symptoms if 
AED were acting as psychotropic drugs 
4
Exacerbation of PNES or symptom substitution in patients who somatise 
when removing the diagnosis of epilepsy and AED
 
 
 
4.3. Methods  
 
The current study  was based at the Southern General Hospital PNES clinic, 
which is part of the West of Scotland Epilepsy regional unit.  
 
As  part  of  routine  clinical  practice,  all  patients  had  an  extensive  clinical 
assessment  including  detailed  description  of  the  events  by  patients  and 
eyewitness.  All  subjects  had  video  EEG  confirmation  of  the  diagnosis  by 
recording all typical events. Once the clinical diagnosis of PNES was confirmed, 
a concomitant diagnosis of epilepsy was regarded as excluded if the following 
criteria were satisfied:  
 
·  All  current  types  of  events  described  were  recorded  and  identified  as 
PNES  
·  No description of past events rising suspicion of epilepsy  
·  No evidence of events during childhood  
·  No inter-ictal epileptiform abnormalities on EEG 
. 
Initially all subjects were investigated as out-patients with “Short Video EEG” 
with  suggestion  (McGonigal  et  al,  2004a)  and  if  this  investigation  was  not 
conclusive patients were then admitted to the ward for video EEG.    70 
 
The  final  diagnosis  was  always  reached  by  consensus  of  at  least  three 
clinicians  (including  a  neurophysiologist).  The  more  complicated  cases  were 
formally discussed in a team clinical meeting.    
 
Once  a  firm  diagnosis  of  PNES  was  made,  patients  were  seen  at  the  clinic 
where the diagnosis was delivered in a non-judgmental and supportive manner.  
 
We developed a written information leaflet on PNES  which was given to the patients and 
relatives at this point (appendix C). In terms of this written information, our intention was to 
ensure that it was relevant and meaningful to the patient group.   
Going by clinical experience we were aware of a specific range of  questions frequently 
asked by patients and relatives at the clinic These questions were used as the basis of the 
leaflet..   
 
The author also recorded all questions asked by 20 new patients and their relatives 
attending the PNES clinic and these were reviewed and thematically grouped to establish 
any dominant themes.  The themes that emerged were:  
￿  The nature and causes of the disorder;  
￿  Diagnostic tests;  
￿  Treatment. 
 
Answers to these questions, combined with ourclinical experience and current research 
evidence were then drafted as the information leaflet   
 
To assess the validity of the questions and responses, the information sheet was passed 
for comment to the epilepsy multi-disciplinary team and 10 consecutive patients at the 
clinic.  The amended information sheet was then piloted at the PNES clinic with further 
patient feedback taken into consideration. 
 
Comments, including the use of terminology, the clarity and relevance of information and 
presentation style, were incorporated into a final version.   
 
 AED medication was withdrawn in all patients with a final diagnosis of PNES-
only and the drugs tapered sequentially following a standard withdrawal protocol 
created  by  the  authors  based  on  clinical  experience  of  AED  withdrawal  in   71 
epilepsy  patients  during  neurosurgical  assessment  (appendix  D).  During  the 
medication  withdrawal  patients  were  reviewed  at  a  minimum  interval  of  3 
months by the epilepsy specialist. In difficult cases, in particular when coexistent 
epilepsy could not be confidently excluded, medication was withdrawn in an in-
patient setting. 
 
Information  on  all  patients  seen  at  the  PNES  clinic  was  prospectively  and 
systematically  collected  in  a  comprehensive  database.  Follow  up  information 
was collected at 6 and 12 months of the completion of the AED withdrawal. 
 
The main outcomes of interest were the potential risks in terms of morbidity and 
mortality  associated  with  AED  withdrawal  as  presented  in  table  4.1.  Other 
outcomes recorded were reduction of attacks and AED status at follow up.   
 
Data were entered prospectively into an Access database on a dedicated PC 
and were regularly checked for completeness and accuracy.  For the current 
descriptive study the information was taken from this Access database and for 
the purpose of analysis the data was transferred to SPSS. 
 
4.4. Sample 
 
Of the total cohort of 235 consecutive patients referred at the clinic between Jan 
2000 and Jan 2003, 184/235(78.2%) had a video EEG confirmed diagnosis of 
PNES  and  satisfied  criteria  for  “no  epilepsy”.  The  reminder  were  still  either 
awaiting video EEG (25/235, 10, 6%) at the end of the study, or had coexisting 
epilepsy (26/235, 11.1%).   
 
Of the 184 subjects with confirmed diagnosis of PNES alone, 99 (53.8 %) were 
taking AED. The remaining 38(20.6%) had never been on AED or their drugs 
had been withdrawn before clinic attendance (47/184, 25.5%). 
 
Of the 99/235 patients with the diagnosis of PNES-only that were taking AED, 
78/99 were eligible for the study. The remaining 21/99 (21.2%) patients were 
excluded for the following reasons; 12/99 (12%) patients were lost to follow up, 
2/99  (2%)  patients  refused  to  come  off  medication,  and  7/99  (7%)  were  still 
reducing AED at the time of the analysis (Table 4.2).   72 
 
Table 4.2: Reasons for participant exclusion. 
 
Lost after diagnosis 12 12
Still reducing medication 7 7
Patient refused to withdraw 2 2
Withdrawal completed
(Study population)
Patients on AED N=99 %
78 78
 
 
4.5. Results  
 
4.5.1. Antiepileptic drug status 
 
Over half of the patients had been started on AED by a neurologist or general 
physician and we were unable to ascertain who had commenced prescription in 
25% of patients. At the time of referral, patients were taking a median of 2 AED 
(range 1-3); 28/78 (36%) were on more than two AED and 20/78 (28%) reported 
side effects on their medication.  
 
When questioned about the impact of AED on their attacks, 4/78 (5%) patients 
felt worse on starting AED but others reported feeling better on the medication 
6/78  (8%)  or  a  temporary  improvement  when  the  drugs  were  started  27/78 
(35%). The rest 36/78 (46%) did not report any change. 
 
4.5.2. Antiepileptic drug withdrawal 
 
All  study  patients  were  instructed  to  come  off  medication.  In  the  majority  of 
cases this was done as an out-patient by giving clear instructions to the patients 
and their GP, with regular review at the clinic. Only 14/78 (18%) patients were 
admitted for drug withdrawal, the reason for admission were as outlined below.  
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·  Patients  with  a  possible  underlying  well  controlled  epilepsy  (4/14).  All 
these patients  had current or  past pathology  that could  be  associated 
with epilepsy (e.g. severe head injury, brain tumour, meningitis). 
·  Patients in whom standard diagnostic procedures had failed to confirm 
the  diagnosis  (5/14).  In  all  these  patients  medication  was  withdrawn 
during admission as part of the diagnostic process.  
·  Patients  with  mild  learning  disability  (5/14).  This  group  had  difficulties 
understanding the diagnosis of PNES and the withdrawal schedule. In 
addition, patients and their carers also expressed anxiety about coming 
off medication. Three of these patients had failed to complete previous 
attempts of withdrawal as out-patients and all were regular users of the 
emergency services. 
   
The remainder of the cohort (64/78), were able to successfully complete AED 
withdrawal as an out-patient: Of the patients coming off medication at home, 
57/64  (89%)  were  able  to  follow  the  slow  titration  protocol  as  planned.  Five 
patients (5/64, 7.8%) stopped medication as soon as the diagnosis was given 
and in two patients (2/64, 3%) the medication was suddenly stopped by their 
GP.  None  of  the  patients  who  stopped  medication  suddenly  (7/64,  10.9%) 
reported  any  adverse  effect.  There  was  no  evidence  of  withdrawal  seizures 
(although none were taking barbiturates or benzodiazepines). 
 
4.5.3. Demographic and clinical characteristics 
  
Fifty-seven out of 78 (73%) were female, 34/78 of whom were of child bearing 
age,  the  mean  age  at  the  time  of  presentation  at  the  clinic  was  39.6  years 
(sd14.3) and the mean age of onset of events was 32.4 year (sd15.4). Nine out 
of 78 (11.5%) patients had a mild learning disability. Patients had been referred 
to  the  clinic  mainly  by  epilepsy  specialists  or  neurologists  60/78  (77%).  As 
shown in table 4.3 the above figures were comparable with the rest of the PNES 
clinic population. 
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Table 4.3: Characteristics of the study population. 
Study population n=78
Clinic population n=219,                                      
Confirmed diagnosis of PNES-only
Gender distribution
FEMALE 57 (73%) 166(76%)
MALE 21(27%) 53(24%)
Source of referral
NEUROLOGY/EPILEPSY  60 (77%) 145 (66%)
GP 8 (10%) 42 (19%)
GEN PHYSICIAN 7 (9%) 19 (8.6%)
PSYCHIATRIST 3 (3.8%) 10 (4.5%)
Missing data 0 3   (1.3%)
Mean age first event 
(years) 32.4 (15.4) 33 (14.4)
18(8%)
Mean age at referral 
(years) 39.6 (14.3) 40 (14.1)
Learning disability 9 (11.5%)
 
At the time of referral this represented a complex group of patients.  There was 
a high prevalence of morbidity of all  types; as a result of the direct physical 
consequence of the ‘seizures’, associated psychopathology, as well as a very 
high prevalence of  coexistence of other medically unexplained symptoms (table 
4.4) 
 
Table 4.4: Patients overall characteristics at baseline. 
PATIENTS CHARACTERISTICS AT 
REFERRAL N=78 %
Psychopathology:
CONTACT WITH 
PSYCHOLOGY/PSYCHIATRY 44/78 56.00%
DEPRESSION 44/78 56%
SUICIDE ATTEMPTS 15/78 19%
SELF-HARM 7/78 9%
MEDICALLY UNEXPLAINED SYMPTOMS
56/78 71.70%
Impact of PNES 
INJURY THROUGH ATTACKS 26/78 33%
ATTACK FREE FOR >1 MONTH 23/78 29%
PSEUDOSTATUS 23/78 29%
VISIT TO A&E 43/78 55%
Social impact:
BENEFITS 53/78 68%
EMPLOYED 9/78 11.50%
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4.5.4. Outcome after AED withdrawal 
 
At follow up we had data up to 6 months in all patients. In 56/78 (78%) patients 
we had data up to 12 months and for 28/78 (36%) we had follow up information 
at 18 months after AED withdrawal. 
 
As outlined above we looked at the following end points: evidence of emergent 
epilepsy,  AED  restarted,  frequency  of  PNES,  newly  reported  symptoms  and 
morbidity as a result of AED withdrawal 
 
4.5.4.1. Evidence of coexisting epilepsy after drug withdrawal: 
 
Three patients 3/78 (3.8%) presented with a new type of attack, that turned out 
to be epileptic, in all cases conforming to complex partial seizures.  
 
The coexistence of ES as well as PNES was promptly recognised in these three 
patients  and  AED  medication  re-started,  bringing  epileptic  seizures  quickly 
under control in all cases. 
 
In one case we had high suspicion of coexistence of underlying ES, therefore 
diagnosis  and  AED  withdrawal  was  done  during  a  prolonged  in-patient 
admission. The patient did not present with the new attacks until a year after 
AED  withdrawal.  .We  had  not  suspected  coexisting  epilepsy  in  either  of  the 
other  two  cases;  neither  had  predisposing  factors  or  a  childhood  history  of 
epilepsy and the only events reported by patients and witness were the ones 
recorded during video EEG. 
 
In terms of outcome, ES was controlled in all patients after restarting AED. In 
two cases this represented a reduction to mono-therapy from the two AED they 
were  taking  at  referral.  All  three  patients  accepted  the  dual  diagnosis,  two 
remain free of PNES and the third had a substantial reduction. 
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4.5.4.2. AED restarted: 
 
Two patients had been restarted on AED, in one case by the GP in view of 
persistence of events and for the other patient as a result of attendance at A&E. 
In both cases medication was withdrawn again successfully. 
 
In one patient, at the first follow up visit (6 weeks), we noticed that the GP had 
continued  to  issue  repeat  prescriptions  of  AED.  Contacting  the  GP  over  the 
phone as well as through a letter rectified this. 
 
4.5.4.3. Frequency of PNES after drug withdrawal: 
 
There was a significant and sustained reduction of attacks over time, whether 
attack  frequency  data  was  analysed  by  changes  between  groups,  within 
individual subjects, or by the total number of patients attack free (see table 4.5). 
 
Table 4.5: Changes in attack frequency from baseline. 
Attack frequency per 
month
mean                 SD median RANGE  N
AT REFERRAL 22.23 30.78 15 0.5-180 N=78
 6 MONTHS FOLLOW UP 13.01 38.46 2
0-300 N=78
AT 12 MONTHS FOLLOW 
UP
10.66 36.4 0
0-250 N=56
AT 18 MONTHS FOLLOW 
UP
3.96 11.05 0.75
0-60 N=28
 
  
A Wilcoxon signed rank test showed that there was a significant difference in 
attack frequency between referral and six month follow up (p<0.001). Fifty-six 
patients were followed up at 12 months. These patients had significantly less 
attacks than at referral (p<0.001) or at 6 month follow up (p<0.001).  Twenty-
eight patients were followed up at 18 months. Attack frequency was less than at 
referral (p<0.001) and at 6 months (p=0.001).  
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At 12 months after AED withdrawal, 35 of 71 patients (49%) had been free of 
attacks for more than two months. 
 
An increase of frequency of their usual events 6 months after AED withdrawal 
was reported by 8/78(10%) patients. In most patients (7/8) this represented an 
increase of over 50% with a median of 15 attacks per month at referral versus 
30 at 6 months. This was a transitory effect in all cases and no particular action 
was required for any of these patients.  
 
4.5.4.4. Morbidity and mortality after AED withdrawal: 
 
As  shown  in  table  4.6,  no  serious  adverse  events,  including  admissions  to 
intensive care (ITU) or death, were reported. 
 
Table 4.6: Morbidity and mortality after AED withdrawal. 
 
Morbidity and mortality after
AED withdrawal N=78 %
Pseudostatus
(prolonged attack treated with
benzodiazepines)
Status epilepticus 0/78 0%
Reporting injuries for the first
time  0/78 0%
Continue to sustain minor injury
10/78 12.80%
Admissions to ITU 0/78 0%
Death 0/78 0%
4/78 5%
 
Our definition of pseudostatus was a prolonged PNES thought to be epileptic 
and treated by administering AED medication. Twenty three patients (29%) had 
episodes  of  pseudostatus  before  withdrawal,  but  only  four  had  episodes 
afterwards (all had previous episodes). Ten patients (13%) continued to report 
minor injury (bruises and grazes) after withdrawal.  
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4.5.4.5. Newly reported medical and psychological symptoms: 
 
Fourteen patients (18%) reported new symptoms, while three (3.8%) reported 
an exacerbation of previous symptoms, and nine (11.5%) had investigations for 
new  complaints.  In  two  patients  the  new  complaint  (chest  pain  and  fatigue) 
represented the main source of disability and health care utilisation at follow up. 
Ten  patients  (13%)  were  started  on  new  drugs,  in  most  cases  (6/10)  an 
antidepressant drug (see table 4.7).  
 
Table 4.7: Report of new clinical events after AED withdrawal. 
New physical complaints 
after withdrawal
N=78 %
New physical symptoms 14/78 18%
Exacerbation of long 
standing symptoms
3/78 3.80%
New medication started 10/78 12.80%
Undergoing new 
investigations
9/78 11.50%
 
As  shown  in  table  4.8,  five  patients  (6.4%)  reported  new  psychological 
symptoms:  low  mood  (three  patients),  irritability,  and  anxiety  however,  none 
required psychiatric intervention. One patient with a past psychiatric history self 
harmed transiently after AED withdrawal.  
 
Table 4.8: New reports of psychological complaints following AED withdrawal.  
New psychological complaints 
following AED withdrawal
N=78 %
New symptoms 5/78 6.40%
Self harm 1/78 1.20%
Suicide attempts 0/78 0%
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4.6. Discussion 
 
To our knowledge this study is the largest observational study of the outcome of 
AED  withdrawal  in  this  complex  population.  Although  the  study  population 
represents  a  selected  sample,  the  general  characteristics  of  the  group  were 
comparable with the rest of our clinic patients and with those described in most 
reports on PNES (Moore & Baker, 1997; Reuber & Elger, 2003c; O’Sullivan et 
al, 2007) although the mean age of onset of events of our group was at the 
upper end of the range of most studies.  
 
Despite our selected  sample,  we do feel that with this study we have been able 
to present data that might address the concerns that arise in the care of patients 
with PNES, in particular the safety or otherwise of withdrawing AED. 
 
As  well  as  data  on  the  safety  aspects  of  AED  withdrawal,  the  current  study 
provides some interesting information on other aspects of AED prescription in 
patients with PNES. In terms of the effect that prescribing AED had on these 
subjects, it is interesting to point out that almost half of the patients reported 
some  benefit  at  least  initially  from  the  AED  and  only  a  minority  reported  an 
exacerbation of attacks. Transient response to AED in terms of a reduction of 
PNES frequency has been described by some authors (Bowman & Markand, 
1996; Sirven & Glosser, 1998) but an exacerabtion of attacks with AED is more 
often reported in the literature, being cited as a distinguishing factor between ES 
and PNES.  However this was not the case in our group.  
 
In terms of patient safety, the main outcome of the study, two factors are critical 
in our view: the confidence with which possible underlying epilepsy is excluded, 
and the quality of monitoring of the patients during and after AED withdrawal. 
 
The best indicator of the accuracy of criteria for excluding epilepsy is whether or 
not  epileptic  seizures  occur  on  withdrawal  of  AED.  Interestingly,  relapse 
occurred  soon  after  withdrawal  in  the  two  patients,  in  whom  it  occurred 
unexpectedly, indicating that these patients had controlled epilepsy rather than 
epilepsy in remission. In the third patient, who had a history of resected frontal 
low grade glioma, complex partial seizures occurred just over a year after AED 
withdrawal. This suggests that either a pre-existing epilepsy was in remission or   80 
that a new epilepsy had arisen (not inconceivable given the past history), and 
suggests the need to monitor patients over an extended period.  
 
Our study ended in January 2003 and no other patients have since had epileptic 
seizures. This is compatible with the results of studies of relapse rate in patients 
with  epilepsy  following  AED  withdrawal,  which  shows  that  the  majority  of 
relapses  occur  within  six months  after  withdrawal (Chadwick  &  Scherokman, 
1991).  
 
Our criteria for excluding epilepsy are straightforward, and are applied with care, 
particularly  in  the  matter  of being  sure that descriptions  of  all  events  are  as 
accurate as they can be, and that they are carefully compared with the events 
that have been recorded. Nonetheless, when a patient has controlled epilepsy 
and has not had an epileptic seizure for some years, it may be unrealistic to 
expect accurate descriptions of early events in all cases. This may particularly 
be  the  case  if  the  original  events  were  complex  partial  seizures  that  were 
promptly  controlled,  and  when  the present  PNES  are much more frightening 
and dramatic in the eyes of relatives.  
 
Despite the absence of recurrent major seizures in our series, it is clear that close 
supervision of the withdrawal process is an important safety measure, not only to ensure 
that the occurrence of epileptic seizures is rapidly detected and communicated to the 
PNES team, but also to ensure that patients (and doctors) comply with withdrawal 
schedules. There is evidence that re-introduction of AED in this group of patients is not 
uncommon, presumably in association with a lack of acceptability of the diagnosis by 
patients, carers and GP’s (Lempert et al, 1990; Walczak et al, 1995; Jongsma, 1999; 
O’Malley, 2000). In the current study great effort and time was devoted to promote the 
acceptance of the diagnosis as intrinsic to the success of the intervention . 
 
We ensured that; patients, relatives and General Practitioners received clear and 
consistent information in terms of the diagnosis and the importance of coming off 
medication. Extra appointments were offered if concerns arose from the patients or the 
relatives regarding the diagnosis or medication withdrawal.  Clear and detailed letters 
were sent to the GP’s and for a few patients letters were also sent to their local Accident 
and Emergency to forestall inappropriate treatment of apparent status epilepticus. 
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For example, one of the patients included in the study was re-started on AED by his GP 
after he reported an increase of nonepileptic attacks as the medication was withdrawn. 
Because of the frequency of follow up contacts, we were able to quickly identifiy and 
address the problem. After establishing that there was no evidence of emerging epilepsy, 
clear explanation and reassurance were given to the patient together with further 
instruction to withdraw AED. To ensure the success of the second attempt at drug 
withdrawal the patent’s GP was contacted by phone to clarify any concerns and this was 
followed by a letter. 
 
Over-treatment of epileptic seizures is common in patients who also have PNES 
(Blumer et al, 2006). For the small number of our patients in whom epileptic 
seizures  appeared  after  AED  withdrawal  we  were  able  to  re-introduce  AED 
treatment sensibly, resulting in mono-therapy and lower doses.  
 
The  level  of  reporting  of  new  physical  or  psychological  complaints  following 
AED withdrawal was low in our patients, particularly considering the high rates 
of reported psychopathology and physical symptoms at presentation. In those 
who reported new medically unexplained symptoms, it was unclear whether this 
was associated with the removal of the diagnosis of epilepsy, with withdrawal 
itself, or with the reduction in PNES frequency that took place at the same time. 
Medically unexplained symptoms are common in patients with PNES (Lempert 
& Schmidt, 1990; Ettinger et al, 1999; Reuber et al, 2003) and it is perhaps 
unsurprising that the removal of one psychogenic symptom might sometimes 
provoke the appearance of another.  
 
Overall our patients had a generally good outcome with a significant reduction in 
frequency  of  PNES  after  drug  withdrawal  and  only  a  minority  of  patients 
reporting an increase. Similar rates of reduction of attack frequency following 
diagnosis of PNES have been reported in other follow up studies using different 
methods  of diagnosis and management (Ettinger et al ,1999; Selwa et al, 2000; 
Reuber et al, 2003, Goldstein et al, 2004) which suggests that the reduction is 
probably a result of multiple factors, of which AED withdrawal is only one. It 
would require a randomised controlled trial of drug withdrawal to establish the 
extent to which there is a causal relation between AED withdrawal and a good 
outcome of PNES and we are in the process of carrying out such a trial. 
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The MRC AED  withdrawal  study indicates that a  patient  who  has had  tonic-
clonic convulsions but has been seizure-free on a single AED for two years has 
a  60%  risk  of  seizures  in  the  first  year  after  drug  withdrawal  (Chadwick  & 
Scherokman,  1991).  While  the  number  of  patients  in  our  study  is  relatively 
small,  our  data  suggest  a  much  lesser  risk  in  appropriately  selected  and 
monitored  patients  with  PNES,  yet  patients  often  remain  on  AED.  We  cited 
some  potential  adverse  consequences  of  AED  in  the  introduction;  it  may  be 
worth adding that of the 34 of our patients who were women of childbearing age 
nine had had pregnancies while on AED.  
 
 
4.7. Conclusion  
 
Overall, from the point of view of safety, which was the main objective of the 
study, the outcome of patients after medication withdrawal was positive, with 
minimal and not serious adverse events. Even for the three patients in whom 
the  diagnosis  of  epilepsy  emerged  after  drug  withdrawal  AED  withdrawal 
allowed clarification of diagnosis and rationalisation of treatment.  
 
We  conclude  that  in  appropriately  selected  patients  with  PNES,  and  where 
suitable expertise and monitoring are available, AED withdrawal can be safe. 
Patients  who  are  thought  to  have  PNES  should  therefore  be  referred  to 
appropriate centers.  
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Chapter 5: 
 
Clinical  outcome  of  a  Randomised  Controlled  Trial  comparing  the  effects  of 
immediate  versus  delayed  withdrawal  of  Antiepileptic  drugs  in  patients  with 
nonepileptic seizures. 
 
An abbreviated version of the contents of this chapter are published as follows: 
Oto. M, Espie CA, Duncan R. (2010) An exploratory randomised controlled trial 
of immediate versus  delayed  withdrawal  of antiepileptic  drug  in  patients  with 
psychogenic nonepileptic seizures(PNEAs). Epilepsia. 
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5.1. Abstract 
 
Background:  Psychogenic  nonepileptic  seizures  (PNES)  are  psychologically 
mediated  attacks  that  resemble  and  are  often  mistaken  for  epilepsy.  Most 
patients with PNES are treated with AED and continue to receive medication 
even  after  the  diagnosis  is  confirmed.  A  failure  to  withdraw  AED’s  may 
undermine the diagnosis of PNES and hinder adjustment to the removal of the 
diagnosis of epilepsy and negatively affect outcome. 
  
Main hypothesis: Withdrawing AED following the diagnosis of PNES is in itself a 
therapeutic  step  and  enhances  the  positive  effects  of  a  clear  delivery  of  the 
diagnosis. 
.  
Methods:  A  Randomized  controlled  trial  of  AED  withdrawal  in  patients  with 
PNES.  Patients  were  randomized  to  immediate  or  delayed  (9  months) 
withdrawal  of  AED.  We  recorded  attack  frequency,  changes  of  the  use  of 
emergency  medical  services  and  a  variety  of  psychosocial  measures  at 
baseline, 9 months and 18 months.  
 
Result:  Of  193  patients  screened,  38  fulfilled  entry  criteria,  13  declined 
participation and 25 were randomised. Fourteen patients were randomized to 
immediate withdrawal (IW), 11 patients to delayed withdrawal (DW). There was 
a significant reduction in spell frequency from baseline to 9 months in the IW 
group  but  not  in  the  DW  group  (p=0.028).  There  was  a  significantly  greater 
reduction in use of rescue medication in the IW group compared to the DW 
group  between  baseline  and  9  months  (p=0.002).  Emergency  healthcare 
utilization dropped to zero in both groups by the end of the study. Psychological 
measures reflecting internal locus of control increased significantly more in the 
IW group (p=0.005). 
 
Conclusion: The present study may be regarded as an exploratory exercise and 
as such has provided a suggestion that withdrawing AED enhances the effect of 
a clear delivery of the diagnosis. This effect is reflected in a persistent reduction 
in  attack  frequency  and  a  cessation  of  the  use  of  emergency  services  and 
medication following AED withdrawal. Importantly none of our data show any 
negative effects.    85 
 
5.2. Introduction 
 
Psychogenic  nonepileptic  seizures  (PNES)  may  be  defined  as  paroxysmal 
events that resemble and could be mistaken for epileptic seizures, without being  
associated  with  any  measurable  alteration  in  brain  electrical  activity.  The 
underlying  cause  for  PNES  could  be  plausibly  attributed  to  psychological 
processes  as  opposed  to  alternative  physiological  processes  such  as  faints. 
PNES  present  to  virtually  all  health  care  professionals,  account  for 
approximately  18%  of  patients  presenting  with  blackouts  and  represent  a 
significant  management  problem  to  epilepsy  specialists  (Kotsopoulos  et  al, 
2003). 
 
A  variety  of  psychological  interpretative  paradigms  have  been  proposed  to 
explain  or  understand  PNES.  These  range  across  the  traditionally 
psychodynamic, the strictly behavioural and the eclectically psychosocial, and 
allude  to  a  variety  of  psychological  mechanisms  including  dissociation, 
hysterical re-enactment, learned behaviour and frank malingering (Bowman & 
Markand, 1996; Gates, 2002; Salomon et al, 2003; Marchetti et al, 2008).  As 
such,  the  difficulties  of  assessment  of  the  various  treatments,  of  an  already 
heterogeneous disorder (Lesser et al, 2003; Cragar et al, 2005; Baslet et al, 
2010), are compounded by the breadth of approaches adopted. Unsurprisingly, 
a recent Cochrane review on the behavioural treatment of PNES concluded that 
there is no reliable evidence to support the use of any one specific treatment 
(Brooks et al, 2007). 
 
Nevertheless,  elements  of  management  indicated  by  clinical  consensus  are 
beginning to receive some support from published research. In particular, there 
is increasing evidence that an initial clear and unambiguous communication of 
the diagnosis of PNES and the removal of an erroneous diagnosis of epilepsy is 
an integral part of management. In itself this may constitute the decisive and 
only necessary intervention for a minority of patients. (Shen et al, 1990; Farias 
et al, 2003; Hall-Patch et al, 2010).  
 
Almost 80% of patients with PNES are exposed to Antiepileptic drugs (AED) 
and  about  40%  remain  on  AED  after  the  diagnosis  of  PNES  has  been   86 
established  (Benbadis,  1999:  Reuber  et  al,  2003;  O’sullivan  et  al,  2007). 
Consequently, despite the emphasis placed on delivering a clear (un)diagnosis, 
insufficient  attention  has been  placed on  the  potential impact  that continuing 
AEDs may have on the prognosis, course or outcome of PNES thereafter. 
 
Studies across a range of physical and psychological disorders have confirmed 
that  such  inconsistency  between  diagnosis  and  management  undermines 
compliance  and  outcome  (Barski  &  Borus,  1999).  Thus  it  seems  at  least 
plausible that a failure to withdraw AEDs may undermine the diagnosis of PNES 
and hinder adjustment to the removal of the diagnosis of epilepsy. 
 
Our working hypothesis is that an immediate withdrawal of AEDs following the 
diagnosis of PNES would enhance the therapeutic effect of a clear delivery of 
the diagnosis. 
 
In a previous study we showed that AED withdrawal in the context of PNES is 
safe  (Chapter  4).  The  next  step  and  the  aim  of  the  present  study  was  to 
investigate the potential therapeutic benefit of a planned withdrawal of AEDs 
following  the  diagnosis  of  PNES.  We  designed  a  randomised  controlled  trial 
comparing  changes  in  attack  frequency  in  patients  following  differing  AED 
withdrawal regimes. In one group medication was withdrawn immediately after 
the presentation of the diagnosis of PNES. In a second group, withdrawal of 
AED  was  delayed  until  9  months  after  the  delivery  of  the  diagnosis.  The 
rationale  for  this  comparison  was  to  observe  any  possible  differences  in 
outcome between the group who had the intervention (AED withdrawal at time 
of diagnosis) and the control group which continued to take the medication. 
 
5.3. Methods  
 
5.3.1. Aim 
   
The study aim was to investigate the therapeutic effect of a planned withdrawal 
of  antiepileptic  drugs  in  patients  with  PNES.  More  specifically,  to  consider 
potential benefits of immediate relative to delayed withdrawal, as measured by; 
reduction in the number of attacks, number of patients that become attack free, 
changes in physical and psychological health status and healthcare utilisation.   87 
 
5.3.2. Study design 
 
Pragmatic randomised controlled trial comparing two groups (immediate AED 
withdrawal (IW) vs. delayed  AED  withdrawal (DW)) with repeated measures. 
The study therefore comprises a controlled comparison phase, followed by a 
replication of the drug withdrawal effect. The design of the study is illustrated in 
appendix E. The study design adhered to the CONSORT guidelines (Moher et 
al, 2001; appendix F). 
 
5.3.3. Participants 
  
The  trial  was  based  at  the  Glasgow  PNES  regional  clinic  in  the  Institute  of 
Neurological Sciences at the Southern General Hospital. Patients are referred 
from  a  wide  variety  of  sources  throughout  the  West  of  Scotland,  including 
primary and secondary care (total population 2.7 million). 
 
All patients referred to the clinic between April 2001 and January 2004 were 
screened as potential eligible subjects. Patients were eligible if they had video 
EEG confirmed diagnosis of PNES, without coexisting epilepsy, and taking at 
least one AED. Inclusion criteria are shown in table 5.1 and the flow-chart of 
recruitment is presented in figure 5.1. 
 
 
Table 5.1: Inclusion criteria for the study.  
1 Taking at least one Antiepileptic drug
2 Active NES (> 1 event per month) 
3 Diagnosis of NES confirmed by video EEG
4 No evidence of coexisting epilepsy
5 Patient able to give informed consent.
6
Female, if of childbearing age, must not be 
pregnant and must be using a medically acceptable 
form of contraception
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Figure 5.1: Flow-chart of RCT design. 
 
 
 
 
  
 
 
Assessment for eligibility 
                 n=219  
       Eligible for trial: diagnosis of PNES   
                                  n=193 
          Fulfill entry criteria: n=38 
       Randomised: n=25 
Delayed AED withdrawal  
                 n=11 
Immediate AED withdrawal  
                 n=14 
 
Completed study n=11 
Analysed n=11 
Completed study n=13 
Analysed n=14 
Declined to participate 
             n=13  
Excluded: N=155 
 
 Not on AED n=75 
 
 Awaiting video EEG n=37 
 
 Coexisting epilepsy n=19 
 
 Other n=21 
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Emphasis  was  placed  on  accurate  diagnosis  with  a  strict  protocol  and  a 
minimum of three clinicians (two epilepsy specialists and a neurophysiologist) 
were  involved,  each  one  assessing  the  case  independently.  Details  of  the 
diagnostic criteria are shown in appendix G. 
 
5.3.4. Interventions  
 
Subjects were randomly allocated to immediate withdrawal (IW) of antiepileptic 
drugs or delayed withdrawal (DW). As shown in figure 5.1, patients randomised 
to IW were asked to immediately start a gradual withdrawal of their AED at the 
time  when  the  diagnosis  of  PNES  was  given.  Patients  randomised  to  DW 
continued to take their medication for a further nine months at which point their 
medication  was  slowly  withdrawn.  The  full  protocol  with  details  of  the 
intervention  is  attached  in  appendix  H  along  with  participant  consent  form 
(appendix I). 
 
In  order to standardize the information given to  patients, the research fellow 
followed the script of a purposely designed semi-structured interview which can 
be viewed in appendix J. This was based on pilot work described in chapter 4, 
to  elucidate  the  most  frequently  asked  questions  by  patients  at  the  clinic 
following the diagnosis of PNES.  
 
All  patients  with  the  confirmed  diagnosis  of  PNES  were  also  given  an 
information leaflet in the form of questions and answers which had also been 
designed by the author. Further information on the purposely designed patient 
information sheet can be found in appendix K. 
   
Assessment and data collection took place pre-randomisation (baseline data) 
and at 9 months post randomisation with subsequent data collection 18 months 
later  at  the  end  of  the  replication  phase.  The  period  of  9  months  from  the 
randomisation  point  was  chosen  to  ensure  that  all  subjects  had  been  off  all 
AEDs for at least two months by the end of the controlled phase. 
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5.3.5. Drug withdrawal 
 
Medication  was  gradually  withdrawn  in  weekly  decrements  following  our 
standard protocol, which had been used regularly at the PNES clinic for a year 
before the start of the research trial. For patients taking more than one AED, 
drugs were withdrawn sequentially following our own protocol (appendix D).  
 
5.3.6. Outcomes and data collection 
 
The primary outcome measure was change in self reported attack frequency 
from baseline to 9 months and at the end of replication phase at 18 months. As 
well as comparing the absolute reduction of attacks we also analysed data in 
terms of clinically significant change. Clinical response was defined as reduction 
of attacks grater than 50%, and remission as being attack free. As secondary 
outcomes we also measured any changes between and within groups in illness 
attribution  and  health  care  utilisation,  as  well  as  differences  in  physical  and 
psychological health status from baseline to 9 and 18 months. 
 
Patients  reported  attack  frequency  retrospectively  at  each  visit  since  self 
reporting of attacks in these patients has been shown to be reliable (Quigg et al, 
2002). Most patients also used the diary we offered to record the attacks. For 
secondary  outcomes,  at  all  visits,  patients  completed  the  same  set  of 
questionnaires. All information was recorded in the clinical notes. 
 
The Hospital Anxiety and Depression Scale (HADS) (Zigmond & Snaith, 1983; 
appendix  L)  was  used  to  assess  changes  in  mood  over  time.  To  assess 
changes  related  to  AED  side  effects,  in  particular  tiredness  (a  frequently 
reported side effect), we used the Side Effects and Life Satisfaction Inventory 
(SEALS) (Brown & Tomlinson, 1982; Gillham et al, 2000 – see appendix M). 
Finally  the  Illness  Perception  Questionnaire  IPQ  (Weinman  et  al,  1996; 
appendix N) which assesses patients’ illness representation was employed. We 
were particularly interested in assessing changes when on or off medication in 
their perceived control over their condition. 
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We  recorded  basic  demographic  data  for  all  patients  screened  for  the  trial. 
Progress data for all participants were collected three monthly at the clinic or 
otherwise through a telephone consultation. 
 
5.3.7. Sample size and power considerations 
 
The  only  available  data  on  which  to  base  our  power  calculation  were  from 
descriptive  retrospective  cohort  studies.  These  data  suggest  that,  after 
diagnosis  of  PNES,  up  to  one  third  of  the  patients  become  attack  free  or 
demonstrate  a  substantial  reduction  of  attack  frequency  regardless  of 
management.  
 
Based on the above a power calculation based on an alpha of 0.05 estimated 
that the sample size required to detect an effect of medium size with 80% power 
would  be  87,  reducing  to  26  for  a  large  effect  (Cohen  1992).    Various 
constraints made it impossible to aspire to anything approaching a sample size 
of greater that 30 but other steps were taken to maximize power via reducing 
variance  such  as  imposition  of  strict  entry  criteria,  the  choice  of  clear  and 
unambiguous  end  points  and  maximising  treatment  fidelity.  Despite  these 
manouevres the possibility of inadequate power persisted but it was felt ethically 
appropriate  to  proceed  with  an  exploratory  trial  since  there  had  been  no 
previous controlled trials on management of PNES.  
 
5.3.8. Blinding 
  
Blinding of participants or the clinician was not possible. Due to the nature of the 
intervention (coming off or remaining on AED), patients had to know in which 
group they had been allocated. It was the impact of coming off medication or 
remaining on it, after the diagnosis, that we were interested in assessing, rather 
than the effects of any AEDs. 
 
The clinician, however, was blinded to adherence with the withdrawing regime 
which was tested by measuring drug levels in blood. These results were sent to 
an independent clinician who kept the results confidential until the end of the 
trial. 
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Furthermore, the research assistant who administered rating scales at baseline 
was blind to participant allocation. At the 9 and 18 months visit, patients self-
rated the same scales in an attempt to minimise bias and to increase reliability 
of  measures.  The  scales  were  scored  by  the  research  assistant  and  results 
made available to the investigator upon completion of the trial.   
  
5.3.9. Randomisation 
 
A random number list was generated using Excel by an independent clinician 
who was not involved with the trial. The random list was given to a secretary 
from another department who again had no knowledge or involvement of the 
trial. Each time a patient agreed to participate, the nominated secretary was 
contacted by telephone to obtain a random number. A simple random allocation 
method  was  used  with  patients  who  were  allocated  an  even  number 
randomised to IW and patients with an allocated odd number randomised to the 
DW group. 
 
5.3.10. Statistical methods 
 
The evaluation of the data was performed with the computer program SPSS 
version 14. A descriptive analysis of all data showed that the primary outcome 
variable  (attack  frequency)  was  not  normally  distributed.  Thus  within  and 
between group comparisons were made using the appropriate non parametric 
tests  (Wilcoxon  Paired  Rank  Test  and  Wilcoxon  Two  Sample  respectively).  
Similarly dichotomous outcomes were compared within and between groups on 
the appropriate measures (McNemar’s test and Fisher’s exact test respectively) 
All analyses were intention to treat, with last observation carried forward used 
for missing values.  A p value < .05 was considered statistically significant.  
 
5.4. Results 
  
5.4.1. Sample characteristics at baseline  
 
From April 2001 to Jan 2004 we screened 219 patients of whom 25/219 (11%) 
were  ultimately  randomised.  Of  the  excluded  patients,  26/219  (11.8  %)  had 
epilepsy  only,  79/219  (36%)  were  not  on  AED  at  the  time  of  the  study  and   93 
13/219  (6%)  declined  to  participate.  The  remaining  76/219  (35%)  of  the 
excluded patients had a clinical diagnosis of PNES and were taking AED, but 
were excluded because: they did not have video EEG confirmation of diagnosis 
within  the  recruitment  period  (37),  had  coexisting  epilepsy  (19)  or  for  other 
reasons,  including  pregnancy,  inability  to  consent  or  history  of  childhood 
epilepsy (total 21).  
 
At  baseline  we  had  data  on  the  168/194  patients  with  PNES  who  were  not 
included  in  the  study  and  were  able  to  compare  them  with  the  randomised 
patients as shown in table 5.2 (26/194 of the excluded did not have PNES). 
 
Table 5.2: Comparison at baseline, between randomised patients and the rest of patients with 
NES not included in the study. 
 
Excluded n=168 Randomised n=25  
 
Female 126/168 (75 %) 20/25 (80 %)
Married  98/168 (58 %) 17/25 (68 %)
Employed or students  38/168 (22 %) 4/25 (16 %)
State benefits 96/168 (57 %) 16/25 (64%)
Reported sexual abuse 43/168 (25.5 %) 8/25 (32 %)
Age at presentation at clinic, Mean 37.6 (sd 14.4) 41 (sd 14.4)
Duration of  NES (months), Mean 70.8 (sd 50.8) 57.4 (sd 48.6)
Convulsive attack  114/168 (67 %) 13/25 (52 %)
 
Following  randomisation,  the  groups  assigned  to  immediate  or  delayed 
withdrawal were compared on demographic and clinical characteristics as well 
as well as factors reported as being of prognostic significance in PNES (Reuber 
& Elger, 2003). We also rated items identified from our semi structured interview 
that reflected the impact of PNES in support needs and daily activities (Table 
5.3). We found no statistically significant differences between groups. 
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Table 5.3: Baseline between-groups comparison of possible prognostic factors. 
Immediate withdrawal Delayed withdrawal
N=14 N=11
Age in years  40.7 sd14.1 41.4 sd 15.5
(mean) (16-62) (19-65)
Duration NES in months 59.3 (sd 51.2) 59 (sd 47.4)
(mean, range) (3-144 ) (9-129)  
Taking >1 AED 5/14 (35.7%) 6/11(54%)
Attack frequency 
(median, range)
None Compliant with AED 1/14 (7 %) 1/11 (9%)
Daily activity limited by NES  8/14 (57.1%) 5/11 (45.5%)
 20(5-720)   12(6-120)
Female(n) 12/14 (85.7%) 8/11(72.7%)
 
For the randomised patients, there was no difference in input from a clinical 
psychologist; four patients (two in each group) declined referral, and the rest 
were seen by one of the psychologists a mean number of 4 times (IW range 0 to 
7 and DW range 0 to 8). Only one patient from the IW group dropped out at four 
months after initial visit however she was included in the study using the method 
of last observation carried forward. At the end of the study, one subject from 
each group (2/25, 8%) was found to have none detectable serum levels of AED 
suggesting that the group as a whole were concordant with the medication. 
 
5.4.2. Outcome  
 
5.4.2.1. Primary outcome: changes in attack frequency   
 
Our primary outcome was the effect of our intervention (medication withdrawal) 
on attack frequency at the end of the controlled phase of the study at 9 months 
from the start of the trial.  The control group was in turn exposed to the same 
intervention at 9 months in a subsequent replication phase with patients being 
followed up for 18 months in all.  
 
At baseline all patients (n=25) reported monthly attacks ranging between 10 and 
295; the data were not normally distributed. As a result, and considering the   95 
small size of our sample, we used the median values to compare groups as a 
more stable way to illustrate the group central tendency. 
 
At  baseline  the  median  of  attacks  of  the  IW  group  was  20(range  5-720) 
compared with a median of 12 (range 6-120) for the DW group, this difference 
was not statistically significant (p=.700). 
 
As can be seen in figure 5.2, median number of attacks declined across the 
study in both groups. At the end of the controlled phase the IW group reported a 
median attack frequency of 2(0-295) compared with 6 (0-100) for the DW which, 
when compared, was not a statistically significant. By the end of the replication 
phase the medians had reduced further in both groups to a median of 1(0-6) in 
the IW group and of 4(0-32) in the DW group, which again when compared was 
not statistically significant. It is noteworthy that in both groups of theses values 
had reduced considerably. 
 
Figure 5.2: Changes in median number of attacks between IW and DW groups at main end 
points.  
 
 
 
 
 
 
 
 
 
 
 
 
Visual inspection of figure 5.2 suggests that subjects in the IW group had  a 
greater reduction from baseline than the DW group at the end of the controlled 
phase. Using within group change scores for comparison of median values the 
reduction for the IW group was statistically significant (p=.028) and that was not 
the case for the DW group.  
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5.4.2.2. Clinically significant changes between groups 
 
To assess the clinical impact of our intervention we compared both groups for 
the proportion of patients attack free and the proportion with >50% reduction of 
attacks as well as differences in health care utilisation as shown in table 5.4.  
 
Table  5.4:  Clinical  and  social  outcomes  between  groups  from  baseline  to  end  of  the  study 
(*P<.05) 
Baseline   9 months  18 months  
IW IW IW
DW DW DW
 
Attack frequency (median and 
range)
  20  (5-720)                                 
12 (6-12)
 2    (0-295)                                   
6 (0-100)
1  (0-60)                             
4 (0-32)
Attack free  0/14                                 
0/11
3/14(21%)                      
3/11(23%)
7/14(50%)               
3/11(27%)
Use of emergency medication 6/14(43%)                    
4/11(36%)
0/14*                             
4/11(36%)
0/14                            
0/11
Use of emergency services for NES  3/14(21%)                    
5/11(45%)
1/14(7%)                       
3/11(23%)
0/14                           
0/11
Use of emergency services for 
other than NES 
10/14 (71%)                  
8/11(2%)
4/14(28%)                    
4/11(36%)
 0/14                          
0/11
Working  2/14(14%)                       
0/11       
 2/14(12%)                      
0/11                         
4/14*(28%)                  
0/11         
Receiving  state benefits 11/14(78%)                  
10/11(91%)
11/14(78%)                
10/11(91%)
9/14 (64%)              
8/11 (72%)
 
Inspection of the data in figure 5.3 (below) shows a sustained increase in the 
number of patients achieving >50% reduction of attacks throughout the study. 
This  improvement  continues  beyond  the  controlled  phase,  and  is  particularly 
noticeable in the IW group by the end of the study, although this difference is 
not statistically significant (p=.700). As shown in figure 5.4 at the end of the 
controlled phase (9months) both groups had a similar proportion (IW 21% vs 
DW 27%) of patients who had achieved full remission status for at least two 
months. Interestingly, at the end of the extension phase, the number participant 
numbers had doubled under IW (50%), suggesting some enhanced effect in the 
longer  term  that  was  not  evident  in  DW  (27%)  at  that  time  point.  Formal 
analysis, however, did not support this visual impression (p= .076).    97 
Figure 5.3: Changes in percentage of patients with > 50% reduction of attacks between IW and 
DW group at main end points.  
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Figure 5.4: Changes in percentage of attack free patients between IW and DW group at main 
end points.   
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In terms of health care utilisation, at baseline a similar proportion of patients in 
both  groups  received  antiepileptic  emergency  medication  to  control  their 
attacks,  at  9  months  however  no  patients  from  the  IW  group  were  using 
emergency  medication  compared  with  4/11(36%)  patients  in  the  DW  group,   98 
representing  a  statistically  significant  difference  (p=0.026).  This  effect 
disappeared by the end of the replication phase when all patients were off AEDs 
and  no  patient  in  either  group  was  receiving  antiepileptic  emergency 
medication.   
 
A  similar  pattern  of  improvement  was  observed  in  the  use  of  emergency 
services due to PNES related symptoms, although in this case the difference 
between groups at 9 months was not statistically significant. By the end of the 
replication phase again no patients were using emergency services because of 
their attacks.   
 
The use of health care services for other chronic symptoms remained stable 
throughout the study in both groups. Only a small percentage of patients (IW: 
3/14 -21%, DW; 2/11-18%) presented to medical services with new symptoms 
arising since the start of the trial at 9 months, by the end of the study, however, 
no use of medical services for new symptoms were reported in either group. 
 
5.4.2.3. Psychosocial outcomes  
 
In terms of social outcomes, little change was noted in either group by the end 
of  the  controlled  phase.  At  the  end  of  the  replication  phase,  the  number  of 
subjects receiving state benefits and the reported level of disability due to PNES 
were reduced in both groups. We observed a change in working status for the 
IW group (4/14, 28%) at the end of the study, which was significantly greater 
than the DW group where no patients were employed.  
  
From the psychological rating scales, the HADS mean scores for anxiety were 
at the lower end of mild (>10) in both groups at baseline and remained at the 
same level throughout the study (see table 5.5)  
 
 
 
 
 
 
   99 
 
Table 5.5: HADS scores over the three assessment points, between groups.  
       Baseline       9 months      18 months 
IW                DW  IW          DW  IW          DW
Anxiety 
Mean -SD 10.9              9.9 8.7          8.1 10.0           9.5
(6.4)            (3.4) (4.4)      (4.3) (3.2)       (3.4)
Depression 
Mean –SD  9.0                 6.2 6.2          7.5 6.9            7.0
(5.5)            (4.0) (4.8)      (3.5) (3.5)       (3.8)
 
 The mean scores for depression appear to improve for the IW group by the end 
of the control phase as opposed of the DW group were the score increased 
slightly, however this was not statistically significant. 
 
As shown in table 5.6, the only statistically significant difference detected on the 
SEALS questionnaire, was the significantly higher number of patients from the 
DW  at  the  end  of  the  controlled  phase  (who  were  still  on  medication) 
complaining of tiredness. By the end of the replication phase (18 months), when 
all  patients  were off AEDs,  the  scores in  the DW  group  were  lower and not 
significantly different from the IW group. For the rest of the domains there were 
no significant differences between the two groups throughout the study. 
 
Table 5.6: SEALS scores for the three assessment points, between groups. 
  Baseline    9 months  18 months 
  IW         DW IW          DW IW         DW
Worry    8          7.9 7.7              6.3 8             7.6
(Mean-SD)  (2.8)     (4.9) (2.4)         (3.5) (2.5)      (2.6)
Cognition  25.8       24.9 24.2         31.2 26.3       26.8
(Mean-SD) (12.6)      (11) (12.1)      ( 7.6) (12)      (12.9)
Temper   7             6 7.2            6.4 6.6         6.2
(Mean-SD) (3.7)       (3.1) (3 )          (3.3) (3.5)     (3.2)
Tiredness  7.6           9.2 7.1 *         10.6 9.2         8.2
(Mean-SD) (3.9)       (4.7) (4.1)        (3.8) (3.5)      (4.7)
Dysphoria 9.5         10.9 8.7            9.4 11.3       11.4
(Mean-SD) (5.2)       (3.3) (4.7)         ( 4) (3.8)     (3.2)
*P<0.05  
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As illustrated in Table 5.7, the domains from the IPQ that reflected an internal 
locus  of  control  (attacks  caused  by;  stress,  state  of  mind,  own  behaviour) 
increased in both groups  throughout the study, this increase was statistically 
significant for the IW group by the end of the replication phase, where more 
subjects were attributing their attacks to their mental state (p=0.005). At that, 
point,  a  higher  proportion  of  subjects  in  the  IW  group  which  had  been  off 
medication for 18 months were also attack free. For the remaining domains of 
the IPQ there were no statistically significant differences between groups.  
 
Table 5.7: IPQ scores for the three assessment points, between groups. 
 Baseline   9 months 18 months         
IW                    DW                 IW                   DW                      IW                     DW                
Number of symptoms  8.3(2.2)          7.3(2.5) 7.4(4.3)             8(2.4) 6.6(4.2)           5.2(3.5)
External locus of control  14.6(5.6)       16.3(4.7) 14.4(4.5)        14.7(4.4) 14,3(4.9)        14.4(3.6)
Internal locus of control  8(3.4)              8(2.6) 10(2.4)               9(3.4) 11.2(1.8)         8.3(2.8)
Control cure 3(0.4)              3(0.2) 3.1(0.7)          3.2(0.6) 2.5(0.8)           2.7(0.3)
Consequence  3.8(0.7)          3.3(0.8) 3.4(6.5)          3.4(6.0) 3.3(0.7)             3.2(1)
Time line 3.1(0.4)            3(0.5) 2.7(0.5)            3(0.3) 3.4(0.8)            3.2(0.7)
 
 
 
 
5.5. Discussion 
 
This is the first controlled  trial  aimed  at determining  the possible therapeutic 
effect of scheduled AED withdrawal at the time of diagnosis of PNES (Bodde et 
al, 2009). Our hypothesis was that immediate AED withdrawal would enhance 
the therapeutic benefit of clear and unambiguous delivery of the diagnosis.  
 
Our  hypothesis  was  partially confirmed by  statistical  differences  between  the 
pattern and extent of reduction in attack frequency in the IW group relative to 
the control group. These effects however, have to be seen in  the context of 
overall benefit in giving the diagnosis clearly in the first place. 
 
A tentative suggestion could be made that the co-delivery of the diagnosis and 
medication withdrawal resulted in a statistically significant and persistent fall in   101 
attack frequency manifested over the course of the study as compared to the 
group where the interventions were delivered separately. 
 
Clinical improvement throughout the study was observed and by 18 months all 
but one of the patients in the IW group had a >50% reduction and half were 
attack  free  which  represents  a  good  outcome  when  compared  with  current 
literature (29%-52%) including a pilot study evaluating the impact of Cognitive 
Behaviour Therapy as a treatment for PNES (Ettinger et al, 1999b; Reuber et al, 
2003a; Goldstein et al, 2004) 
 
Our  other  clinical  outcome  measures  provide  some  clearer  suggestion  of  an 
effect of AED withdrawal following the delivery of the diagnosis of PNES. The 
use of emergency services for PNES dropped to zero in the IW and DW group, 
as did the use of emergency AEDs; this change was noted earlier in the IW 
group and in the case of use of emergency AED, the difference between groups 
was significant. This is consistent with our previous study which also showed a 
drop in use of emergency services following the diagnosis and AED withdrawal 
which was also independent of continuation of the attack disorder (McKenzie et 
al, 2009). 
 
This  reduction  in  demand  for  emergency  healthcare  suggests  a  change  in 
attitude  of  the  attacks  themselves,  on  the  part  of  carers  if  not  patients.  A 
possible explanation could be that the withdrawal of medication has the effect of 
discouraging  ‘medicalisation’  of  symptoms.  Another  important  point  is  the 
potentially  detrimental effect  of health  care contacts in  this  group of patients 
(Barsky & Borus, 1999). A reduction of contacts may therefore be beneficial in 
the long term; however this issue requires further study. 
 
There exists a concern that patients who cease have will go on to develop new 
somatic complaints. Our data are reassuring in this regard since only a minority 
of  patients  in  each  group  presented  with  new  symptoms,  all  of  which  had 
resolved buy the end of the study. 
 
Occupational  status  is  poor  in  patients  with  PNES,  and  existing  evidence 
suggests it remains so even in patients whose attacks cease to be dependent   102 
(Quigg et al, 2002; Reuber et al, 2003a) and our relatively short-term data is 
consistent with this. 
 
At the start of the study all our patients were taking AEDs which are known to 
have  mood  stabilising  effects  and  are  routinely  used  to  treat  emotional 
dysregulation and affective disorders (LaFrance, 2007). One possible outcome 
of  the  AED  withdrawal  would  therefore  be  exacerbation  of  anxiety  and 
depression.  The  HADS  scores  however  remained  stable  for  both  groups 
throughout the study.  
 
As  might  be  expected  the  SEALS  tiredness  scores  at  9  months  were 
significantly  higher  for  the  DW  patients  who  were  still  on  medication.  This 
finding  is  an  example  of  the  negative  impact  that  medication  has  in  these 
patients. 
 
One of the hypotheses behind the study was that removing medication would 
enhance the message that PNES are not a result of a neurological condition 
and change patients illness attributions. Patients’ perception that the cause of 
their attacks was due to stress increased steadily in the IW group becoming 
significantly higher at the end of the study, reflecting a greater internal locus of 
control. For the rest of the IPQ results, it is difficult to draw conclusions because 
of  the  potential  for  multiple  testing  effects.  Importantly  none  of  the  small 
changes in scores throughout the study reflected deterioration.   
 
5.5.1. Methodological considerations 
 
This  study  was  conceived  as  an  exploratory  trial  which  could  inform  future 
research in a field lacking in evidenced-based treatments and we are therefore 
aware of the limitations of the study, particularly our small sample size (n=25). 
This was on the other hand a pragmatic trial conducted within a busy regional 
epilepsy service which potentially makes our experience and results relevant to 
other epilepsy units. 
 
Despite a high patient through-put, our difficulty in recruiting participants can be 
partly explained by the fact that our inclusion criteria were very strict; however   103 
we deemed the robustness of the diagnosis of PNES essential in terms of the 
validity of the study.  
 
Retention was on the other hand very high, possibly reflecting the effort of the 
investigators to keep as many patients as possible by using a proactive and 
flexible approach regarding appointments. There is no doubt that from that point 
of  view  all  our  subjects  received  a  great  deal  of  attention  which  may  have 
influenced  the  outcome,  particularly  in  a  group  of  patients  that  often  feels 
rejected and misunderstood by physicians (Mokleby et al, 2002; Carton et al, 
2007) 
 
The fact that the groups were small was problematic, particularly considering 
that we were testing the effect of a single intervention in a group of complex and 
heterogeneous  patients (Lesser et al, 2003; Cragar et al, 2005; Baslet et al, 
2010). We tried to minimize this variability by comparing our groups at baseline 
not  only  on  demographic  data  but  also  other  factors  which  had  shown  to 
influence the outcome of patients with PNES in previous observational studies 
and in all these aspects both groups were very similar. 
 
An important factor to consider in terms of the effect of our main intervention is 
that in our daily practice, we positively emphasise and explain the importance of 
withdrawing medication to all patients as a crucial step to a complete recovery. 
In order to assess the impact of this intervention and to randomise and consent 
patients  we  had  to  be  neutral  when  discussing  the  effects  of  medication 
withdrawal, therefore diluting the message of the importance of coming off AED 
and possibly reducing impact of the intervention. 
 
Recruitment  and  retention,  the  heterogeneity  of  the  patients,  controlling  for 
Hawthorne  effects  and  choice  of  adequate  outcome  measures  were  all 
methodological issues we encountered. Reassuringly, La France et al., in their 
report of their pilot study for a treatment trial of PNES, describe very similar 
difficulties and make some recommendations for the success of future research 
(LaFrance et al, 2007). 
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5.5.2. Ethical considerations 
 
The ethical implications of leaving subjects with NES on AEDs for 9 months 
after the diagnosis, was discussed extensively by the team. We were clear in 
the fact that our study was designed to compare two pragmatic management 
alternatives and although it is our feeling that patients with PNES should not be 
maintained on AEDs, in practice they often are to the point that it constitutes 
treatment as usual for many physicians (Reuber et al, 2003b; O’sullivan et al, 
2007; Hall-Patch et al, 2010).  
 
 
5.6. Conclusions 
 
Our  research  represents  a  methodologically  rigorous  attempt  to  evaluate  an 
intervention on the management of these very complex patients and represents 
an  important  contribution  to  the  very  few  studies  designed  to  test  a  specific 
management strategy for PNES. 
 
The present study may be regarded as an exploratory exercise and as such has 
provided  a  suggestion  that  withdrawing  AED  enhances  the  effect  of  a  clear 
delivery  of  the  diagnosis.  This  effect  is  reflected  in  a  persistent  reduction  in 
attack  frequency  and  a  cessation  of  the  use  of  emergency  services  and 
medication following AED withdrawal. Importantly, none of our data show any 
negative effects.  
 
. 
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Chapter 6: 
 
 
Psychosocial outcomes of patients with psychogenic nonepileptic seizures 18 
months after diagnosis  
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6.1. Abstract  
 
Background:  Psychogenic  nonepileptic  seizures  (PNES)  are  psychologically 
mediated  attacks  that  resemble  and  are  often  mistaken  for  epilepsy.  The 
evidence base regarding the management of PNES is limited; however, clinical 
consensus  increasingly  supports  a  clear  communication  of  the  diagnosis 
followed by medication withdrawal as the first management step. 
 
Aims: To assess the longer term psychosocial outcomes of AED’s withdrawal in 
a group of patients with PNES. 
 
Methods:  The  current  study  is  an  observational  extension  of  a  pragmatic 
randomised trial comparing the clinical outcomes of PNES patients randomised 
to  immediate  (IW)  versus  delayed  withdrawal  (DW)  of  AED  following  the 
diagnosis.  Comprehensive  psychosocial  data  for  the  whole  sample  was 
collected at baseline and 18 months latter when all subjects were off AED’S  
 
Results: We found significant changes in illness perception with a reduction in 
reported symptoms, a shift towards a more internal locus of control and fewer 
patients reporting a chronic view of PNES. Patients’ mood also improved with 
significantly  lower  depression  scores  at  the  end  of  the  study.  For  the  social 
outcomes  we  detected  a  significant  improvement  in  self  reported  level  of 
functioning as well as an almost significant reduction of patients receiving state 
benefits  because  of  PNES  only.  Employment  status  did  not  change  from 
baseline. 
 
Conclusion:  A  clear  delivery  of  the  diagnosis  of  PNES  followed  by  AED 
withdrawal is successful in removing the label of epilepsy, helping patients to 
shift towards a more psychologically based explanation without negative effects 
on their psychosocial status. 
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6.2. Introduction 
 
Psychogenic  non  epileptic  seizures  (PNES)  are  paroxysmal  events  that 
resemble or are mistakenly ascribed to epilepsy, without being associated with 
epileptiform discharges in the brain. Non epileptic attacks are relatively common 
and represent a significant part of the workload of epilepsy specialists and other 
physicians (Martin et al., 1998). An underlying psychological process is often 
assumed but whether causal or not, patients presenting with PNES certainly do 
describe  high  levels  of  associated  psychopathology,  with  depression  and 
anxiety being most frequently reported (Bowman & Markand, 1996; Moore & 
Baker, 1997; Mokleby et al., 2002; Bailles et al, 2004; D’Alessio et al, 2006). 
Their experience of disability, unemployment and receipt of benefits is just as 
high as in patients with epilepsy (Szaflarski et al, 2003; Hixson et al, 2006).   
 
The purpose of this study is to present the 18 month outcome of a consecutively 
and  prospectively  recruited  series  of  patients  with  a  video  EEG  confirmed 
diagnosis of PNES, and who underwent a planned withdrawal of medication and 
subsequent brief psychological therapy. 
 
6.2.1. Background and rationale for this paper 
 
Increasing  awareness  of  the  diagnosis  of  PNES  and  the  introduction  and 
subsequent  wide  availability  of  simultaneous  video  EEG  has  substantially 
improved the accuracy of diagnosis and the differentiation between PNES and 
epilepsy  (Cragar  et  al,  2002).  The  same  cannot  be  said  for  prognosis  and 
management  (LaFrance &  Devinsky,  2004). Most available  treatment studies 
are methodologically poor, and difficult to interpret, and give little support to a 
single  overarching  rationale  or  approach.  However,  one  area  of  growing 
consensus  within  the  literature  is  the  acceptance  that  the  initial  step  of 
communicating  the  diagnosis  effectively  can  in  and  of  itself  have  substantial 
therapeutic efficacy.  Communicating the diagnosis in a clear and unambiguous 
way  has  been  shown  to  help  patients  understand  and  ultimately  accept  the 
diagnosis,  an  essential  prerequisite  of  future  engagement  with  any  potential 
therapeutic  intervention,  whatever  its  form  and  rationale  (Shen  et  al,  1990;   108 
Farias et al, 2003; Hall-Patch et al, 2010).. 
 
Most  patients  with  PNES  are  originally  diagnosed  as  having  epilepsy  and 
treated  with  AED.  AEDs  have  deleterious  effects  on  physical  health  and 
psychological well-being and their inappropriate prescription courts substantial 
iatrogenic harm (Niedermeyer et al., 1970; Howell et al., 1989; DeToledo et al., 
2000; Peruca & Meador, 2005). Over and above this, however, the fact of being 
prescribed  AED  may  amplify  and  reinforce  illness  perceptions  towards 
‘organicity’  and  attenuate  and  undermine  the  message  that  NES  is  a  ‘non-
organic’  disorder,  perhaps  militating  against  the  patient’s  engagement  with 
behavioural or cognitive treatments designed to help them gain insight into or 
control their attacks (Jacoby et al., 1992; Carton et al., 2003).  Observational 
work (Reuber & Elger, 2003c) suggested an association between remaining on 
anticonvulsants  post  diagnosis  of  PNES  and  a  poor  prognosis  and  the  RCT 
described in the previous chapter confirms the specific efficacy of diagnosis and 
medication and medication withdrawal as an intervention in PNES. 
 
Although attack reduction or cessation is the goal of treatment, there is a lack of 
consensus as to what might constitute a good outcome. Although reduction or 
cessation of attacks has obvious face validity and is easily and reliably rated as 
a measure of the ’disorder’, it may not translate into or correlate with broader 
psychosocial recovery (Quigg et al, 2002; Reuber et al, 2005).   
 
Studies  of PNES  have been criticised for their over narrow concentration on 
seizure frequency as an endpoint (Reuber et al., 2005; LaFrance et al., 2008). 
There is also evidence from studies looking at recovery beyond reduced seizure 
frequency  that  report  ongoing  psychological  morbidity  and  poor  social 
functioning even when a significant proportion of patients report a reduction or 
cessation of attacks. (Quigg et al, 2002; Reuber & Elger, 2003c; McKenzie et al, 
2009). 
 
In  summary,  the  evidence-base  regarding  the  management  and  outcome  of 
PNES is limited, but the converging imperatives of good practice and clinical 
consensus  regarding  the  clear  communication  of  the  diagnosis  and  early 
withdrawal  of  medication,  are  beginning  to  find  a  level  of  support  in 
observational studies (Shen, 1990; Farias, 2003; Thompson, 2005; Hall-Patch   109 
et  al.,  2010)  as  well  as  the  experimental  work  described  elsewhere  in  this 
thesis.  
Following on from the RCT described in chapter 5 the purpose of this paper is to 
present  the  longer  term  psychosocial  outcomes  in  24  prospectively  recruited 
patients  with  PNES  following  their  exposure  to  a  consistent  and  thorough 
diagnostic assessment and management strategy. 
 
6.2.2. Aims of the study  
 
To  assess  the  longer  term  psychosocial  outcomes  of  AED’s  withdrawal  in  a 
group of patients with PNES. 
 
6.2.3. Research questions 
 
Are there any significant changes in patient’s mood following AED withdrawal? 
 
Are  there  any  significant  changes  in  patients  well-being  following  AED 
withdrawal? 
 
Are there any significant changes in patient’s attribution and representation of 
PNES following the withdrawal of AED’s? 
    
6.3. Methodology 
 
The current study is an observational extension of a pragmatic randomised trial 
comparing  the  clinical  outcomes  of  PNES  patients  randomised  to  immediate 
(IW) versus delayed withdrawal (DW) of AED following the diagnosis of PNES. 
Delayed  withdrawal  took  place  at  9  months  following  diagnosis.  The  current 
study  presents  a  cohort  comprising  the  subjects  from  both  arms  when  all 
patients  had been  off medication for at least 6 months  following the gradual 
withdrawal of AED’s. 
 
The trial was based at the Glasgow PNES clinic in the Institute of Neurological 
Sciences at the Southern General Hospital between April 2001 and December 
2003. Patients are referred from a wide variety of sources throughout the West   110 
of Scotland (total population 2.7 million). Full details of the research protocol 
can be found in appendix H. 
 
6.3.1. Management (intervention) 
 
The diagnosis of PNES was confirmed by video EEG and explained in a clear 
and supportive manner, this was backed up with written information to ensure 
that all the same points were covered (see appendix J for scripts of the visits 
and patient information).  
 
As detailed in chapter 5, all patients were seen 3 monthly to monitor medication 
withdrawal  and  assess  progress.  In  terms  of  psychological  intervention, 
following the diagnosis, all subjects were given the option to attend a clinical 
psychologist  for  up  to  6  sessions  of  a  Cognitive  Behaviour  Therapy  based 
intervention. 
 
All participants were offered an appointment with one of the two psychologists 
of our service; the referrals were allocated alternatively to psychologist A or B. 
All subjects were seen within four weeks of referral and had at least two visits 
during the first 9 months of the study. 
 
The team psychologists delivered a cognitive behaviour therapy (CBT) based 
treatment, with an initial session focusing on the acceptance and understanding 
of the diagnosis, subsequent sessions dedicated to identifying triggers for the 
attacks, possible stressors and relaxation training with a final session to review 
the  therapeutic  intervention  and  discuss  relapse  prevention  techniques. 
Because of the limited availability of clinical psychologists subjects were offered 
a minimum of 2 fortnightly sessions and a maximum of 6.     
 
At the start of the study all patients were on AED medication since this was one 
of the inclusion criteria and by 18 months all participants had been gradually 
withdrawn as part of the management plan. 
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6.3.2. Measures 
 
This  paper  focused  on;  psychological  and  general  health  outcomes  as 
measured by the IPQ, HADS and SEALS, and social and occupational status 
and adjustment as indicated by proxy measures such as employment, receipt of 
benefits  and  perceived  functional  status.  Because  of  time  and  personnel 
constraints all scales were self reported.    
 
Clinical outcomes as attack frequency, as measured by a diary and health care 
utilisation are reported in detail in Chapter 5.  
 
All  scales  were  completed  at  baseline,  3  monthly  follow  up  and  upon  study 
completion, scored by a research assistant and the results concealed from the 
primary researcher and those involved in administering psychological treatment 
until the end of the study.   
 
The scales were as follows:   
 
6.3.2.1. Seizure diary  
To record attack frequency subjects were given a standardised diary designed 
specifically for the study. The reason for creating our own attack diary was to 
ensure  that  it  contained  no  reference  to  epilepsy  or  epileptic  seizures  which 
could potentially send mixed messages and affect patient’s view of the attack 
disorder. The diary was completed based on self report and carer and relative 
comment (see appendix O). 
 
6.3.2.2. National Adult Reading Test (NART-2nd edition) 
 
A list of 50 irregularly spelled words is read aloud by participants, and scored for 
pronunciation errors to determine a predicted full scale IQ. Subjects with a score 
lower than 70 were not included. 
 
An IQ within the normal limits was one of the inclusion criteria for the trial. As 
well as ensuring that all subjects had the capacity to understand there is also 
evidence that patients with a low IQ have a distinct underlying mechanism for 
PNES (Duncan et al, 2008).   112 
 
6.3.2.3. Side Effects and life satisfaction inventory (SEALS; Brown & Tomlinson, 
1982) 
 
This inventory is a 50 item self reported questionnaire derived from, designed 
for, and validated in subjects with epilepsy which is sensitive to change over 
time. In general terms it corresponds to a measure of well being and physical 
and psychological health with particular reference to the day to day problems 
and drug side effects reported by patients with epilepsy. The scale was derived 
from symptoms and side effects reported by patients, with principal component 
analysis identifing five main areas of difficulty; “cognition” ,”dysphoria” ,”temper”, 
“tiredness”  and  “worry”.  Each  subscale  contains  a  series  of  positively  and 
negatively phrased items with a four point response matrix between 0 and 3 
with 0 being “never” and 3 “many times”. 
 
The SEALS inventory has been found to have the qualities of validity, reliability 
and responsiveness to be used in research and clinical settings. The scale has 
a good internal consistency with a Cronbach’s coefficient >0.7 for all subscales. 
It is a valid tool to investigate and monitor the effect of AED therapy on quality of 
life and to measure changes in patient’s well-being in response to changes in 
management (Gillham et al, 2000). 
 
This scale, although originally designed for patients with epilepsy, seemed the 
most appropriate tool to assess potential changes following the withdrawal of 
AED as part of the management of PNES. 
 
6.3.2.4.  Hospital  Anxiety  and  Depression  Scale  (HADS;  Zigmond  &  Snaith, 
1983). 
 
The HADS was developed to identify possible cases of anxiety and depression 
amongst  patients  in  non-psychiatric  hospital  clinics  and  to  monitor  mood 
changes over time. To avoid confounding by physical illness, the symptoms of 
anxiety  and  depression  relating  to  physical  illness  were  excluded  from  the 
questionnaire.  The  HADS  is  a  self-report  scale  comprising  of  14  items  that 
probe aspects of depression and anxiety in the past 7 days. The scale can be 
divided  into two subscales  (anxiety and depression),  with  higher sum scores   113 
indicating more anxiety and depression. Scores <8 indicate the normal range, 
scores  between  8  and  10  reflect  mild  symptoms  and  scores  >11  indicate 
clinically relevant symptoms. The scale has a sensitivity of 83.3% and specificity 
of 61.5% for identification of psychiatric cases. The HADS has similar screening 
properties  when  compared  with  more  comprehensive  instruments  used  to 
identify anxiety and depression (Bjelland,   2002). 
 
6.3.2.5. Illness Perception Questionnaire (Weinman et al 1996) 
 
This  provides  a  quantitative  assessment  of  the  five  components  of  illness 
representation  derived  from  Leventahl’s  Self-Regulatory  Model.  The  model 
proposes that symptoms generate and are interpreted and acted upon via an 
overarching cognitive and emotional representation of the illness. The scale is 
divided into 5 subscales:  
 
·  Identity: the label the person uses to describe the illness and symptoms 
they view as being part of the disease.  
·  Consequences: the expected effects and outcome of the illness. 
·  Cause: the patient’s idea about the cause of their illness.  
·  Time-line: patient perception of how long the illness will last. 
·  Control: the extent to which the person will recover or control the illness. 
  
The  first  subscale  is  Illness  identity  and  comprises  12  core  symptoms  that 
patients rate for frequency on a four point scale, ranging from all the time to 
never. The cause subscale can be subdivided into attribution to external factors 
(germ or virus, pollution, hereditary factors, poor medical care and chance) and 
internal factors (stress, my state of mind, own behaviour, other people had a 
role).The other three subscales included a series of statements related to time 
line, consequences or control. The individual items are scored on a 1-5 scale 
indicating  the  strength  of  the  agreement  with  the  individual  statement  with 
higher scores indicating stronger agreement. An average score of the individual 
items is obtained. 
 
For the time-line subscale, higher scores represent beliefs that the illness will 
last a long time, higher scores on the consequence subscale reflect a belief of   114 
greater consequences and, finally, higher scores for the control-cure subscale 
reflects patients’ impression of lack of control. 
 
This early version of the IPQ has been found to have a good re-test reliability 
and internal consistency (Cronbach’s Alpha >0.7) as well as discriminant and 
predictive validity (Weinman & Petrie, 1997). 
 
6.3.3. Statistical analysis 
 
The evaluation of the data was performed with the computer program SPSS for 
Windows version 14.  
 
A descriptive analysis of the data for continuous variables (i.e. IPQ, HADS and 
SEALS)  showed  that  the  results  were  essentially  normally  distributed  (as 
assessed by kurtosis and skewedness, with both metrics lying between -1 and 
+1),  paired  t-tests  were  therefore  used  throughout.  Sensitivity  analysis  via 
equivalent  non  parametric  tests  did  not  significantly  alter  the  results.  To 
maximise ecological validity social functioning data was captured as a series of 
real world dichotomous outcomes such as employed vs. unemployed, analysed 
using  McNemar’s  test.  Finally  a  post  hoc  analysis  was  conducted  for  all 
outcomes  for  the  grouping  /  predictor  variable  of  attack  freedom,  using 
independent t tests or Fishers test as appropriate to assess for any difference in 
baseline or outcome for those subjects demonstrating attack freedom.  
 
For all statistical analyses a p value <.05 was considered statistically significant. 
Outcome data were also presented after correcting for multiple testing using the 
Bonferroni correction.  
 
One of the patients (1/25, 4%) randomised to immediate withdrawal was lost to 
follow up after the second control visit; all their data has been excluded from 
analysis subsequent to this point. 
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6.4. Results 
  
6.4.1. Demographics and baseline characteristics 
 
The mean age of the subjects at presentation to the clinic was 41 years (sd 
14.4), ranging from 16 to 65. The majority of patients were female (20/25, 80%) 
and  17  /25  (68%)  had  a  partner  or  were  married.  All  patients  were  on 
medication as it was one of the entry criteria with a median number of AED of 1 
ranging between 1 and a maximum of 3.  
 
The mean IQ as estimated by the NART was 99.6(sd 8.4), ranging between 80 
and 115. At baseline, 14/25(56%) patients had previous contact with psychiatric 
services  and  8/25(32%)  were  prescribed  an  antidepressant.  Five  out  of  the 
twenty five patients (20%) had previously attracted a diagnosis of personality 
disorder, 7/25 (28%) reported other chronic physical symptoms, and 8/25(32%) 
disclosed a history of sexual abuse.  
 
In terms of the psychotherapeutic intervention, 4/25(16%) subjects declined to 
see a psychologist and the rest had a median of 3.8 sessions (range 1-8). At the 
end  of  the  study  4/10  of  the  attack-free  patients  and  5/14  had  managed  to 
complete  the  6  sessions,  this  was  not  statistically  significant  (McNemar  test 
p=0.26).   
 
At baseline the median attack frequency was 20 per month (range 5- 700); as 
compared to 2 per month (range 0- 60) at the end by which time 10/24 (41.6%) 
patients had been attack free for at least 2 months. Following drug withdrawal 
no patient was in contact with the emergency services or had received acute 
anticonvulsant  treatment,  a  significant  reduction  of  healthcare  utilisation 
compared with baseline (p< 0.002). 
 
One of the patients (1/25, 4%) randomised to immediate withdrawal was lost to 
follow up after the second control visit, all their data has been excluded from 
analysis subsequent to this point. 
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6.4.2. Psychological outcomes 
 
As shown in Table 6.1, the mean scores for anxiety and depression at baseline 
were within the mild range. There were no significant differences between the 
HADS scores of the 8 patients on Antidepressants and the rest of the sample at 
baseline. By the end of the study the mean score for depression had decreased 
significantly (p=0.05) with a mean within the normal range. 
 
Table 6.1: Comparison of the mean(sd) scores on psychological outcome measures between 
baseline and end of the study at 18 months.   
At presentation At 18 months 
Mean (sd) Mean (sd)
HADS
SEALS
Worry 7.7 (3.9) 6.7 (2.5) 0.89
Temper 6.6 (3.4) 6.8 (3.1) 0.67
Cognition 24.9 (11.7) 26.5 (3.5) 0.68
Tiredness 8.3 (4.09) 8.6  (4.3) 0.66
Dysphoria 10.1 (4.5) 9 (4.3) 0.25
IPQ
7.8 (2.4) 5.9 (3.9) 0.03*
External locus of 
control 15.4 (5.2) 14.4 (4.3) 0.4
Internal locus of 
control 8 (3) 10 (2.7) 0.01*
Paired T test ,* P< 0.05
0.14
Control 3 (0.5) 3.3 (0.8) 0.15
Consequences 3.5 (0.8) 3.2 (0.8)
0.05
Number of reported 
symptoms
Time line 3 (0.3) 2.6 (0.6) 0.01*
Depression 8.5 (4.9) 6.7 (3.5)
p- value
Anxiety 10.5 (5.3) 9.8 (3.2) 0.5
 
  
 
Despite withdrawal of medication we did not detect any significant changes in 
the SEALS scores between baseline and the end of the study. 
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As shown in Table 6.1, the IPQ scores significantly decreased from baseline for 
several domains; at 18 months there was a significant reduction in number of 
symptoms reported, measures reflecting a higher internal locus of control had 
improved and patients were less likely to perceive their disorder as chronic. 
 
6.4.3. Social outcomes 
 
At  baseline  3/25  (8%)  subjects  were  working  or  in  full  time  education  and 
22/25(88%) were unemployed and on disability benefits (see table 6.2). 
 
Table 6.2: Comparison of social functioning outcome data from baseline to end of the study at 
18 months.  
At baseline At follow up p
Employment status: Working  2/25(8%) 4/24(16%) 0.50
On social security benefit
No 4/25(16%) 8/24 (33%) 0.25
Yes for NES 7/25(28%) 2/24 (8%) 0.06
Yes for other 14/25(56%) 15/24 (56%) 0.22
Able to attend clinic alone 5/25 (20%) 10/24 (40%) 0.18
Level of activity
Premorbid level 0/25 8/24 (32%) 0.008*
#
Limited by NES 13/25(52%) 7/24 (28%) 0.22
Limited by other 12/25 (48%) 10/24 (40%) 0.62
McNemar test ,* P<0.05
# remained sig. after Bonferroni correction
 
In terms of previous occupation, most patients had unskilled jobs (14/25, 56%) 
and 3 patients had never worked. Interestingly 5/25 (20%) patients had jobs in 
social care, four as care assistants and one as a nursery nurse. At 18 months, 
three patients moved on to further education; one subject started a psychology 
degree and the other two a nursing a degree. One patient had stopped working; 
however, 3 had managed to get back to employment by the end of the study. 
  
Seven patients in the study were awarded benefits only because of the attacks 
and based on an initial diagnosis of epilepsy. At the end of the study, only two of 
these  7  patients  were  still  receiving  benefits,  this  reduction  showing  a  trend 
towards significance (p = 0.06). As shown in table 6.2, measures of dependence 
also improved with twice as many people able to attend the clinic alone and a   118 
significant higher number of subjects reporting levels of daily activity back to a 
pre morbid level.   
 
6.4.4. Post-hoc analysis of attack free patients 
 
At outcome, and as presented in table 6.3, subjects who were attack free were 
compared  with  the  remainder  on  psychosocial  outcome  to  investigate  any 
relationship between attack freedom and broader measures of recovery. 
 
Table 6.3: Post-hoc analyses comparing attack or not attack free patients with all outcomes 
which significantly changed from baseline .    
Attack Free patients Non-Attack Free p-value
Depression scores (HADS), Mean (sd) 4.9(2.9) 5.6(2.1) 0.01*
Number of reported symptoms (IPQ), Mean 
(sd)
4.2(4.1) 7.2(3.4) 0.05*
NES seen as chronic, Mean (sd)  2.2(0.6) 2.9(0.4) 0.03*
Internal locus of control (IPQ), Mean (sd)  9.4(2.8) 10.8(2.4) 0.23
Attribution to stress, Mean (sd) 2.4(1) 2.9(1.1) 0.35
Pre-morbid level of activity  1/24(%) 7/24(%) 0.01*
On benefits because of NES only  2/24(%) 0/24(%) 0.58
 
 
Patients in the attack free group had lower scores of depression as assessed by 
the HADS questionnaire; were reporting lower number of symptoms; and were 
less  likely  to  regard  their  condition  as  chronic.  There  were  no  differences 
between groups in terms of locus of control. 
 
In terms of the social outcomes, attack free patients were more likely to report 
activity at a pre-morbid level but there were no significant changes for receiving 
benefits  because  of  PNES.  Only  a  small  number  of  patients  had  been  on 
benefits  purely  because  of  PNES,  and  although  this  number  clearly  fell  in 
absolute terms there was insufficient power to demonstrate this statistically.   
 
6.5. Discussion 
 
These results are encouraging because they show a significant improvement 
from baseline on a number of psychological and social functioning measures.   119 
However, when looking at these results, in the context of the 40% of attack free 
patients 18 months after the diagnosis, these changes appear modest. 
 
Our results are in line with other outcome studies reporting limited improvement 
of  social functioning variables at follow-up (Quigg et al, 2001; Reuber et al, 
2005; Kuyk et al, 2008). Poor social outcomes have also been reported in other 
medically unexplained symptoms (Stone et al, 2003; Sharp et al, 2010).  
      
We found significant changes in illness perception with a reduction in reported 
symptoms,  and  a  shift  towards  a  more  internal  locus  of  control  as  well  as 
significantly  lower  depression  scores  at  the  end  of  the  study.  For  the  social 
outcomes  we  found  a  significant  improvement  on  a  self  reported  level  of 
functioning, as well as an almost significant reduction of patient receiving state 
benefits because of NES only. Employment status on the other hand did not 
change significantly from baseline. 
 
Considering the nature of our intervention, an important outcome of this paper is 
the fact that by the end of the study none of our patients had been restarted on 
AED.  Re-introduction  of  AED  in  this  group  of  patients  is  not  uncommonly 
reported and has been linked with a lack of acceptability of the diagnosis by 
patients, carers and GP’s (Lempert et al, 1990; Walczak et al, 1995; Jongsma, 
1999; O’Malley, 2000). Accepting the diagnosis of PNES is in itself important for 
engagement  with  future  treatment  (Sirven  &  Glosser,  1998;  O’Malley  et  al, 
2000) and also has been associated with good prognosis (Ettinger et al, 1999). 
Our management appears therefore to have been successful in removing the 
label of “epilepsy” and helped patients to accept the diagnosis of PNES. 
 
6.5.1. Psychosocial outcomes  
 
At the end of the study the anxiety scores of the HADS had remained stable 
however  the  depression  scores  had  significantly  improved.  Although  a 
statistically significant change the clinical impact of the reduction of depression 
scores  is  modest  if  compared  with  the  effect  size  expected  in  trials  of 
antidepressants. 
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Interestingly the post hoc analysis showed that attack free patients were more 
likely to have lower scores of depression; it can be argued that the reported 
improvement  of mood is  a reflection  of clinical  improvement. This  raises  the 
question discussed by other authors of whether the attack disorder in itself is 
the cause or at least a significant factor contributing to the frequently reported 
depressed mood of patients with PNES (Bodde et al, 2008; Fiszman & Kanner, 
2010). 
 
We also need  to consider the fact that the improvement in mood could also 
been a result  of  the  attention  given  to  the subjects  as  part  of the study. As 
previously discussed by LaFrance, this effect may be a particular issue in this 
group of patients that frequently feel rejected or accused of pretending by health 
professionals (Green et al, 2004; LaFrance, 2007; Thompson et al, 2009).  
 
As  part  of  our  intervention,  medication  was  withdrawn  in  all  patients; 
continuation of AED however has been justified by some authors on the basis of 
the potential mood stabilising and impulse control effects of AED’s (Ettinger et 
al, 1999; LaFrance, 2008). Our results, however, show no deterioration in mood 
or behaviour following the withdrawal of AED. O’Sullivan et al. also found no 
differences  when  comparing  outcomes  between  patients  on  AED  with  mood 
stabilising effects or not. Our view is that the benefits of withdrawing AED in 
patients  with  PNES  outweigh  any  hypothetical  benefits  from  continuing  a 
medication originally prescribed for suspected epilepsy.  
 
In summary, we detected a significant improvement of the depression scores 
which  may  be  a  result  of  our  intervention  or  other  factors.  The  fact  that 
withdrawal of medication did not result on a deterioration of mood is possibly 
more  relevant  in  the  context  of  our  intervention  and  would  support  our 
management strategy. 
 
In terms of illness representation, we know that patients with PNES are likely to 
have  a more external locus of control and are less likely to see  stress as a 
relevant factor (Goldstein et al., 2000; Stone et al., 2004). Our study showed 
that by 18 months subjects, had a greater internal locus of control were more 
likely to attribute their condition to psychological causes and were less likely to 
see their condition as chronic.   121 
 
The  changes  in  locus  of  control  and  attribution  however  did  not  seem  to 
translate into clinical improvement, since by the end of the study attack free 
patients did not have a higher internal locus of control when compared with non-
attack free patients. This finding was surprising since higher internal locus of 
control  and  reattribution  to  stress  is  an  important  objective  of  psychosocial 
interventions for PNES and used as markers of improvement (Goldstein et al, 
2004;  LaFrance  et  al,  2009).  Since  all  the  patients  from  our  study,  were 
constantly advised that PNES were caused by stress, there is a possibility that 
the observed shift toward a psychological explanation partly reflects a response 
bias rather than a true change of insight. 
 
It  is  also  interesting  that  the  external  locus  of  control  did  not  change 
significantly; in fact the scores were low at baseline and remained low. It does 
not appear that the attribution changed for external causes to psychologically-
based  ones.  This  scale’s  validity  was  originally  established  in  patients  with 
chronic  fatigue  syndrome  leading  to  items  attributing  illness  to  germs  and 
pollution.  As such it is possible that this particular scale (IPQ) did not cover 
external factors of specific relevance to our group who would might be expected 
to attribute their condition to, for example, a neurological disorder (Weinman, 
1996).  
 
For  a  future  longer  term  outcome  study  an  important  issue  would  be  to 
determine weather reattribution to stress or mental state correlated with a real 
shift in locus of control and insight in patients with PNES. 
 
Finally, by the end of the study patients were less likely to see their condition as 
chronic,  particularly  for  attack-free  patients,  which  is  intuitively  appealing. 
Interestingly, a pilot study of CBT treatment with a similar number of attack-free 
patients showed no changes on the perception of chronicity (Goldstain et al., 
2004).  
 
A wider number of physical symptoms has been associated with poor prognosis 
of PNES (Reuber et al., 2004) and our results seem to corroborate this finding 
since by the end of our study, patients in the attack free group were reporting 
less symptoms when compared with patients that were still having attacks.   122 
 
As  part  of  our  comprehensive  psychological  outcome  measures,  we  were 
interested in the potential impact of AED. The negative impact of antiepileptic 
medication on the quality of life of patients with epilepsy is well documented 
(Jacoby  et  al.,  1992;  Perucca  &  Meador,  2005)  and  from  that  point  of  view 
patients with PNES treated with AED are exposed to the same potential side 
effects if not more.  
 
We used the SEALS questionnaire which is sensitive to medication changes; 
however,  we  found  no  significant  differences.  It  is  possible  that  the  SEALS 
questionnaire which was designed for epilepsy patients was unable to detect 
any  differences  in  a  distinctly  different  group  of  patients  with  high  levels  of 
psychopathology,  including  disorders  of  personality  and  other  somatic 
symptoms  as  chronic  pain  and  fatigue  (Devinsky,  1996b;  Galimberi,  2003; 
Benbadis, 2005) 
 
 6.5.2. Social outcomes  
 
As reported by other authors the overall social outcomes of the study were poor 
(Reuber, 2003; O’Sullivan, 2007; Duncan & Oto, 2008; Kuyk, 2008). Some of 
the results, however, were encouraging,  particularly  the  reduction of patients 
receiving state benefits because of PNES.  
 
A  high  proportion  of  patients  with  PNES  receive  benefits  and  this  has  been 
consistently reported as factor of poor prognosis. (Kristensen, 1992; Lempert, 
1999; Reuber et al., 2003b; McKenzie et al., 2009). Most outcome papers report 
the percentage of patients on social security benefits without any further details; 
however the reason for receiving benefits may have nothing to do with PNES. In 
this paper we distinguished between patients on social security because of the 
attacks only, or due to other reasons. 
  
One of the most interesting findings from the present study is the fact that Social 
security benefits were stopped for most of the patients reporting PNES as the 
only disability. Since all these patients were initially diagnosed with epilepsy and 
treated  accordingly  with  AED,  a  firm  diagnosis  of  PNES  followed  by  the   123 
withdrawal of AED appears to have removed the epilepsy label and the need for 
benefits.  
 
A significant number of patients also reported a return to the level of activity of 
before PNES, and these subjects were significantly more likely to be attack free. 
This improvement, however, has to be viewed with caution since the reported 
level of activity of many of our subjects had been very limited even before they 
developed PNES. 
 
6.5.3. Methodological considerations  
 
The current study has some methodological limitations and our findings need to 
be viewed with caution. The sample size was small, particularly considering the 
amount of statistical tests performed; we acknowledged this limitation and also 
presented  the  results  correcting  for  multiple  testing.  However,  given  the 
exploratory  and  observational  nature  of  the  study,  the  aim  was  to  detect 
potentially important differences in the first place by protecting against Type 2 
error. The results of the current research therefore require confirmation by an 
appropriately powered study.  
 
In terms of the characteristics of the sample, a potential confounder was the 
variation in chronicity amongst patients; there is evidence that the length of the 
disorder has an impact on outcome (Lempert, 1990; Buchanan, 1993; Walczak, 
1995) although this has also been disputed (McKenzie, 2010). It can also be 
argued  that  eighteen  months  may  be  too  short  a  period  to  detect  certain 
changes, particularly employment and benefit status (LaFrance et al., 2006). 
 
As part of our treatment protocol, all our subjects were offered up to 6 sessions 
with  clinical  psychologists,  not  all  patients  attended  and  only  less  than  half 
completed the course. Although this was our TAU, when presenting the results 
of the whole group, the fact that not all patients had the same input in terms of 
psychotherapeutic intervention, was a potential confounder. 
 
We  also  acknowledge  the  fact  that  this  paper  is  based  on  an  original 
Randomised  Controlled  Trial  investigating  the  effects  of  withdrawing  AED  in 
patients with PNES.   124 
  
The main strengths of the present study on the other hand include; the accuracy 
of the diagnosis and the homogeneity of the sample in terms of management 
and length of follow up, which is a recognised problem for most outcome and 
prognosis  studies  on  PNES  (Bowman,  1998;  LaFrance,  2007;  Bodde  et  al, 
2008). Our sample represents a purer group of patients when compared with 
other larger studies (Reuber et al, 2003) since all patients had the diagnosis of 
PNES confirmed by video EEG and none had coexisting epilepsy. 
 
6.6. Conclusion 
 
With this paper we present psychosocial outcome data for a group of patients 
with PNES following a study design that overcomes some of the methodological 
problems encountered in other published studies, in terms of diagnostic rigour 
and sample homogeneity.  
 
Despite  the methodological limitations,  the  results of this observational  study 
are  encouraging;  including  an  improvement  of  depression  scores,  a  shift 
towards a more internal locus of control, less restricted levels of activity and a 
significant reduction of the number of patients receiving Social Security benefits 
because of PNES only.  
 
Our main management strategy was based on the idea of diagnostic clarity and 
from this point of view we were successful in removing the label of epilepsy and 
shifting  the  focus  to  a  more  psychologically  based  explanation  without 
destabilising the patients. 
 
Further research, with purposely designed studies, larger samples and longer 
follow up periods is still needed in this area. 
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7.1. Thesis findings: Summary 
 
The subject of AED in the context of PNES is increasingly recognised as an 
important  issue  and  although  discussed  in  many  review and  opinion  papers, 
there is very little original research to confirm clinical opinion. The current thesis 
intends to investigate the effects of the continuation or withdrawal of AED in 
patients with PNES. The main findings are presented in table 7.1.  
 
Table 7.1: Key findings from current thesis.  
Chapter     Key Findings 
     
2   
A systematic review of the literature found three observational studies reporting the continuation 
of AED as a prognostic factor.  
   
Two papers reported association between continuation of AED and a poor prognosis and a third 
paper reported no effect. 
   
Due to important methodological problems in all three studies, we were unable to reach a 
conclusion. 
     
4    An observational outcome study on the safety of AED withdrawal in  patients PNES, showed: 
   
- 3/78 patients presented with new attacks (complex partial seizures) during withdrawal, but were 
fully controlled by the end of the study   
    - 4/78 were medically treated for prolonged attacks (significantly lower number) 
    - 14/78 reported new symptoms after AED withdrawal. 
    - No serious medical complications were reported  
    - At the end of the study there was a significant reduction of attack frequency 
     
5   
An exploratory Randomised Controlled Trial evaluating the possible therapeutic effects of  AED 
withdrawal: 
    - 25 subjects were recruited ,14 randomised to IW and 11 to DW 
   
- The IW group had a significant reduction of the use of emergency treatment for PNES, and a 
lower proportion was using emergency services when compared with the DW group. The IW group 
was less likely to report tiredness as assessed by the IPQ. 
   
- The IW had a sustained reduction of attacks throughout the study; by the end of the study 50% 
were attack free as compared with 27% in the DW group (NS). 
    - There was no evidence of clinical deterioration in the IW group or the DW group after   
     
6   
An observational study assessing the longer terms outcomes of  patients with PNES showed the 
following significant findings: 
    - Improvement of the depression scores of the HADS   
   
- Increase of internal locus of control and less patients reporting their condition as chronic as 
assessed by the IPQ  
   
- Less restricted levels of activity as well as a reduction in the number of patients receiving benefits 
because of PNES  
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Chapter 1 comprises the introduction of the thesis, which gives an overview and 
background  to  PNES.  The  introduction  also  starts  to  set  the  scene,  with 
particular reference to the iatrogenic harm associated with the use of AED and 
the inappropriate medicalisation of PNES that may perpetuate symptoms and 
worsen prognosis. 
 
In chapter 2, a systematic review of the literature concludes that there is a lack 
of good quality research and, therefore, of any reliable evidence on the effects 
of AED treatment in patients with PNES, justifying the need for further original 
research in this area.  
 
Chapter 4 presents the results of a large observational study to establish the 
feasibility  and  safety  of  supervised  AED  withdrawal  in  patients  with  an 
established  diagnosis  of  PNES.  The  conclusion  of  this  study  is  that  the 
withdrawal of AED is a safe intervention in terms of mortality and morbidity.  
 
To evaluate the potential therapeutic effect of AED withdrawal we next designed 
a randomised controlled trial which is presented in chapter 5. The results of this 
exploratory trial suggested a possible therapeutic effect of AED withdrawal, with 
a sustained reduction of attacks following the withdrawal of medication and a 
significant reduction in health-care utilisation.  
 
The  last  original  paper,  presented  in  chapter  6,  investigates  the  longer  term 
psychosocial outcome data on the whole group. The study reports significant 
improvement in some psychosocial measures and at the same time highlights 
some of the difficulties in assessing outcomes with current available measures 
in this heterogeneous group of patients. 
 
This last study also presents the results of a sample of patients subject to a 
rigorous  diagnostic  procedure,  a  standardized  management,  and  with  equal 
length of follow up time. These are unusual methodological features, and indeed 
strengths, over most of the currently published observational studies (Kanner et 
al, 1999; Carton et al, 2003; Reuber at al, 2003b; O’Sullivan et al, 2006). 
 
In conclusion, the research presented in this thesis has provided evidence that 
taking patients with PNES off AED, following diagnosis, is as safe as a clinical   128 
intervention, and has potentially beneficial effects as a therapeutic intervention 
in  the  shorter  and  longer  term  for  a  variety  of  clinical  and  psychosocial 
dimensions.  The  RCT  (chapter  5)  also  represents  an  important  contribution 
adding to the very few methodologically sound studies in the field of PNES. 
  
7.2. Methodological considerations 
 
Above all, the original research presented in this thesis represents a rigorous 
attempt to investigate this complex and heterogeneous group of patients. Only 
patients  diagnosed  with  the  gold  standard  test  were  included,  patients  were 
recruited  prospectively,  and  great  emphasis  was  placed  on  ensuring  the 
standardisation of the intervention.  
 
Research with this group of patients however is complicated by several factors:  
 
·  A  relatively  low  incidence,  often  resulting  in  highly  selected  or 
opportunistic samples. 
·  The limited availability of the main diagnostic test (Video EEG).  
·  The heterogeneity of the group in terms of associated psychopathology 
and underlying aetiology for PNES. 
·  The paroxysmal nature and variable course of the disorder. 
·  No evidence for any particular management strategy and, therefore, no 
gold standard. 
 
The  research  presented  in  this  thesis  attempted  to  address  some  of  these 
difficulties;  however  individual  chapters  do,  admittedly,  have  some 
methodological problems which need to be discussed. 
 
Our  subjects  were  recruited  from  the  only  epilepsy  service  in  the  West  of 
Scotland, most patients being referred directly by the GPs rather than tertiary 
referral centres and from that point of view we feel the sample population is 
representative  of  the  wider  PNES  population.  However,  for  the  RCT  only,  a 
relatively small proportion of the patients screened were eligible for the study. 
Although we detected no significant differences between the two groups, it is 
possible that this minority of selected patients had unknown confounders.    129 
 
To  limit  heterogeneity,  only  patients  with  video  EEG  confirmation  of  the 
diagnosis were included and all patients with coexisting epilepsy were excluded. 
Despite our efficient protocol for video EEG monitoring, this entry criteria limited 
our recruitment, particularly for the RCT (chapter 5). 
 
If our entry criteria for the diagnosis of PNES had been less restrictive, we could 
have recruited a further 37 patients who had the clinical diagnosis of PNES but 
were  awaiting  video  EEG  (chapter  5).  A  recent  RCT  on  CBT  treatment  for 
patients with PNES achieved the required number of subjects by sacrificing a 
degree of diagnostic accuracy (Goldstein et al, 2010). 
 
The issue of differences in co-morbid psychopathology or underlying causes for 
PNES, was possibly less relevant for the first study (chapter 4) since we were 
testing the clinical safety of an intervention, and in the second study (Chapter 5) 
the  randomisation  ensured  that  at  least  both  groups  were  similarly 
heterogeneous. The last study, however, represents a heterogeneous sample 
from that point of view. 
 
None of the studies in this thesis were blinded in that subjects were aware of 
the intervention.  However the observational study reported in chapter 4 had to 
take place with explicit consent and the pragmatic nature of the RCT and its 
subsequent  extension  entailed  the  presentation  to  patients  of  real  world 
alternatives with the foreknowledge that patient expectation would be a part of 
the  effect  both  in  the  experimental  setting  and  beyond.    In  terms  of  other 
safeguards  against  bias  all  evaluations  could  have  been  independent  of  the 
principal researcher.  
 
In  terms  of  the  psychotherapeutic  interventions  offered  to  our  subjects  we 
acknowledge that although delivered by very experienced neuro-psychologists 
who  followed  a  basic  agreed  structure,  their  input  was  not  completely 
standardised. This is not ideal from a scientific point of view; however in the 
context of the studies presented in this thesis it is possibly less relevant since 
our aim was to assess the initial steps of management within a neurology clinic 
setting focusing on a shift in medical explanation and management. 
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For a study looking at the further management of PNES beyond the diagnosis a 
strict protocol of any intervention would be essential to evaluate its effectiveness 
as in the case of the studies presented by LaFrance et al and Goldstein et al 
which we see as complementary to our studies (LaFrance et al, 2009; Goldstein 
et al , 2010).  
 
To ensure treatment fidelity we agreed on a series of scripts for all patients’ 
contacts, it proved however impossible to perform an analysis of its delivery. 
 
Finally,  since  recruitment  for  the  RCT  was  so  difficult,  strenuous  efforts  to 
ensure retention were undertaken to ensure the viability of the study and the 
results  may  be  a  reflection  of  a  Hawthorne  effect  deriving  from  this  added 
attention and effort.  Other authors have recognised this problem (LaFrance et 
al, 2009; Goldstein et al, 2010). 
 
7.2.1. Outcome measures 
 
Choosing  relevant  and  valid  outcome  measure  for  this  group  of  patients  is 
complicated.  As  discussed  by  other  authors,  the  choice  of  measures  has  to 
balance comprehensiveness with practicality (Quigg et al, 2002; Reuber et al, 
2005; LaFrance et al, 2006). 
 
Seizure  freedom  and  to  a  lesser  extent  attack  reduction  are  recognised  as 
objective and valid measures of improvement, however, as already discussed in 
this thesis they are not comprehensive enough as isolated outcomes. Broader 
psychosocial outcomes are necessary to evaluate improvement and outcome of 
patients with PNES (La France et al, 2006). 
 
On the one hand, adding a wide range of outcome measure would ensure a 
more  comprehensive  assessment  of  outcome  and  avoid  missing  potentially 
important changes due to the intervention. On the other hand, a large number of 
measures can compromise statistical power, a particularly relevant point in this 
field, where prospective recruitment of large number of patients is difficult. 
 
A consensus statement form a group of experts following a workshop on the 
development  of treatment for PNES suggested  a list  of measures which  are   131 
listed in table 7.2. The use of standardised measures, with solid psychometric 
properties  and  sensitivity  to  the  intended  treatment  change,  was  also 
recommended. 
 
Table 7.2: Potential outcome variables for treatment studies of PNES.  
 
1 Attack frequency 
2 Individual concerns
3 Employment status 
4 Psychiatric symptoms and personality characteristics 
5 Health related quality of life 
6 Psychophysiologycal variables (e.g., arousal)
7 Family/psychosocial factors 
8 Healthcare utilisation 
9 Illness cognition /representation 
 
 
For the three studies included in this thesis our choice of measures aimed to be 
comprehensive,  combining  attack  frequency  with  a  variety  of  psychosocial 
outcome measures, and covered most of the domains suggested in table 7.2. 
We chose a number of standardised scales as well as relying on self reports for 
some domains.  
 
In terms of standardised questionnaires, we had to use available measures from 
other areas since there are no scales specifically designed to assess PNES. 
The  IPQ  had  been  validated  for  other  somatisation  disorders  (e.g.  ME);  the 
SEALS was designed to evaluate quality of life in patients with epilepsy, taking 
into account the side effects of AED; and the HADS had been previously used 
for patients with PNES to assess mood changes. 
 
Using scales designed for patients with epilepsy has some logic, since epilepsy 
is also a paroxysmal disorder which has an important impact on patient’s quality 
of  life  (Jacoby  et  al,  2009).  Patients  with  PNES,  however,  have  different 
characteristics  when  compared  with  patients  with  epilepsy,  with  a  higher 
proportion with personality disorders, higher levels of somatisation as well as 
distinct ways of perceiving and expressing their distress (Frances et al, 1999; 
Reuber,  2003;  Galimberti  et  al,  2003;  Binzer  et  al,  2004).  The  SEALS   132 
questionnaire was an appropriate choice for our research, particularly since we 
were interested in outcomes associated with AED, although it is possible that 
with so much ‘background noise’ from the study population, this questionnaire 
was not sensitive enough to detect changes. 
 
The IPQ on the other hand was designed to assess illness beliefs for a wide 
variety of illnesses and is validated for a somatoform disorder (ME). There is no 
doubt that assessing illness beliefs in PNES patients is important, particularly 
since our hypothesis was based on how continuation of AED affects patients’ 
understanding  of  their  disorder,  however  there  are  some  considerations  that 
need to be made. 
 
The version of the IPQ which we used had some problems that have since been 
addressed  in  a  revised  version,  but  this  was  unavailable  at  the  time. 
(MossMorris et al, 2002). As well as strengthening the psychometric properties 
of the scale, a cyclical time line subscale was included for paroxysmal disorders 
which would obviously have been of particular relevance to PNES. 
 
However, for all versions of the IPQ, researchers are encouraged to adapt the 
scale to their particular subject. In retrospect it would have been interesting to 
add symptoms in the ‘identity subscale’ relevant to the attack disorder, and a 
question in the ‘cause subscale’ referring to epilepsy as a possible cause.  
 
For  the  social  outcomes  measures  we  relied  on  patient  self  reports, 
corroborated  by  relatives,  as  well  as  including  more  objective  measures  like 
employment status  and  ability  to attend  the clinic  alone. Other authors have 
used validated scales to assess social adjustment and disability like the Work 
and Social Adjustment Scale (Mundt, 2002) or the SF- 36 (Ware & Sherbourne, 
1992)  which  are  validated  instruments,  are  relatively  short  and  easy  to  use 
(Goldstein  et  al,    2004).  Using  one  of  these  scales  could  have  added  more 
rigour to our studies. 
 
We felt that health care utilisation was another important outcome to measure 
and, for the sake of clarity, we concentrated mainly on emergency contacts. The 
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important  the  savings  resulting  of  our  intervention,  relative  to  say  other 
interventions for standardised comparisons. 
 
A difficulty in choosing specific standardised measures to assess outcomes in 
the  studies  presented  in  this  thesis  is  the  fact  that  some  of  the  potentially 
relevant  factors  may  be  difficult  to  measure  using  an  existing  scale.  In  this 
context,  the  use  of  qualitative  methods  would  have  allowed  a  more 
comprehensive exploration of the impact that giving the diagnosis of PNES and 
withdrawing medication has in this group of patients. 
 
Our  assessments  were  all  quantitative  and  as  such  we  perhaps  lacked  the 
ability to conduct a more fine grained enquiry into patients’ views. It would have 
been  useful  to  elicit  patients  views  of  their  condition  and  the  impact  of  our 
intervention (AED withdrawal) and relate this to their outcome in the study.  
   
In  early  discussions  around  the  design  of  the  study  it  was  proposed  that  at 
recruitment qualitative methodology be employed to explore patient perceptions 
of the role of AED prescription and withdrawal.  Unfortunately resources were 
not available to conduct interviews and subsequent analysis along the lines of 
classical  qualitative  research.  A  more  modest  qualitative  approach  could 
perhaps  have  been  adopted  by  eliciting  the  views  of  patients  as  the  study 
progressed and then using these views as a basis for items in the baseline or 
follow up assessments of subsequent patients.  However it was felt that this 
approach,  which  would  effectively  have  meant  that  the  nature  of  the 
assessment  evolved  as  the  study  progressed,  would  have  compromised  the 
reliability and validity of our assessments.  
 
In  summary,  the  quality  of  studies  presented  in  this  thesis  could  have  been 
enhanced by the use of; the IPQ-R version, a validated scale to measure social 
adjustment, and a more comprehensive measure of health-care utilisation.  The 
use of qualitative measures would have also allowed a more fine grained and 
evocative account of the patient experience. 
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7.3. Clinical implications  
 
The findings of the body of work presented in this thesis are relevant to clinical 
practice,  since  this  research  was  conducted  in  a  real  life  clinical  setting 
comparable to most regional epilepsy services, where most patients with PNES 
are assessed and treated. 
 
Overall, it is hoped that this research raises awareness of the very serious issue 
of iatrogenic harm. Our three studies have shown that a clear diagnosis and 
consistent management of PNES results in a reduction of health-care utilisation, 
specifically a reduction of emergency services and treatment of pseudo status. 
It  is  important  to  stress  that  our  intervention  was  relatively  simple  and 
achievable and that these positive results were maintained at follow up. 
 
The study presented in chapter 4 demonstrates that AED withdrawal in patients 
with PNES is a safe clinical intervention. This paper, published by the JJNP and 
was  the  editor’s  choice  at  the  time,  has  already  proved  to  have  influenced 
scientific opinion, and continues to be referenced in many papers as the main 
evidence to guide physicians who wish to withdraw AED in a safe manner. It will 
take some time however to determine if indeed clinicians are more likely to take 
patients off AED. 
 
The results of the exploratory randomised control trial (chapter 5) also show the 
importance  of  withdrawing  medication  to  limit  iatrogenic  harm,  in  this  case, 
when compared with delayed withdrawal, a pragmatic alternative. The impact of 
the intervention can be illustrated by the experience of one of the participants; 
patient X was randomised to delayed withdrawal, she had three admissions to 
ITU in the past and had been repeatedly treated for prolonged PNES in hospital. 
For  the  first  9  months  after  the  diagnosis  she  continued  to  use  emergency 
medication for prolonged attacks and was treated on two occasions in Accident 
and  Emergency  despite  showing  a  letter  with  a  clear  explanation  of  her 
diagnosis of not epilepsy. From 9 months onwards however as she came off her 
medication  there  was  no  contact  for  emergency  services  or  use  of 
Benzodiazepines  to  treat  prolonged  events  although  she  continued  to  have 
attacks.  
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The  above  anecdotal  illustration  encapsulates  the  idea  behind  much  of  this 
thesis  research.  Underpinning  our  research  is  the  idea  that,  the  use  of 
medication  as  a  treatment  for  a  disorder  has  powerful  effects,  not  just  at  a 
physiological level but affecting patient’s behaviour and their understanding of 
their disorder.  
 
Finally,  with  the  last  paper  (chapter  6),  we  can  reassure  clinicians  that 
withdrawal of AED after the diagnosis is not only safe as a clinical intervention, 
but also does not result in a negative psychological impact. This last study also 
gives an interesting insight into the potential pitfalls of illness reattribution. As 
one of the objectives of therapy, the reattribution of PNES to stress has only 
value if it reflects a real change in locus of control and commitment to recovery. 
 
In  summary  the  work  presented  in  this  thesis  has  helped  to  establish  AED 
withdrawal as an intervention in its own right. AED withdrawal should therefore 
be included in current and future protocols of the initial management and taken 
into consideration in future treatment studies. 
 
7.3.1. PNES in the context of other medically unexplained symptoms (MUS) 
 
Medically unexplained symptoms (MUS) are common in neurology clinics and 
the overall outcome is also poor (Carson et al, 2003; Sharp et al,  2010). 
   
As pointed out by other authors, knowledge from current studies on other MUS 
could  be  a  good  source  of  information  for  the  development  of  effective 
treatments for PNES. Conversely, knowledge of PNES can also contribute to 
our understanding of other somatisation disorders. 
 
PNES  have  the  distinct  characteristic  of  having  a  sensitive  and  specific 
diagnostic  test  which  other  disorders,  like  pain  or  fatigue,  do  not  have.  The 
diagnostic  certainty  of  PNES  makes  research  on  iatrogenic  harm  or  on  the 
effects of over treatment much easier; the results however can also be applied 
to other MUS.  
  
Lessons could be learned then from the research presented in this thesis, since 
iatrogenic harm is a universal problem in medically unexplained symptoms with   136 
a majority of patients treated with multiple drugs or surgery, and, as in PNES, 
the evidence for an effective treatment is sparse (Barsky & Borus, 1999; Mayou 
et al, 2000). 
 
The research presented  in  this  thesis shows  that,  a clear explanation  and  a 
removal of a treatment intended for an erroneously diagnosed physical illness, 
greatly  reduces  iatrogenic  harm  and  has  a  positive  effect  on  psychological 
outcomes as well as reducing symptoms. 
 
If nothing else this thesis should inform physicians of what not to do. Treating 
patients  for  something  they  do  not  have  potentially  does  more  physical  and 
psychological harm than no treatment at all.  
 
7.4. Future directions  
 
There  is  no  doubt  that  further  research  on  the  management  of  PNES  is 
required,  however,  it  is  unlikely  that  any  single  intervention  beyond  the 
presentation  of  the  diagnosis  and  removal  of  AED  would  be  suitable  for  all 
patients. 
 
As a result of a workshop to discuss the development of treatment for patients 
with PNES, a three arm trial comparing regular review by neurology with CBT or 
antidepressants was proposed (LaFrance et al, 2006). To achieve the power 
necessary to detect changes in such a varied population, this would have to be 
a multi-centre trial. 
 
For a multi centre trial, however, the diagnostic accuracy of PNES would be an 
issue;  to  ensure  the  quality  of  the  diagnosis  the  gold  standard  technique  of 
video EEG would be required. As shown in this thesis, the use of video EEG is 
a factor that limits recruitment. 
 
Targeting or excluding specific subgroups of patients (for example people with a 
personality disorder, multiple other MUS, chronic symptoms) would make future 
studies easier to achieve in terms of retention and sample variance, however 
this would limit their relevance. 
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A multi-centre pragmatic trial with a study design reflecting the stepped care 
model approach seems the only way forward to conduct further research on 
management of PNES with sufficient power.  
 
Following video EEG confirmation of the diagnosis of PNES, all patients would 
be  initially  randomised  to  a  comprehensive  protocol  for  the  delivery  of  the 
diagnosis of PNES (clear and supportive explanation, basic psycho education 
and written information) or to a clear however basic explanation accompanied 
by written information, offered by the treating neurologist within the constrains of 
a general neurology clinic. For patients on AED the withdrawal of the medication 
would be immediate or delayed.. 
 
Following  this  first  phase  patients  whose  attacks  continued  would  be  re-
randomised to a course of CBT or treatment with an SSRI. The group of attack 
free patients would remain as a control group and reviewed at the end of phase 
two. 
 
Power to detect a moderate effect would be substantially diluted by the third of 
patients who seem to respond regardless of the intervention.  
 
Follow up of all patients should be at least two years long because of the often 
reported longer term deterioration of some early responders. 
 
Clinical  outcomes  should  be  attack  freedom,  health  care  utilisation  drug  and 
AED use and evidence of new physical symptom. Psychosocial outcome should 
include  measures  of;  social  functioning,  anxiety  and  depression  as  well  as 
measures reflection insight into the diagnosis of PNES and shifts of locus of 
control. Ideally an initial psychiatric screening would be also useful. 
 
The  above  study  as  well  as  researching  the  effectiveness  of  the  different 
management  interventions  would  also  allow  an  initial  exploration  of  possible 
predictors of outcome and identification of subgroups of patient which are more 
likely to respond to particular management strategies  
 
The above represents a gold standard and may not be practically achievable.  
However, there are still many unanswered questions that could be addressed   138 
through  more modest studies, further  research on; patients illness beliefs as 
well as doctors beliefs; cultural bound differences; the influence of underlying 
psychopathology or the natural course of PNES amongst others. All of these 
have  been  only  minimally  explored  and  could  increase  our  understanding  of 
PNES and help towards the design of a larger study on the management of 
PNES.  
 
Alternatively  there  may  be  some  value  in  a  complete  paradigm  shift  and 
consider PNES as one of the phenotypical expressions of somatisation as some 
authors have argued (Wessely, 2004). If we conceptualise PNES as one more 
of  the  functional  somatic  symptoms,  generic  research  including  all  medically 
unexplained symptoms could be the way forward. 
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Appendices 
 
Appendix A: Checklist for the assessment of quality of observational studies on 
the outcome of psychogenic nonepileptic seizures.  
 
1-Is  the  study  based  on  a  representative  sample  selected  from  a  relevant 
population of patients with NES 
Yes  
No   
 
2-Are the criteria for inclusion explicit  
Yes  
No  
 
3-Were patients with co-existing epilepsy excluded 
Yes  
No 
 
4-Was there an established reliable system for selecting all the cases 
Yes  
No 
 
5-Was the diagnosis of NES confirmed by video-EEG Case definition 
Yes 
No  
 
6-Did all individual entered the survey at a similar point on time in the diseases 
progression  
Yes  
No 
 
7-Was the sample size >75    
Yes  
No  
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8-Was the follow up sufficiently long to assess improvement of NES 
Yes  
No   
 
9-Were cases assessed at a similar point after the diagnosis?  
 
Yes  
No  
 
10-Was the proportion of the sample followed up >60% 
Yes  
No 
 
11-Were  all  subjects  exposed  to  the  same  intervention  or  standardised 
management  
  
Yes  
No 
12-Were the outcome measures valid and comprehensive (including other than 
attack reduction) 
Yes  
No 
 
13 Were tall the outcome measures clearly stated? 
Yes  
No 
 
14-Did the authors used  objective  measures of outcome (attack  diary, rating 
scales) ?  
 
Yes  
No 
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Appendix B: Checklist for reports of observational studies (STROBE statement) 
 
Title and abstract   a/Indicate the study design  
b/Provide an informative and balanced summary 
Introduction 
 
Background  
Objectives  
 
 
Explain scientific background and rationale 
State specific objective and prespecified hypothesis 
Methods 
 
Study design 
Settings  
Participants 
 
Variables 
 
Data 
source/measurements 
Bias 
Study size 
Quantitative variables 
  
Statistical methods  
  
Present key elements of the study  
 
 
Describe setting, location and relevant dates 
Give eligibility criteria and the source and method of data 
collection  
Define all outcomes, exposure, predictors and potential 
confounders as well as diagnostic criteria  
For each variable give sources of data and details of methods of 
assessment  
 
Describe any efforts to address potential bias  
Explain how the study size was arrived at 
Explain how quantitative variables were handled in the analysis 
a/Describe all statistical methods, including those used to control 
confounding  
b/Explain how missing data was addressed 
c/Describe methods used to examine subgroups and interactions 
 
Results 
 
Participants  
 
 
Descriptive data 
 
 
Outcome data 
Main results  
Other analysis  
 
 
a/Report number of individuals at each stage of study 
b/give reasons for none participants  
c/Consider use of a flow diagram  
a/Give characteristics if the study participants  
b/Indicate number of participants with massing data for each 
variable  
Report numbers of outcomes events or summary measures  
Give unadjusted estimates and confounder adjusted estimates  
Report other analysis done  
Discussion 
 
Key results  
Limitations 
  
Interpretation 
 
  
Generalisability  
 
 
Summarise key results with reference to study objectives  
Discuss limitations of the study, taking into account sources of 
potential bias 
Give a cautious overall interpretation of results considering 
objectives, limitations, multiplicity if analysis and results form 
similar studies  
Discuss the generalisability(external validity)of the study 
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Appendix C: Patient information sheet on PNES. 
 
NON EPILEPTIC SEIZURES – patient information  
 
 
As we discussed at the clinic you know now that the results of the test show that 
your  attacks  are  not  epileptic.  You  have  Non  Epileptic  Seizures  (NES)  or 
Pseudoseizures. 
 
Many of the people that we see in this clinic have been told that they suffer from 
an illness called epilepsy. Other people have never been given a clear answer 
at all. 
 
With this leaflet we are hoping to answer some of the questions that you may 
have about this condition. 
 
 
1-What are Non Epileptic Seizures? 
 
These are turns that look like epileptic attacks and in fact are often mistaken for 
epilepsy but, unlike epilepsy, the cause is not due to something being wrong 
with your brain  waves. These attacks  are caused  by psychological problems  
(stress, emotional problems, worries). 
 
This is not an uncommon problem. We run a clinic especially for people with 
these kind of attacks and we can see up to three new patients a week. 
 
In fact about two out of ten people who are thought to have untreatable epilepsy 
suffer from non epileptic seizures. 
 
 
2-What do you mean by a psychological or emotional cause? 
 
You may find it very difficult to understand how these attacks are caused by 
stress or to think of any causes for your turns.   143 
 
The relationship between your emotional upset or stress and the attack is not 
always straightforward 
 
Our body can show stress or distress in a very physical way. For example some 
people can be physically sick because of worry. The person is being sick but the 
cause is not due to a stomach problem but to stress. 
 
Stress and worries can build up, sometime without a person being aware of it. 
But it may build up to a point that the pressure is too much and you have an 
attack to let go off the pressure . 
We can think of these turns as a way of coping, like a pressure release valve or 
“time out”. 
 
 
3-Does that means that I am putting them on? 
 
NO 
 
These attacks are a very real problem but the root of the problem is emotional, 
not physical. 
 
The fact that there is not a physical cause for your attacks does not mean that 
you are “mad” or pretending. What it may mean is that your are more upset or 
stressed than you realise. 
 
Having these attacks can be very unpleasant and upsetting as well as making 
you day-to-day life very difficult. 
 
 
4-What makes me have these attacks? 
 
For  some  people  the  problem  is  related  to  an  unpleasant  or  traumatic 
experience  from  the  past. For others it can  be due  to  a  number of different 
problems.  
   144 
In some people it takes some time before we find the underlying problems. 
5-What about the result of the test ? 
 
Recording an attack during a Video EEG test is the best test we have for the 
diagnosis of NES. Is very accurate and we can trust the results  
  
With this test we are able to monitor your brain waves and take a video at the 
same time  
 
Your brain waves change depending if you are awake, asleep or even drowsy. 
By  looking  at  you  brain  waves  during  an  attack  we  can  tell  if  you  are 
unconscious or there is something affecting the way your brain works. 
 
The test has shown that your brain waves did not change or become epileptic 
before during or after the attacks we recorded. This confirms the diagnosis of 
Non Epileptic Seizures. 
 
6-How come I was told that I had epilepsy?  
(by doctors, nurses and paramedics) 
 
The diagnosis of your type of attacks can be difficult. Because the attacks can 
look so much like epilepsy, they are often confused and treated as epilepsy. 
 
However we now know that NES is not a rare condition. A psychological cause 
has to be considered when patients present with attacks that seem difficult to 
control with medication. 
Better tests are also available nowadays to help us with the diagnosis. 
 
7-Can Non Epileptic Seizures be treated? 
 
This kind of attack can often be successfully treated. There are a number of 
things we can do to make sure you have a good result. 
 
Some people improve just by having a clear answer and explanation for the 
attacks. Knowing what’s wrong with you is helpful in itself . 
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We  think  that  being  looked  after  by  the  same  people  is  important  for  a 
successful recovery. We will support you through the recovery process and will 
not pass you on to any other doctors.  
 
You will also be able to see one of the two psychologists on our team. They are 
experienced at helping people with your kind of attacks. 
The psychologist will help you to find the cause (s) for your attacks and will also 
help you to have control over the attacks.  
 
 
9-What can this clinic do for me? 
 
•  Give you a clear answer about the cause of you attacks  
•  Help you to gain control over the attacks  
•  Give you support 
•  Give you advice on practical matters such as driving and work 
 
 
 
 
 
 
IF YOU HAVE ANY FURTHER QUESTIONS PLEASE CONTACT DR MARIA 
OTO AT:                                      
 
                        PHONE:  
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Appendix D: Drug withdrawal protocol.  
 
Drug withdrawal protocol  
 
Withdrawal programme agreed and discussed with patient 
Patients and primary care physicians given written withdrawal programme 
Patients,  relatives  and  primary  care  physicians  instructed  to  report  any  new 
event type to the clinic 
Contact phone number supplied 
Clinical follow up at 3 monthly intervals 
Psychology treatment programme of 2-6 visits during study period 
 
Drug withdrawal schedules 
 
Phenytoin 
100mg/week till dose is 100mg/day, then 25mg per week 
Carbamazepine 
200mg/week till dose is 1000mg/day, then 100mg/week 
Sodium valproate 
500mg/week till dose is 500mg, then 200mg/week 
Vigabatrin 
500mg every 2 weeks until dose is 500mg, then 500mg alternated days for 2 
weeks 
Lamotrigine 
100mg/week till dose is 300mg, 50mg/week till dose is 50mg, then 25mg/week 
Gabapentin 
800mg/week till dose is 1200mg, then 400mg/week 
Topiramate 
100mg/week till dose is 200mg, 50mg/week till dose is 50mg, then 25mg/week 
Levetiracetam 
500mg/week till dose is 1000mg, then 250mg/week  
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145 Appendix F: CONSORT Checklist of items to include when reporting a 
randomized trial      
 
PAPER SECTION 
And topic 
Item  Description  Reporte
d on 
Page # 
TITLE & 
ABSTRACT 
1  How participants were allocated to interventions (e.g., 
"random allocation", "randomized", or "randomly 
assigned"). 
 
INTRODUCTION 
Background 
2  Scientific background and explanation of rationale.   
METHODS 
Participants 
3  Eligibility criteria for participants and the settings and 
locations where the data were collected. 
 
Interventions  4  Precise details of the interventions intended for each 
group and how and when they were actually 
administered. 
 
Objectives  5  Specific objectives and hypotheses.   
Outcomes  6  Clearly defined primary and secondary outcome 
measures and, when applicable, any methods used to 
enhance the quality of measurements (e.g., multiple 
observations, training of assessors). 
 
Sample size  7  How sample size was determined and, when 
applicable, explanation of any interim analyses and 
stopping rules. 
 
Randomization -- 
Sequence 
generation 
8  Method used to generate the random allocation 
sequence, including details of any restrictions (e.g., 
blocking, stratification) 
 
Randomization -- 
Allocation 
concealment 
9  Method used to implement the random allocation 
sequence (e.g., numbered containers or central 
telephone), clarifying whether the sequence was 
concealed until interventions were assigned. 
 
Randomization -- 
Implementation 
10  Who generated the allocation sequence, who enrolled 
participants, and who assigned participants to their 
groups. 
 
Blinding (masking)  11  Whether or not participants, those administering the 
interventions, and those assessing the outcomes were 
blinded to group assignment. When relevant, how the 
success of blinding was evaluated. 
 
Statistical 
methods 
12  Statistical methods used to compare groups for 
primary outcome(s); Methods for additional analyses, 
such as subgroup analyses and adjusted analyses. 
 
RESULTS 
Participant flow 
 
13  Flow of participants through each stage (a diagram is 
strongly recommended). Specifically, for each group 
report the numbers of participants randomly assigned, 
receiving intended treatment, completing the study 
protocol, and analyzed for the primary outcome. 
Describe protocol deviations from study as planned, 
together with reasons. 
 
Recruitment  14  Dates defining the periods of recruitment and follow-
up. 
 
Baseline data  15  Baseline demographic and clinical characteristics of 
each group. 
 
Numbers 
analyzed 
16  Number of participants (denominator) in each group 
included in each analysis and whether the analysis 
was by "intention-to-treat".   State the results in 
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Appendix G: Diagnostic criteria and diagnostic process for PNES. 
 
The  diagnostic  process  considered  not  only  the  diagnosis  of  nonepileptic 
seizures (NES) but also the diagnosis of possible coexisting epilepsy. 
 
An  initial  “provisional”  clinical  diagnosis  of  NES  was  made  following  an 
assessment  by  an  epilepsy  specialist,  based  on  witness  descriptions  of  all 
attacks and the patient account. The definite diagnose of NES was established 
following the recording of a typical attack during video EEG monitoring. 
 
The epilepsy specialist also assessed the patient for any evidence of current or 
past epilepsy (one of the exclusion criteria for the study) by reviewing clinical 
records and the reports of previous EEG and the descriptions of past attacks.     
 
To  ensure  the  accuracy  of  the  diagnosis  the  following  criteria  which  were 
agreed by the team of senior epileptiologists was applied.  
 
 
Diagnostic criteria for Epilepsy.  
 
•Reports of attacks before the age of 12 years. 
•Description of past or present attacks (by patient, eyewitness or reported in the 
notes) compatible with epileptic seizures. 
•Interictal  epileptiform  abnormalities  in  past  or  current  EEG  (as  agreed  by  a 
neurophysiologist and an epilepsy specialist) 
•Video EEG recording of any attack with associated EEG epileptic discharges. 
 
Any EEG reported as abnormal in the past this will be reviewed and reported by 
a nerophysiologyst. 
 
Diagnostic criteria for NES 
 
•Attack  descriptions  compatible  with  known  clinical  presentation  of 
pseudoseizures  (e.g.  alternating  movements,  pelvic  thrusting,  and  emotional 
content). 
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•Video  recording  of  attack  semiology  was  available  and  compatible  with 
eyewitness account.  
 
•EEG record of attack showed no modification or associated EEG abnormalities.  
 
•ECG  recording  showed  no  arrhythmia  during  the  attack  (tachycardia 
acceptable if all other features compatible with pseudoseizure). 
 
Diagnostic accuracy and diagnostic process  
 
To minimize the risk of diagnosis error at least three clinicians (two epilepsy 
specialists and a neurophysiologist) were involved in the diagnostic process and 
each clinician assessed each case independently. 
 
The definitive diagnosis depended on video EEG confirmation of the provisional 
clinical diagnosis. Until we had been able to record all types of typical events on 
video EEG, the diagnosis of NES was not given to the patients. 
 
Before  presenting  the  diagnosis  to  the  patients,  all  cases  were  routinely 
discussed  at  the  “epilepsy  team  clinical  meeting”  (attended  by  all  epilepsy 
specialist and neurophysiologists). Video recordings and EEG’s were reviewed 
at that point. 
 
In  some  cases  if  there  are  doubts  about  diagnosis  or  there  are  conflicting 
opinions from the physicians involved, patients were discussed separately at the 
NES clinical meeting. Were a more formal presentation of the case including the 
results of all past and present investigations were reviewed and a decision was 
reached by consensus of all the physicians involved...    
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Appendix H: RCT protocol. 
 
An exploratory randomised controlled trial of withdrawal of antiepileptic drugs 
(AED) in patients with PNES. 
PROTOCOL 
 
Referral process 
 
All  new  referrals  will  be  sent  an  appointment  to  attend  the  PNES  clinic.  
Subjects  will  see  the  research  assistant  for  administration  of  psychological 
measures followed by their 1st appointment with the research fellow.   
 
The appointment letter will contain a diary for the patient to prospectively record 
attack frequency prior to the PNES clinic appointment.   
 
Patient will be seen within 8 weeks of referral.   
 
The  research  assistant  will  call  all  those  referred  (with  available  telephone 
numbers) at the time of appointment allocation to collect 2-month retrospective 
information (historic attack frequency and healthcare utilisation) 
 
Screening: Pre-trial visit 
 
Psychology assistant: 
 
Administer psychological rating scales   
-NART 
-SEALS 
-HADS 
-ILLNESS PERCEPTION QUESTIONNAIRE  
   
Collect information regarding healthcare utilisation over the previous 6 months:   
-Out of hours and  emergency health contacts for PNES or other  and use of 
rescue drugs for NES 
   
First Visit (immediately after pre-trial visit)   152 
 
Patient  seen  by  the  Research  Fellow  who  will  review  medical  records  and 
gather  routine  clinical  information,  in  order  to  establish  a  provisional  clinical 
diagnosis.  The  provisional  clinical  diagnosis  will  be  one  of  the  following: 
Epilepsy or PNES or Epilepsy and PNES 
 
Group  A:    Patients  that  at  the  time  of  referral  had  the  diagnosis  of  PNES 
confirmed by Video EEG 
 
-Patient counselled and information about the trial given. 
-Patient consent ascertained. 
-Randomised to immediate or delayed withdrawal of AED: randomization will be 
by the EEG secretary using a random number list. 
-Phased withdrawal begins in immediate withdrawal group (see attached drug 
withdrawal protocol). 
-Phased withdrawal in delayed group will commence 9 months later 
-Anti-epileptic drug levels checked in both groups to monitor compliance. 
-To send a standard letter informing GP about the trial (see attached letter). 
 
Group B: Patients that following the screening visit have a provisional clinical 
diagnosis of PNES without video EEG confirmation 
 
All these patients will be referred for video EEG monitoring. Once the diagnosis 
is confirmed the same procedure as outlined for Group A takes place. 
 
TRIAL VISITS SCHEDULE 
Immediate withdrawal arm: 
 
0 months (trial visit 1) - RANDOMISATION VISIT.  Commence withdrawal of 
AED. 
 
3  months  (trial  visit  2)  -  Monitor  withdrawal  and  collect  data  on  seizure 
frequency and health care utilisation. 
 
6  months  (trial  visit  3)  -  Monitor  withdrawal  and  collect  data  on  seizure 
frequency and health care utilisation.   153 
 
9  months  (trial  visit  4)  -  Collect  data  on  seizure  frequency  and  health  care 
utilisation.  Psychological rating scales re-administered and check blood drug 
levels. 
 
12 months (trial visit 5) - Control visit.  Collect data on seizure frequency and 
health care utilisation. 
 
15 months (trial visit 6) - Control visit.  Collect data on seizure frequency and 
health care utilisation 
 
18  months  (trial  visit  7)  -  FINAL  VISIT.    Collect  data  on  seizure  frequency, 
health care utilisation and social functioning.   Psychological rating scales re-
administered. 
 
Delayed withdrawal arm:  
 
0 months (trial visit 1)- RANDOMIZATION VISIT. 
 
3 months (trial visit 2) - Control visit.  Collect  data  on seizure  frequency and 
health care utilisation. 
 
6 months (trial visit 3) - Control visit.  Collect  data  on seizure  frequency and 
health care utilisation. 
 
9 months (trial visit 4) - Commence withdrawal of AED.  Collect data on seizure 
frequency  and  health  care  utilisation.    Psychological  Rating  Scales  re-
administered and check drug blood levels.   
 
12  month  (trial  visit  5)  -  Monitor  withdrawal  and  collect  data  on  seizure 
frequency and health care utilisation. 
 
15  months  (trial  visit  6)-    Monitor  withdrawal  and  collect  data  on  seizure 
frequency and health care utilisation.   154 
18  months  (trial  visit  7)  -  FINAL  VISIT.    Collect  data  on  seizure  frequency, 
health  care  utilisation  and  social  functioning.  Psychological  rating  scales  re-
administered and check drug blood levels.   
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Appendix I: Patient consent form for RCT.  
CONSENT FORM 
 
 
 
I have read the information sheet attached for the anti-epileptic drug 
withdrawal study. 
 
I know that I do not have to take part in this study.  I am aware that if I choose 
not to take part my treatment will not be affected in any way. 
 
By signing this form I am agreeing to take part in the study.  However, I can 
withdraw from the study at any time by letting my doctor know. 
 
 
 
 
Signed_________________________________      Date__________________ 
 
 
Witness signature 
 
 
 
Signed_________________________________      Date__________________ 
 
 
CONSENT FORM 
 
 
 
I have read the information sheet attached for the anti-epileptic drug 
withdrawal study. 
 
I know that I do not have to take part in this study.  I am aware that if I choose 
not to take part my treatment will not be affected in any way. 
 
By signing this form I am agreeing to take part in the study.  However, I can 
withdraw from the study at any time by letting my doctor know. 
 
 
 
 
Signed_________________________________      Date__________________ 
 
 
Witness signature 
 
 
 
Signed_________________________________      Date__________________  
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Appendix J: Scripts for study visits.  
 
Presenting the diagnosis of NES: The same for all subjects  
 
Step 1  
Review the results of video EEG to confirm that the attacks recorded are typical 
and that all have been recorded. 
 
Step 2 
The good news:“this attacks are not epilepsy “ 
Explanation of the EEG results and emphasise the accuracy of our diagnosis  
 
Step 3  
Explain the nature of attacks: Attacks that resemble and are often confused by 
epilepsy however the cause is not an abnormal discharge of electricity in the 
brain but a result of psychological difficulties  
 
Normalise and instil hope –It is a common condition and we see and help many 
patients with this disorder 
Explanation  of  underlying  mechanism  using  the  model  of  predisposing, 
precipitating and perpetuating factors. 
 
Step 4 
Answer questions referring to our information leaflet created following  
 
Step 5 
Discuss  management  and research project and give  written information. The 
patients  information  for  the  DW  group  will  not  have  the  question  answer  of 
medication. 
 
SCRIPT FOR VISITS:  3 and 6 months 
 
AED delayed withdrawal group: 
 
1-“How are you feeling at the moment?,(asked to rate using an interval scale 
from 1-10)   157 
2- Have you had any turns since last appointment? Can I see you diary?” 
-If  there  has  been  a  reduction  of  attacks:  “this  is  very  encouraging  there  is 
already improvement in only twelve weeks, you are doing very well” 
-If  there  has  been  no  improvement,  (try  not  to  put  too  much  emphasis  on 
number  of  attacks):”At  this  stage  we  often  don’t  see  a  difference  on  the 
numbers of attacks, is OK, these can take time” 
3-“Have  you  been  taken  to  hospital,  called  an  ambulance  or  been  given 
emergency medication because of the turns since the last appointment?” 
-If  the  answer  is  no,  positive  reinforcement  particularly  to  the  carer”  That  is 
really good, this shows that things are getting better. Its very important that you 
keep away from emergency ambulances and casualty departments “ 
-If the answer is yes, go over again with patient and carer (assertive way)” It’s 
very important that you keep away from ambulances and casualty departments. 
As we discussed you will not come to any harm through the attacks and the 
best way to deal with it is to leave the person alone, you will come round in your 
own  time  any  contact  with  emergency  services  will  complicate  matters  and 
potentially make you worse it’s important that everyone understands that this is 
not epilepsy”  
4-How  do  you  feel  now  about  the  diagnosis?  Depending  on  the  degree  of 
resistance to the diagnosis at this point go over a number or all the points made 
at the initial consultation about diagnosis and cause of PNES. 
5-Have you any new problems since I last saw you? Are you on any new drugs? 
(if new physical complaint ,record but do not show too much interest) 6-Have 
you got any questions for me? 
7-I will see you in X months time, but get in touch before if there is a problem. 
Make sure that you keep your diary up to date. 
 
AED immediate withdrawal group: 
 
1-Hour are you, feeling? ,(asked to rate using an interval scale from 1-10) 
2-How are you getting on with the reduction of the medication, any problems? 
Find out current medication and give written instructions of further reduction. 
3-Have you had any turns since the last appointment? Can I see your diary?” 
-If  there  has  been  a  reduction  of  attacks:”  this  is  very  encouraging  there  is 
already an improvement in only twelve weeks, you are doing very well”   158 
-If  there  has  been  no  improvement,  (try  not  to  put  too  much  emphasis  on 
number  of  attacks):”At  this  stage  we  often  don’t  see  a  difference  on  the 
numbers of attacks, is OK, these can take time” 
4-Have  you  been  taken  to  hospital,  called  an  ambulance  or  been  given 
emergency medication because of the turns since the last appointment?” 
-If  the  answer  is  no,  positive  reinforcement  particularly  to  the  carer”  That  is 
really good, this shows that things are getting better. Is very important that you 
keep away from emergency ambulances and casualty departments “ 
-If the answer is yes, go over again with patient and carer (assertive way)” Its 
very important that you keep away from emergency ambulances and casualty 
departments.  As  we  discussed  you  will  not  come  to  any  harm  through  the 
attacks and the best way to deal with it is to leave the person alone, you will 
come  round  in  your  own  time  Any  contact  with  emergency  services  will 
complicate matters and potentially make you worse Its important that everyone 
understands that this is not epilepsy”  
5-How  do  you  feel  about  the  diagnosis  now?    Depending  on  the  degree  of 
resistance to the diagnosis at this point go over a number of all the points made 
at  the first consultation about diagnosis and cause of NES . 
6-Have  you  any  new  problems  since  I  last  saw  you?  Are  you  on  any  new 
medication? (if any new physical complaint ,record but do not show too much 
interest) 
7-Have you any other questions? 
8-I will see you in X months time, but get in touch before if there is a problem. 
Make sure that you keep you diary up to date. 
 
SCRIPT FOR VISIT: 9 months 
 
Delayed withdrawal group 
1-How are you feeling? ,(asked to rate using an interval scale from 1-10) 
2-As we discussed this visit will be longer since we would like  you to complete 
the questionnaires again .At this important stage of you treatment we need to 
assess your progress by collecting all this information again and compare it with 
your previous results .We will also repeat the blood tests . 
3-I will also ask you to start withdrawing the tablets from now on. We will take 
you off one medicine at a time gradually following this protocol. I will give you   159 
written instructions on how to reduce the tablets. Do you have any worries about 
coming off medication at this point (if yes answer questions and reassure) 
4-Have you had any turns since last appointment? Can I see you diary?” 
If  there  has  been  a  reduction  of  attacks:”this  is  very  encouraging  there  is 
already an improvement in only four weeks, you are doing very well” 
If there has been no improvement, (try not to put too much emphasis on number 
of attacks):”At  this stage  we often  don’t see  a difference  on  the  numbers of 
attacks, is OK, this can take time” 
5-Have  you  been  taken  to  hospital,  called  an  ambulance  or  been  given 
emergency medication because the turns since last appointment?” 
If the answer is no, positive reinforcement particularly to the carer” That is really 
good this shows that things are getting better. Is very important that you keep 
away from emergency ambulances and casualty departments “ 
If the answer is yes, go over again with patient and carer (assertive way)” Is 
very important that you keep away from emergency ambulances and casualty 
departments.  As  we  discussed  you  will  not  come  of  any  harm  through  the 
attacks and the best way to deal with it is to leave the person alone, you will 
come  round  in  your  own  time  any  contact  with  emergency  services  will 
complicate matters and potentially make you worse Is important that everyone 
understands that this is not epilepsy”  
6-How  do  you  feel  now  about  the  diagnosis?  Depending  on  the  degree  of 
resistance to the diagnosis at this point go over a number or all the points made 
at the first consultation about diagnosis and cause of PNES . 
7-Have you had any new problems/symptoms since I last saw you? Are on any 
new medication?  
8-Have you got any other questions? 
9-I will see you in X month’s time, but get in touch before if a new problem 
arises. Make sure that you keep you diary up to date. 
 
Immediate withdrawal group 
 
1-How are you feeling? ,(asked to rate using an interval scale from 1-10) 
2-As we discussed this visit will be longer since we would like  you to complete 
the questionnaires again .At this important stage of you treatment we need to 
assess your progress by collecting all this information again and compare it with 
your previous results .We will also repeat the blood tests .   160 
3-You have now been of the tablets for sometime, any problems? 
4-Have you had any turns since last appointment? Can I see you diary?” 
If  there  has  been  a  reduction  of  attacks:”this  is  very  encouraging  there  is 
already an improvement in only four weeks, you are doing very well” 
If there has been no improvement, (try not to put too much emphasis on number 
of attacks):”At  this stage  we often  don’t see  a difference  on  the  numbers of 
attacks, is OK, this things take time” 
5-Have  you  been  taken  to  hospital,  called  an  ambulance  or  seen  you  GP 
because the turns since last appointment?” 
If the answer is no, positive reinforcement particularly to the carer” That is really 
good this shows that things are getting better. Is very important that you keep 
away from emergency ambulances and casualty departments “ 
If the answer is yes, go over again with patient and carer (assertive way)” Is 
very important that you keep away from emergency ambulances and casualty 
departments.  As  we  discussed  you  will  not  come  of  any  harm  through  the 
attacks and the best way to deal with it is to leave the person alone, you will 
come  round  in  your  own  time  Any  contact  with  emergency  services  will 
complicate matters and potentially make you worse Is important that everyone 
understands that this is not epilepsy”  
6-How  do  you  feel  now  about  the  diagnosis?  Depending  on  the  degree  of 
resistance to the diagnosis at this point go over a number or all the points made 
at the first consultation about diagnosis and cause of NES. 
7-Have  you  had  any  new  problems  since  I  last  saw  you?  Are  on  any  new 
medication?  (if  new  physical  complaint  ,record  but  do  not  show  too  much 
interest) 
8-Have you any other questions? 
9-I will see you in X month’s time, but get in touch before if there is a problem. 
Make sure that you keep you diary up to date. 
 
VISITS AT 12 AND 15 MONTHS FROM DIAGNOSIS 
Repeat the same script of visits at 3 and 6 months. 
 
FINAL VISIT at 18 months  
 
Same format as visit at 9 months also discuss discharge or need for further 
follow up.   161 
Appendix K: Patient information sheet about RCT. 
 
  
Information Sheet 
 
The tests that you have had show that your attacks are not due to epilepsy.  
They also show that your brain is working normally during the attacks, which 
means that the attacks have an emotional cause. 
 
This kind of attack can often be treated successfully, and there are a number of 
things we do to make sure that you have a good result.   
 
We think it is sensible to withdraw your anti-epileptic medication, but we do not 
know whether this in itself is beneficial to your type of attacks.   
 
We are carrying out a study to measure the effects of this, and would like you to 
participate. 
 
We divide our patients into: 
 
1.  Those who come off medication straight away and 
2.  Those who stay on their medication for 9 months, and then come off of it.   
 
If you agree to take part you will go into one or other group.   
 
The group you go into will be chosen by chance.   
 
Your treatment programme will otherwise be exactly the same. 
 
 
 
You should be clear that you are entirely free not to take part in this study, and if 
you  do  not  then  your  treatment  will  not  be  affected  in  any  way.    The  same 
applies if you find you want to withdraw from the study part way through it: all 
you have to do is let your doctor know. 
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Appendix L: Hospital Anxiety and Depression Scale (HADS) 
 
H A D Scale 
Read each item and place a tick in the box opposite the reply which comes closest to how you 
have been feeling in the past week. 
Don’t take too long over your replies:  your immediate reaction to each item will probably be 
more accurate than a long thought-out response. 
Tick only one box in each section 
 
2.  I still enjoy the things I used to enjoy 
Definitely as much. . . . . . . . . . . . .    
Not quite as much. . . . . . . . . . . . .   
Only a little. . . . . . . . . . . . . . . . . .   
Hardly at all . . . . . . . . . . . . . . . . .   
 
3.  I get a sort of frightened feeling as if 
     something awful is about to happen 
Very definitely and quite badly . . .   
Yes, but not too badly  . . . . . . . . .    
Time to Time, Occasionally  . . . . .   
Not at all  . . . . . . . . . . . . . . . . . . .   
 
4.  I can laugh and see the funny side of 
     things 
As much as I always could  . . . . . .   
Not quite so much now . . . . . . . . .   
Definitely not so much now  . . . . .    
Not at all  . . . . . . . . . . . . . . . . . . .   
 
5.  Worrying thoughts go through my mind 
A great deal of the time  . . . . . . . .   
A lot of the time . . . . . . . . . . . . . .   
From time to time but not too often   
Only occasionally . . . . . . . . . . . . .   
 
6.  I feel cheerful 
Not at all  . . . . . . . . . . . . . . . . . . .    
Not often . . . . . . . . . . . . . . . . . . .   
Sometimes . . . . . . . . . . . . . . . . . .   
Most of the time  . . . . . . . . . . . . .    
 
7.  I can sit at ease and feel relaxed 
Definitely . . . . . . . . . . . . . . . . . . .   
Usually . . . . . . . . . . . . . . . . . . . . .    
Not Often . . . . . . . . . . . . . . . . . . .   
Not at all  . . . . . . . . . . . . . . . . . . .   
 
1.  I feel tense or “wound up” 
Most of the time . . . . . . . . . . . . . .   
A lot of the time . . . . . . . . . . . . . .   
Time to Time, Occasionally . . . . .   
Not at all . . . . . . . . . . . . . . . . . . .   
8.  I feel as if I am slowed down 
Nearly all the time . . . . . . . . . . . . . .    
Very often  . . . . . . . . . . . . . . . . . . .   
Sometimes  . . . . . . . . . . . . . . . . . . .   
Not at all   . . . . . . . . . . . . . . . . . . . .   
 
9.  I get a sort of frightened feeling like      
     butterflies in the stomach 
Not at all  . . . . . . . . . . . . . . . . . . . .   
Occasionally . . . . . . . . . . . . . . . . . .   
Quite often . . . . . . . . . . . . . . . . . . .   
Very often  . . . . . . . . . . . . . . . . . . .   
 
10.  I have lost interest in my appearance 
Definitely   . . . . . . . . . . . . . . . . . . .   
I don’t take so much care as I should   
I may not take quite as much care . .    
I take just as much care as ever . . . .   
 
11.  I feel restless as if I have to be on the 
       move 
Very much indeed . . . . . . . . . . . . .    
Quite a lot. . . . . . . . . . . . . . . . . . .   
Not very much. . . . . . . . . . . . . . . .    
Not at all   . . . . . . . . . . . . . . . . . . .   
 
12.  I look forward with enjoyment to 
       things 
As much as ever I did . . . . . . . . . .    
Rather less than I used to . . . . . . .   
Definitely less than I used to . . . . .   
Hardly at all  . . . . . . . . . . . . . . . . .    
 
13.  I get sudden feeling of panic 
Very often indeed . . . . . . . . . . . . .    
Quite often . . . . . . . . . . . . . . . . . .   
Not very often  . . . . . . . . . . . . . . .    
Not at all  . . . . . . . . . . . . . . . . . . .   
 
14.  I can enjoy a good book or radio or 
      TV programme 
Often   . . . . . . . . . . . . . . . . . . . . .   
Sometimes . . . . . . . . . . . . . . . . . .   
Not Often. . . . . . . . . . . . . . . . . . .   
Very seldom . . . . . . . . . . . . . . . . .    
  For Office use only: 
Total odd = Ax _______      Total even = De _______ 
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Appendix M: SEALS questionnaire. 
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Appendix N: IPQ 
 
 
 
 
   167 
   168 
 
   169 
 
 
   170 
Appendix O: Attack diary 
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